Sentence,class,file
"To view a copy of this license, visit http://creativecommons.org/   licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/f1/3e/mtm201611.PMC5008245.pdf
"To view a copy of this license, visit http://   creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy— Oncolytics  website (http://www.nature.com/mto)",Non-OADS,/arxiv_data1/oa_pdf/c0/7c/mto20165.PMC5008254.pdf
"To view a copy of this license, visit http:// creativecommons.org/ licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy— Oncolytics  website (http://www.nature.com/mto)",Non-OADS,/arxiv_data1/oa_pdf/2d/66/mto20162.PMC5008257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2016:7 89–99Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  89 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S109587Victimization, polyvictimization, and health in  Swedish adolescents Nikolas Aho   Marie Proczkowska- Björklund   Carl Göran Svedin Division of Child and Adolescent  Psychiatry, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenAbstract:  The main objective of this article was to study the relationship between the differ - ent areas of victimization (eg, sexual victimization) and psychological symptoms, taking into  account the full range of victimization domains.",Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
"Studies using extensive  standardized questionnaires with representative samples of children in the US from birth to age 17 years show that a majority (60.6%) experienced a victimization in the Correspondence: Nikolas Aho   Division of Child and Adolescent  Psychiatry, Department of Clinical and Experimental Medicine, Linköping University, SE-581 85 Linköping, Sweden Tel +46 76 319 7068   Email nikolas.aho@liu.seJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Aho et alRunning head recto: Relationship between areas of victimization and psychological symptomsDOI: http://dx.doi.org/10.2147/AHMT.S109587",Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
Available from: http://undocs.org/A/RES/55/25.,OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
Available from: http://www.skolverket.se/polopoly_fs/1.179241!/Menu/article/attachment/SVUS-Original-2012-EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
Available from: http://siris.skolverket.se/apex/ris.elever_gy.rapport?p_ar= 2007&p_lan_ kod=.,OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
Available from: http://www.statistikdata- basen.scb.se/pxweb/en/ssd/START__BE__BE0101__BE0101A/BefolkningNy/?rxid=4b8e9cf8-9fed-433a-ae03-7d90b7491038.,OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
"Adolescent Health, Medicine and Therapeutics 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/47/ahmt-7-089.PMC5008259.pdf
"To view a copy of this license, visit http://   creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy— Oncolytics  website (http://www.nature.com/mto)",Non-OADS,/arxiv_data1/oa_pdf/cc/44/mto201610.PMC5008268.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 273–279Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 273 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S109007 Prevalence and determinants of metabolic  syndrome: a cross-sectional survey of general  medical outpatient clinics using National  Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana Bernard Omech1  Jose-Gaby Tshikuka2  Julius C Mwita1  Billy Tsima2  Oathokwa Nkomazana3  Kennedy Amone-P’Olak4 1Department of Internal Medicine,   2Department of Family Medicine  and Public Health, 3Department of  Surgery, 4Department of Psychology,   University of Botswana, Gaborone,   BotswanaBackground: Low- and middle-income countries, including Botswana, are facing rising preva- lence of obesity and obesity-related cardiometabolic complications.",Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
"1  Metabolic syndrome is associated with an excess risk of atherosclerotic CVDs and type 2 diabetes mellitus 2 and variable complications of nonalcoholic fatty liver diseases  and obstructive sleep apnea.3,4 Although its pathogenesis is incompletely understood, Correspondence: Bernard Omech   Department of Internal Medicine,  University of Botswana, Private Bag UB 00713 Gaborone, Botswana   Tel +267 3 55 4915   Email bgomech@gmail.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Omech et alRunning head recto: Prevalence and determinants of metabolic syndromeDOI: http://dx.doi.org/10.2147/DMSO.S109007",Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 279 Prevalence and determinants of metabolic syndrome  11.,Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
Available from: http://edition.cnn.com/2010/WORLD/africa/10/12/mauritania.force.feed/.,Non-OADS,/arxiv_data1/oa_pdf/c7/29/dmso-9-273.PMC5008444.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/e8/copd-11-2029.PMC5008445.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2029–2034International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2029OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10449 0 highly absorptive curcumin reduces serum  atherosclerotic low-density lipoprotein levels  in patients with mild COPD Masafumi Funamoto1,2 Y oichi sunagawa1–3 Yasufumi Katanasaka1–3 Yusuke Miyazaki1,2 atsushi Imaizumi4 hideaki Kakeya5 hajime Yamakage2 noriko satoh-asahara2 Maki Komiyama2 hiromichi Wada2 Koji hasegawa2 Tatsuya Morimoto1–3 1Division of Molecular Medicine,   school of Pharmaceutical sciences,   University of shizuoka, shizuoka,   2Clinical research Institute, national  hospital Organization Kyoto  Medical Center, Kyoto, 3shizuoka  general hospital, shizuoka,   4Theravalues Corporation, Kioicho,   T okyo, 5Department of system  Chemotherapy and Molecular  sciences, Division of Bioinformatics  and Chemical genomics, graduate  school of Pharmaceutical sciences,   Kyoto University, Kyoto, JapanPurpose:  COPD is mainly caused by tobacco smoking and is associated with a high frequency of  coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/1e/e8/copd-11-2029.PMC5008445.pdf
"Keywords:  curcumin, AT-LDL, COPD, atherosclerosis Introduction COPD is a lifestyle-related disease of the lungs that is primarily caused by regular  smoking.1 It is an inflammatory disease associated with damage to the alveolar septa  and increased levels of inflammatory mediators, such as C-reactive protein (CRP),  interleukin-6, interleukin-1 β, and tumor necrosis factor- α (TNF-α) in the lung  periphery.2 This local inflammation in the lungs spills into the systemic circulation,  where it causes systemic inflammation.3 Research has suggested that the systemic  effects of COPD can also cause comorbidities, such as cardiovascular diseases.3,4  Thus, COPD has attracted attention as a systemic disease.3,5 The systemic inflammation of COPD is suggested to be involved in the pathogenesis  of ischemic heart diseases and arteriosclerosis.6 Several reports demonstrated that  athosclerotic plaques in COPD patients show a low-grade inflammation similar to Correspondence: Tatsuya Morimoto Division of Molecular Medicine, school of  Pharmaceutical sciences, University  of shizuoka, 52-1 Yada, suruga-ku,  shizuoka 422-8526, Japan Tel +81 54 264 5763 Fax +81 54 264 5744 email morimoto@u-shizuoka-ken.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Funamoto et al Running head recto: Curcumin reduces atherosclerotic LDL in mild COPD subjects DOI: http://dx.doi.org/10.2147/COPD.S104490",Non-OADS,/arxiv_data1/oa_pdf/1e/e8/copd-11-2029.PMC5008445.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1e/e8/copd-11-2029.PMC5008445.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/e8/copd-11-2029.PMC5008445.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 427–433ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  427 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S96616Targeting improved patient outcomes using  innovative product listing agreements: a survey of  Canadian and international key opinion leaders Melissa Thompson1 Chris Henshall2 Louis P Garrison3 Adrian D Griffin4 Doug Coyle2,5 Stephen Long6 Zayna A Khayat7 Dana L Anger1 Rebecca Yu8 1Cornerstone Research Group Inc.,   Burlington, ON, Canada; 2Health  Economics Research Group, Brunel  University London, London UK;   3Pharmaceutical Outcomes Research  and Policy Program, School of Pharmacy, University of Washington,  Seattle, WA,  USA;  4Government  Affairs & Policy, Johnson & Johnson,  High Wycombe, UK;  5School of  Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada;   6Health and Life Sciences, Global  Public Affairs, Calgary, AB, 7Health  Systems Innovation at MaRS Discovery District, T oronto, ON,  Canada;  8Strategic Health T echnology  Assessment, Government Affairs & Market Access, Janssen Inc., T oronto,  ON, CanadaObjectives:  To address the uncertainty associated with procuring pharmaceutical products,  product listing agreements (PLAs) are increasingly being used to support responsible funding  decisions in Canada and elsewhere.",Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
"3 However, in a time of high Correspondence: Dana L Anger Cornerstone Research Group Inc., 204‑3228 South Service Road, Burlington, ON L7N 3H8, CanadaTel +1 905 637 6231 ext 232Fax +1 905 637 5014Email danger@cornerstone‑research.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Thompson et alRunning head recto: Canadian product listing agreement surveyDOI: http://dx.doi.org/10.2147/CEOR.S96616",Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics‑and‑outcomes‑research‑journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 433 Canadian product listing agreement survey References  1.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available from: http://eprints.lse.ac.uk/50513.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available from: http://www.ehfg.org/fileadmin/ehfg/Website/Archiv/2011/Presentations/F6/f6-s1-Henshall.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available from: https://secure.cihi.ca/free_products/Prescribed%20Drug%20Spending%20in%20Canada_2014_EN.pdf.,OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available from: http://www.hc-sc.gc.ca/hcs-sss/pharma/acces/index-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available  from: https://www.cadth.ca/about-cadth/what-we-do/products-services/cdr.,OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available from: https://www.cadth.ca/about-cadth/what-we-do/products-services/cdr.,OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
Available from: http://www.pmprovincesterritoires.ca/en/initiatives/358-pan-canadian-pharmaceutical-alliance.,Non-OADS,/arxiv_data1/oa_pdf/df/11/ceor-8-427.PMC5008446.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1149–1157Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1149OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10807 2 Polypharmacy in older adults with human  immunodeficiency virus infection compared  with the general population Mercedes gimeno-gracia1 María José Crusells- Canales2 Francisco Javier Armesto- gómez3 Vicente Compaired-T urlán4 María José rabanaque- hernández5 1Pharmacy Department, lozano  Blesa University Clinical hospital,   Aragon Institute for Health Research,   2Department of Infectious Diseases,   Aragon Institute for Health Research,   lozano Blesa University Clinical  hospital, 3Pharmacy Department,   Aragon health service, 4Pharmacy  Department, lozano Blesa University  Clinical hospital, 5Department of  Public Health, University of Zaragoza,   Zaragoza, SpainBackground:  The percentage of older HIV -positive patients is growing, with an increase in  age-related comorbidities and concomitant medication.",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"This is mainly due to  increased life expectancy as a result of effective antiretroviral therapy (ART)1,2  and, in Spain, there is an increase in the percentage of patients diagnosed at an  older age.3 The introduction of highly active ART has changed the face of HIV  infection by considerably reducing morbidity and mortality, improving quality of Correspondence: Mercedes gimeno- gracia Pharmacy Department, lozano Blesa  University Clinical hospital, C/san Juan  Bosco, 50009, Zaragoza, Spain Tel +34 650 547 519 Fax +34 976 558 095 email mgimenogrsalud@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gimeno-Gracia et al Running head recto: Polypharmacy in HIV -positive older adults DOI: http://dx.doi.org/10.2147/CIA.S108072",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"Available from: https://www.msssi.gob.es/ ciudadanos/enfLesiones/enfTransmisibles/sida/docs/informeEvalu - acion30Agosto2013.pd f. Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"Available from: http://www.msssi.gob.es/ ciudadanos/enfLesiones/enfTransmisibles/sida/publicaciones/profSani - tarios/docEdadAvanzadaVIH.pd f. Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/ AdultandAdolescentGL.pd f. Accessed January 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
Available from:  http://www.whocc.no/atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"Available from:  http://www.gesida-seimc.org/contenidos/guiasclinicas/2015/gesida- guiasclinicas-2015-InfeccionesOportunistasyCoinfeccionesVIH.pd f.  Accessed February 1, 2016.",OADS,/arxiv_data1/oa_pdf/5d/d0/cia-11-1149.PMC5008447.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/fa/copd-11-2009.PMC5008448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2009–2015International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2009OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11377 4 The objective evaluation of obstructive pulmonary  diseases with spirometry sevket Ozkaya1 adem Dirican2 Tibel T una3 1Department of Pulmonary Medicine,   Faculty of Medicine, Bahçes ¸ehir  University, Istanbul, 2Department  of Pulmonary Medicine, samsun  Medical Park hospital, 3Department  of Pulmonary Medicine, samsun  Chest Diseases and Thoracic surgery  hospital, samsun, T urkeyAbstract:  Airway obstruction is variable in asthma, while it is progressive and persistent in chronic  bronchitis and emphysema.",Non-OADS,/arxiv_data1/oa_pdf/6c/fa/copd-11-2009.PMC5008448.pdf
"Although such patients are commonly described as “asthmatic Correspondence: sevket Ozkaya Cıragan Caddesi, Osmanpasa Mektebi  Sokak No 4–6, 34349 Beşiktaş,  Istanbul, Turkey Tel +90 532 474 1309 email ozkayasevket@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ozkaya et al Running head recto: Objective evaluation of obstructive pulmonary diseases DOI: http://dx.doi.org/10.2147/COPD.S113774",Non-OADS,/arxiv_data1/oa_pdf/6c/fa/copd-11-2009.PMC5008448.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6c/fa/copd-11-2009.PMC5008448.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/fa/copd-11-2009.PMC5008448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/dc/dddt-10-2691.PMC5008449.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2691–2699Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2691Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10571 8 Ticagrelor promotes atherosclerotic plaque  stability in a mouse model of advanced  atherosclerosis Michael r Preusch1 Jonas rusnak1 Kathrin staudacher2 carolin Mogler3 lorenz Uhlmann4 Philipp sievers1 Florian Bea1 hugo a Katus1 erwin Blessing1 ingo staudacher1 1Department of internal  Medicine iii, 2Department of  neonatology, 3Department of  Pathology, 4institute of Medical  Biometry and informatics, University  of heidelberg, heidelberg, germanyObjective:  There is increasing evidence supporting the role of platelets in atherosclerotic  vascular disease.",Non-OADS,/arxiv_data1/oa_pdf/df/dc/dddt-10-2691.PMC5008449.pdf
"In vitro studies demonstrate that platelets adhere to intact  but activated endothelium as an initial step in atherogenesis.1 Platelet-induced alterations  of the endothelium support chemotaxis, adhesion, and transmigration of monocytes into correspondence: Michael r Preusch Department of internal Medicine iii –   cardiology, angiology, and Pneumology,  University of heidelberg, University  hospital, heidelberg 69120, germany Tel +49 06221 568 611 Fax +49 06221 567 638 email michael.preusch@med.uni- heidelberg.d e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Preusch et al Running head recto: Ticagrelor and advanced atherosclerosis DOI: http://dx.doi.org/10.2147/DDDT.S105718",Non-OADS,/arxiv_data1/oa_pdf/df/dc/dddt-10-2691.PMC5008449.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/df/dc/dddt-10-2691.PMC5008449.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/dc/dddt-10-2691.PMC5008449.pdf
"Literature Review The literature search was performed with the PubMed search engine of the National Library of Medicine of the National Institutes of Health (http://www.ncbi.nlm.nih.gov/pubmed), using the following keywords: ‘‘bronchiogenic cyst’’; ‘‘intradural extramedullary bronchiogenic cyst’’; ‘‘intradural bronchiogenic cyst’’; ‘‘spinal bronchiogenic cyst’’; ‘‘spinalbronchogenic cyst’’; ‘‘neurenetric cyst’’; ‘‘endodermal cyst’’;‘‘enterdermal cyst’’; ‘‘respiratory’’; ‘‘spinal cord tumor’’.",Non-OADS,/arxiv_data1/oa_pdf/90/43/medi-94-e2039.PMC5008474.pdf
Available from http://tcr.cph.ntu.edu.tw/main.php?Page ¼N2.,Non-OADS,/arxiv_data1/oa_pdf/4c/50/medi-94-e2080.PMC5008479.pdf
"Taiwan, Available from http://nhird.nhri.org.tw/en.",Non-OADS,/arxiv_data1/oa_pdf/4c/50/medi-94-e2080.PMC5008479.pdf
Registered household populations increased by 295.9 thousands in the past year in Shenzhen http://news.sina.com.cn/c/2013-01-22/063926090624.shtml.,Non-OADS,/arxiv_data1/oa_pdf/aa/52/medi-94-e2103.PMC5008480.pdf
"The exact search strategy for PubMed is listed in the Supplementary S1,http://links.lww.com/MD/A559, and search strategies for other databases were similar.",OADS,/arxiv_data1/oa_pdf/86/b4/medi-94-e2176.PMC5008490.pdf
"Severe side effects (RR ¼0.52; 95%CI, 0.36–0.74; P¼0.0003; I2¼0%) and withdrawal due to BCG toxicity (RR ¼0.49; 95%CI, 0.26–0.91; P¼0.02) were also significantly lower in the low-dose arm (Figure 4).Regarding local side effects, there was no significant difference in overall local side effects (RR ¼0.74; 95%CI, 0.73–1.08; P¼0.24; I2¼76%), hematuria (RR ¼0.57; 95%CI, 0.28–1.15; P¼0.12; I2¼87%), and cystitis (RR¼0.65; 95%CI, 0.27–1.59; P¼0.35; I2¼96%), while the frequency was significantly lower in the low-dose arm (RR¼0.62; 95%CI, 0.41–0.95; P¼0.03; I2¼83%) (Figure 4 and Supplementary Figure 1, http://links.lww.com/MD/A560).Concerning systemic side effects, a significant difference was found in overall side effects (RR ¼0.57; 95%CI, 0.34–0.97; P¼0.04; I2¼70%), fever (RR ¼0.47; 95%CI, 0.32–0.68; P<0.0001; I2¼48%), and malaise (RR ¼0.63; 95%CI, 0.44– 0.92; P¼0.02; I2¼50%) (Figure 4 and Supplementary Figure 2, http://links.lww.com/MD/A560).",Non-OADS,/arxiv_data1/oa_pdf/86/b4/medi-94-e2176.PMC5008490.pdf
"No significant evidence of publi- cation bias for primary outcome was detected based on funnelplots (Supplementary Figure 3, http://links.lww.com/MD/ A560).",OADS,/arxiv_data1/oa_pdf/86/b4/medi-94-e2176.PMC5008490.pdf
"Available from http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evi-dence-march-2009/.Medicine /C15Volume 94, Number 49, December 2015 Bacillus Calmette-Guerin for Bladder Cancer Copyright #2015 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/86/b4/medi-94-e2176.PMC5008490.pdf
2011; Available from http://handbook.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/86/b4/medi-94-e2176.PMC5008490.pdf
"In the explanted livers,the histological evidence of necrosis of the larger bile ducts inthe hilar region is particularly worth mentioning (Supplement 1, http://links.lww.com/MD/A550).",Non-OADS,/arxiv_data1/oa_pdf/a2/e0/medi-94-e2188.PMC5008492.pdf
http://www.cosmin.nl/images/upload/File/COSMINchecklistmanualv9.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/65/medi-94-e2191.PMC5008494.pdf
"All variables, definitions, and inclusion criteria in NCD/ Japan are accessible on the NCD website (http://www.ncd.or.jp/).",OADS,/arxiv_data1/oa_pdf/4b/8e/medi-94-e2194.PMC5008495.pdf
"The results are listed in Table 1 of the Supple-mental Data, http://links.lww.com/MD/A563.",OADS,/arxiv_data1/oa_pdf/4b/7a/medi-94-e2211.PMC5008501.pdf
"The resultsare listed in Table 2 of the Supplemental Data, http://links.lww.com/MD/A563.",OADS,/arxiv_data1/oa_pdf/4b/7a/medi-94-e2211.PMC5008501.pdf
"Quality Control Quality control (QC) from the manufacturer (VigilTM Protein control level 1– level 3: 450120, 450125, 450130,VigilTMSerology control level 1–level 3: 450162, 450163, 450164) and the mini-panel of 5 sera were measured every batch.When QC fell in allowable limits, the measurement of samplewill continue (see Table 2 in the Supplemental Data, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/4b/7a/medi-94-e2211.PMC5008501.pdf
"The within- and between-day CVsfor all analytes, listed in Table 2 of the Supplemental Data,http://links.lww.com/MD/A563, did not exceed the desirable limits reported in the Westgard website.",OADS,/arxiv_data1/oa_pdf/4b/7a/medi-94-e2211.PMC5008501.pdf
"Furthermore, the effect of miR-204 to reduce the proportion of SP cells was only abrogated by the supplementation of Sam68-ORF, http://links.lww.com/MD/A552.",Non-OADS,/arxiv_data1/oa_pdf/72/66/medi-94-e2228.PMC5008509.pdf
"Additional details can be found in the OnlineSupplementary File, http://links.lww.com/MD/A553.",Non-OADS,/arxiv_data1/oa_pdf/ad/40/medi-94-e2244.PMC5008514.pdf
"2, http://links.lww.com/MD/A554).",Non-OADS,/arxiv_data1/oa_pdf/ad/40/medi-94-e2244.PMC5008514.pdf
"Correlation of MTAP Homozygous Deletion and Promoter Hypermethylation WithImmunoexpression As shown in Table S1, http://links.lww.com/MD/A553, the presence of either MTAP homozygous deletion or promoter hypermethylation had a strong correlation to the loss of proteinexpression ( P<0.001) in 14 selected NPC samples.",OADS,/arxiv_data1/oa_pdf/49/92/medi-94-e2271.PMC5008521.pdf
Retrieved from http://www.uptodate.com/home/index.html.,Non-OADS,/arxiv_data1/oa_pdf/85/57/medi-94-e2283.PMC5008522.pdf
Medicine (2016) 95:35(e3857)Received: 15 January 2016 / Received in ﬁnal form: 13 March 2016 / Accepted: 26 April 2016 http://dx.doi.org/10.1097/MD.0000000000003857Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ab/5a/medi-95-e3857.PMC5008527.pdf
"Three genotypes ofrs1801131 (A1298C) were detected: AA (204, 29, 28, 22bp), AC (234, 204, 29, 28, 22bp), and CC (234, 29, 22bp) (Supplemental Table 1, http://links.lww.com/MD/B207).",OADS,/arxiv_data1/oa_pdf/ab/5a/medi-95-e3857.PMC5008527.pdf
"Theother 3 SNPs without any restriction enzyme sites, rs3744028, rs1055129, and rs1135889, were genotyped using pyrosequenc- ing on the PyroMark Q24 MDx platform (Qiagen, Valencia, CA)(Supplemental Table 1, http://links.lww.com/MD/B207).",OADS,/arxiv_data1/oa_pdf/ab/5a/medi-95-e3857.PMC5008527.pdf
"First, each SNP was separately assessed for deviation from the Hardy –Weinberg equilibrium in cases and controls using an exact test as implemented in the Finetti program (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl).",OADS,/arxiv_data1/oa_pdf/ab/5a/medi-95-e3857.PMC5008527.pdf
"These inconsistent ﬁndings may mainly result from ethnic differences (Supplemental Table 2, http://links.lww.com/MD/B207).",Non-OADS,/arxiv_data1/oa_pdf/ab/5a/medi-95-e3857.PMC5008527.pdf
"Another possibility may be the low prevalence of rs1801131 in China (Supplemental Table 2, http://links.lww.com/MD/B207).",Non-OADS,/arxiv_data1/oa_pdf/ab/5a/medi-95-e3857.PMC5008527.pdf
Medicine (2016) 95:35(e4057)Received: 28 January 2016 / Received in ﬁnal form: 23 April 2016 / Accepted: 26 May 2016 http://dx.doi.org/10.1097/MD.0000000000004057Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d2/e6/medi-95-e4057.PMC5008528.pdf
Available at: http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/d2/e6/medi-95-e4057.PMC5008528.pdf
Medicine (2016) 95:35(e4143)Received: 21 October 2015 / Received in ﬁnal form: 3 June 2016 / Accepted: 13 June 2016 http://dx.doi.org/10.1097/MD.0000000000004143Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"1, http://links.lww.com/MD/B196, which shows the ﬂow diagram for the selection of study subjects).",Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"[22,23](The detailed methods of data preparation are provided as a SupplementalContent 1, http://links.lww.com/MD/B196.)",Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"These algorithms are brie ﬂy explained in Supplemental Content 1, http://links.lww.com/MD/B196.",Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"[26] To select the best models in 3 datasets, we applied the ROC Convex Hull (ROCCH) method[27,28](see Supplemental Con- tent 1, http://links.lww.com/MD/B196, which provides furtherexplanation).",Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"Characteristics of participants Baseline characteristics of populations are presented in Tables 1 and 2 and Supplementary Table 1, http://links.lww.com/MD/ B196.",OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"To arrive at theﬁnal set, the 4 subsets were reviewed to choose the variables that were observed at least in 2 subsets; therefore, 20, 13, and 20 variables were selected to include in the model building process for men, women, and the total population, respectively (seeSupplementary Table 2, http://links.lww.com/MD/B196, which shows the list of selected variables for model building).",Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"variables for females were selected for including in the DT analysis (Supplementary Table 2, http://links.lww.com/MD/B196).",OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
"2, http://links.lww.com/MD/B196).",Non-OADS,/arxiv_data1/oa_pdf/46/05/medi-95-e4143.PMC5008529.pdf
Medicine (2016) 95:35(e4234)Received: 23 February 2016 / Received in ﬁnal form: 6 June 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004234Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c0/00/medi-95-e4234.PMC5008530.pdf
Medicine (2016) 95:35(e4320)Received: 20 March 2016 / Received in ﬁnal form: 10 June 2016 / Accepted: 16 June 2016 http://dx.doi.org/10.1097/MD.0000000000004320Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/11/de/medi-95-e4320.PMC5008531.pdf
Medicine (2016) 95:35(e4389)Received: 26 January 2016 / Received in ﬁnal form: 11 June 2016 / Accepted: 21 June 2016http://dx.doi.org/10.1097/MD.0000000000004389Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
The validatedtargets were extracted from the Herbal Ingredients ’Targets Database [26](http://lifecenter.sgst.cn/hit/).,OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
"The predicted targets were obtained using ChemMapper[27](http://lilab.ecust.edu.cn/ chemmapper/), an online tool for predicting targets based on 3D similarity.",OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
"The baselines of the patient demographics were equal between patients with and without CHM treatment (Table S1,http://links.lww.com/MD/B218).",OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
"Candidate genes associated with gastric adenocarcinoma A total of 338 genes differentially expressed or harboring genetic variations in gastric adenocarcinoma were obtained from theGEO database after removing redundant entries (Table S2, http://links.lww.com/MD/B218) and categorized according to different functions using ClueGO (Table S3, http://links.lww.com/MD/ B218).",OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
"The number of ingredients, the serial number of each ingredient, DL values,and number of validated/predicted targets are shown in Table S4, http://links.lww.com/MD/B218.",OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
"The detailed target information for the ingredients is shown in Table S5, http://links.lww.com/MD/B218.",Non-OADS,/arxiv_data1/oa_pdf/67/c1/medi-95-e4389.PMC5008533.pdf
Medicine (2016) 95:35(e4425)Received: 13 August 2015 / Received in ﬁnal form: 30 May 2016 / Accepted: 1 July 2016 http://dx.doi.org/10.1097/MD.0000000000004425Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9f/43/medi-95-e4425.PMC5008534.pdf
Medicine (2016) 95:35(e4437)Received: 4 May 2016 / Received in ﬁnal form: 14 June 2016 / Accepted: 20 June 2016 http://dx.doi.org/10.1097/MD.0000000000004437Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6b/a2/medi-95-e4437.PMC5008535.pdf
Medicine (2016) 95:35(e4461)Received: 16 March 2016 / Received in ﬁnal form: 5 July 2016 / Accepted: 9 July 2016 http://dx.doi.org/10.1097/MD.0000000000004461Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/03/9f/medi-95-e4461.PMC5008538.pdf
Medicine (2016) 95:35(e4472)Received: 11 April 2016 / Received in ﬁnal form: 18 June 2016 / Accepted: 11 July 2016 http://dx.doi.org/10.1097/MD.0000000000004472Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/18/c6/medi-95-e4472.PMC5008539.pdf
Follow-up to UNSCEAR 2013 Report on Fukushima-Daiichi accident.http://www.unscear.org/docs/reports/2015/Fukushima_WP2015_web_ en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/c6/medi-95-e4472.PMC5008539.pdf
https://www.pref.fukushima.lg.jp/uploaded/attachment/129301.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/c6/medi-95-e4472.PMC5008539.pdf
http://fmu-global.jp/survey/proceedings-of-the-22nd-prefectural-oversight-committee-meeting-for-fukushima-health-management-survey/.,OADS,/arxiv_data1/oa_pdf/18/c6/medi-95-e4472.PMC5008539.pdf
Medicine (2016) 95:35(e4494)Received: 18 April 2016 / Received in ﬁnal form: 5 July 2016 / Accepted: 11 July 2016 http://dx.doi.org/10.1097/MD.0000000000004494Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/66/0c/medi-95-e4494.PMC5008543.pdf
Medicine (2016) 95:35(e4530)Received: 21 October 2015 / Received in ﬁnal form: 23 May 2016 / Accepted: 14 July 2016 http://dx.doi.org/10.1097/MD.0000000000004530Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0d/cc/medi-95-e4530.PMC5008547.pdf
Medicine (2016) 95:35(e4535)Received: 19 February 2016 / Received in ﬁnal form: 13 June 2016 / Accepted: 15 July 2016 http://dx.doi.org/10.1097/MD.0000000000004535Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4d/c1/medi-95-e4535.PMC5008548.pdf
Medicine (2016) 95:35(e4551)Received: 8 May 2016 / Received in ﬁnal form: 30 June 2016 / Accepted: 15 July 2016 http://dx.doi.org/10.1097/MD.0000000000004551Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/da/2f/medi-95-e4551.PMC5008549.pdf
"Results A total of 535 patients newly diagnosed with HCC were included in this study; patient characteristics are summarized in Table S1,http://links.lww.com/MD/B186.",Non-OADS,/arxiv_data1/oa_pdf/da/2f/medi-95-e4551.PMC5008549.pdf
"Age (hazard ratio [HR], 1.053; 95% con ﬁdence interval [CI], 1.035 –1.071; P<0.001) and the longest diameters of tumors (HR, 1.516; 95% CI: 1.092 –2.105; P=0.013) were independent predictors associated with poor survival (Table S2, http://links.lww.com/MD/B186).",Non-OADS,/arxiv_data1/oa_pdf/da/2f/medi-95-e4551.PMC5008549.pdf
"Child-Pugh score (HR, 1.149; 95% CI, 1.032 –1.279; P=0.011) and the longest diameter of tumors (HR, 1.302; 95% CI:1.054 –1.608; P=0.014) were independent predictors for rapid progression (Table S3, http://links.lww.com/MD/B186).",Non-OADS,/arxiv_data1/oa_pdf/da/2f/medi-95-e4551.PMC5008549.pdf
Medicine (2016) 95:35(e4578)Received: 21 April 2016 / Received in ﬁnal form: 21 June 2016 / Accepted: 8 July 2016 http://dx.doi.org/10.1097/MD.0000000000004578Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/23/ff/medi-95-e4578.PMC5008551.pdf
"These results were not changed even when we used a narrower age categorization of 5- year spans for adults and 1-year spans for children/adolescents(Supplemental Table 2, http://links.lww.com/MD/B248).Intakes of total daily energy and nutrients in US-born and foreign-born adults are presented in Table 5.",Non-OADS,/arxiv_data1/oa_pdf/23/ff/medi-95-e4578.PMC5008551.pdf
Available at: http://www.cdc.gov/nchs/nhanes.htm.,Non-OADS,/arxiv_data1/oa_pdf/23/ff/medi-95-e4578.PMC5008551.pdf
Available at: http://www.cdc.gov/nchs/nhanes/irba98.htm.,Non-OADS,/arxiv_data1/oa_pdf/23/ff/medi-95-e4578.PMC5008551.pdf
Available at: http://www.cdc.gov/nchs/nhanes/response_rates_cps.htm.,OADS,/arxiv_data1/oa_pdf/23/ff/medi-95-e4578.PMC5008551.pdf
Available at:http://www.ars.usda.gov/Services/docs.htm?docid=7710.,Non-OADS,/arxiv_data1/oa_pdf/23/ff/medi-95-e4578.PMC5008551.pdf
Medicine (2016) 95:35(e4582)Received: 5 April 2016 / Received in ﬁnal form: 8 June 2016 / Accepted: 15 July 2016 http://dx.doi.org/10.1097/MD.0000000000004582Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
"The frequency of each component in the diagnostic criteria of MetS was ranged from 8% (blood pressurecriteria) to 46% (HDL cholesterol criteria) (Supplemental Table 1, http://links.lww.com/MD/B220).",Non-OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
"In the univariate analysis using the Cox proportional hazards model, the presence of MetS, postpartum BMI, physical activity at the last postpartum evaluation, fasting plasma glucose during pregnancy, and insulin treatment during pregnancy weresigniﬁcantly associated with development of T2DM (see Supplemental Table 2, http://links.lww.com/MD/B220, which shows the results of univariate analysis of risk factors).",Non-OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
"However, the statistical signiﬁcance disappeared after adjustment for metabolic param- eters (see Supplemental Table 3, http://links.lww.com/MD/B220,which shows the result of multivariate analysis with MetS as acontinuous variable).",Non-OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
"In multivariate analysis, triglyceride and fasting plasma glucosecriteria were still signi ﬁcantly associated with T2DM (Supple- mental Table 4, http://links.lww.com/MD/B220).",Non-OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
"1, http://links.lww.com/MD/B220,which shows the Matsuda index and disposition index in subgroups).",OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
"However,clinical and laboratory parameters, including the prevalence ofMetS, age at delivery, and postpartum BMI, were similar between the groups with or without long-term follow-up (see Supplemen- tal Table 5, http://links.lww.com/MD/B220, which shows similarcharacteristics between the 2 groups).",Non-OADS,/arxiv_data1/oa_pdf/ff/08/medi-95-e4582.PMC5008552.pdf
Medicine (2016) 95:35(e4586)Received: 2 March 2016 / Received in ﬁnal form: 22 July 2016 / Accepted: 22 July 2016 http://dx.doi.org/10.1097/MD.0000000000004586Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/medi-95-e4586.PMC5008554.pdf
Medicine (2016) 95:35(e4587)Received: 14 March 2016 / Received in ﬁnal form: 30 June 2016 / Accepted: 25 July 2016 http://dx.doi.org/10.1097/MD.0000000000004587Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/82/52/medi-95-e4587.PMC5008555.pdf
"3 and Supplementary Table 1, http://links.lww.com/MD/ B240).",Non-OADS,/arxiv_data1/oa_pdf/82/52/medi-95-e4587.PMC5008555.pdf
Medicine (2016) 95:35(e4590)Received: 17 February 2016 / Received in ﬁnal form: 11 July 2016 / Accepted: 22 July 2016 http://dx.doi.org/10.1097/MD.0000000000004590Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/60/9a/medi-95-e4590.PMC5008556.pdf
"The promoter regions of the MC4R andHNF4 agenes were ampli ﬁed by a primer set designed using the PSQ Assay Design software (Biotage AB, Uppsala, Sweden) (Supplemental DigitalContent-Table S1, http://links.lww.com/MD/B242).",Non-OADS,/arxiv_data1/oa_pdf/60/9a/medi-95-e4590.PMC5008556.pdf
"The 4 CpG sites in the P1promoter region are located up to 88 to 115bp, and the 4 CpG sites in the P2 promoter region are located up to 44,903 to 44,920bp upstream of the TSS (Supplemental Digital Content-Figure S1 and Table S3, http://links.lww.com/MD/B242).",Non-OADS,/arxiv_data1/oa_pdf/60/9a/medi-95-e4590.PMC5008556.pdf
"Primer sets and melting temperature for quantitative real-time PCR are describedin Supplemental Digital Content-Table S2, http://links.lww.com/MD/B242.",Non-OADS,/arxiv_data1/oa_pdf/60/9a/medi-95-e4590.PMC5008556.pdf
"In addition, the median methylation status of HNF4 aat 4 CpG sites in the P1 promoter was signi ﬁcantly lower in cord blood cells of preterm infants ( P<0.01), whereas the methylation status of the CpG sites within the P2 promoter wassimilar between the 2 groups (Supplemental Digital Content- Table S4, http://links.lww.com/MD/B242).",Non-OADS,/arxiv_data1/oa_pdf/60/9a/medi-95-e4590.PMC5008556.pdf
"The MC4R and HNF4 apromoter regions contain putative binding sites for transcription factors, including C/EBP alpha and SP1, which are involvedintheregulationoflipidmetabolism(SupplementalDigital Content-Figure S1, http://links.lww.com/MD/B242).",Non-OADS,/arxiv_data1/oa_pdf/60/9a/medi-95-e4590.PMC5008556.pdf
Medicine (2016) 95:35(e4594)Received: 7 April 2016 / Received in ﬁnal form: 1 July 2016 / Accepted: 24 July 2016 http://dx.doi.org/10.1097/MD.0000000000004594Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8f/0b/medi-95-e4594.PMC5008558.pdf
Completed questionnaires and clinical data were collected and entered into the electronic case report form (CRF) at the Korean HCV cohort studygroup homepage (http://www.hcvcohort.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/8f/0b/medi-95-e4594.PMC5008558.pdf
Medicine (2016) 95:35(e4596)Received: 13 July 2016 / Received in ﬁnal form: 20 July 2016 / Accepted: 25 July 2016 http://dx.doi.org/10.1097/MD.0000000000004596Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/00/b8/medi-95-e4596.PMC5008559.pdf
Medicine (2016) 95:35(e4614)Received: 14 March 2016 / Received in ﬁnal form: 15 July 2016 / Accepted: 27 July 2016 http://dx.doi.org/10.1097/MD.0000000000004614Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/88/b7/medi-95-e4614.PMC5008562.pdf
Medicine (2016) 95:35(e4623)Received: 28 June 2016 / Received in ﬁnal form: 27 July 2016 / Accepted: 27 July 2016 http://dx.doi.org/10.1097/MD.0000000000004623Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6e/23/medi-95-e4623.PMC5008565.pdf
Medicine (2016) 95:35(e4637)Received: 1 April 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 1 August 2016 http://dx.doi.org/10.1097/MD.0000000000004637Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e9/59/medi-95-e4637.PMC5008567.pdf
Medicine (2016) 95:35(e4643)Received: 11 May 2016 / Received in ﬁnal form: 29 July 2016 / Accepted: 1 August 2016 http://dx.doi.org/10.1097/MD.0000000000004643Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/60/76/medi-95-e4643.PMC5008568.pdf
Medicine (2016) 95:35(e4651)Received: 22 February 2016 / Received in ﬁnal form: 1 July 2016 / Accepted: 2 August 2016 http://dx.doi.org/10.1097/MD.0000000000004651Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cd/39/medi-95-e4651.PMC5008570.pdf
Medicine (2016) 95:35(e4671)Received: 27 March 2016 / Received in ﬁnal form: 6 July 2016 / Accepted: 21 July 2016 http://dx.doi.org/10.1097/MD.0000000000004671Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/35/96/medi-95-e4671.PMC5008575.pdf
"Search terms included MeSH terms and free texts [e.g., (prenatal OR antenatal OR gestational OR maternal) AND (infection ORchorioamnionitis OR febrile) AND (asthma OR wheeze OReczema)] (search strategy see in sTable 1, http://links.lww.com/ MD/B228 and sTable 2, http://links.lww.com/MD/B228).",Non-OADS,/arxiv_data1/oa_pdf/35/96/medi-95-e4671.PMC5008575.pdf
"A ﬂow diagram of study selection is presented in the supplemental data (PRISMA 2009 Flow Diagram, http://links.lww.com/MD/B228).",OADS,/arxiv_data1/oa_pdf/35/96/medi-95-e4671.PMC5008575.pdf
"eligible studies was moderate to high (sTable 3, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/35/96/medi-95-e4671.PMC5008575.pdf
(2011) Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/35/96/medi-95-e4671.PMC5008575.pdf
Medicine (2016) 95:35(e4672)Received: 28 May 2016 / Received in ﬁnal form: 19 July 2016 / Accepted: 31 July 2016 http://dx.doi.org/10.1097/MD.0000000000004672Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/96/74/medi-95-e4672.PMC5008576.pdf
Medicine (2016) 95:35(e4679)Received: 18 March 2016 / Received in ﬁnal form: 20 July 2016 / Accepted: 28 July 2016 http://dx.doi.org/10.1097/MD.0000000000004679Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4d/ee/medi-95-e4679.PMC5008579.pdf
Medicine (2016) 95:35(e4684)Received: 15 January 2016 / Received in ﬁnal form: 24 July 2016 / Accepted: 3 August 2016 http://dx.doi.org/10.1097/MD.0000000000004684Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4684.PMC5008580.pdf
Medicine (2016) 95:35(e4694)Received: 25 May 2016 / Received in ﬁnal form: 13 July 2016 / Accepted: 3 August 2016 http://dx.doi.org/10.1097/MD.0000000000004694Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
"Results of sensitivity analyses The results of the generalized linear model with clustering care facilities were similar to those of model 2 (Supplemental Digital Content 1, http://links.lww.com/MD/B236).",OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
"The results of all themodels, except for mortality, showed signi ﬁcant relationships between indwelling urethral catheter use and longer LOS and higher TC (logLOS: bivariate analysis: 0.09 [0.06 –0.12] P< 0.001, RA model: 0.08 [0.05 –0.11] P<0.001, PS match mode: 0.06 [0.02 –0.10] P=0.007, PS strati ﬁcation model 0.08 [0.05 –0.11] P<0.001, logTC: bivariate analysis: 0.15 [0.12 –0.17] P<0.001, RA model: 0.14 [0.11 –0.16] P<0.001, PS match model: 0.16 [0.12 –0.19] P<0.001, and PS strati ﬁca- tion model: 0.14 [0.11 –0.17] P<0.001) (Supplemental Digital Content 2, http://links.lww.com/MD/B236).4.",Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
Available at: http://www.stat.go.jp/data/topics/ topi900.htm.,OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/4003185.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
Guideline for prevention of catheter-associatedurinary tract infections 2009. http://www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009 ﬁnal.pdf 2009:1-67. doi:10.1086/651091.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
(http://www2.huhp.hokudai.ac.jp/ ∼ict-w/kansen/3.02_nyoudour yuuticatheter.pdf (in Japanese)):1 –9.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
http://www.kansensho.or.jp/ sisetunai/kosyu/pdf/qa_all.pdf (in Japanese) 2006.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
http://www.fukuoka-kouki.jp/img/medical_expenses_h25_5.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
Available at: http://www.dartmouthatlas.org/ keyissues/issue.aspx?con=2940.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/medi-95-e4694.PMC5008582.pdf
Medicine (2016) 95:35(e4695)Received: 5 July 2016 / Received in ﬁnal form: 2 August 2016 / Accepted: 2 August 2016 http://dx.doi.org/10.1097/MD.0000000000004695Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fc/06/medi-95-e4695.PMC5008583.pdf
"All software parameters analyzed are shown in R script (See in Supplement File, http://links.lww.com/MD/ B221 ).",OADS,/arxiv_data1/oa_pdf/fc/06/medi-95-e4695.PMC5008583.pdf
Medicine (2016) 95:35(e4699)Received: 3 July 2016 / Received in ﬁnal form: 21 July 2016 / Accepted: 22 July 2016 http://dx.doi.org/10.1097/MD.0000000000004699Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9f/77/medi-95-e4699.PMC5008584.pdf
Medicine (2016) 95:35(e4701)Received: 8 April 2016 / Received in ﬁnal form: 27 July 2016 / Accepted: 27 July 2016 http://dx.doi.org/10.1097/MD.0000000000004701Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4a/98/medi-95-e4701.PMC5008585.pdf
Available at: https://en.wikipedia.org/w/index.php?title=Earplug&oldid=728038666.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/medi-95-e4701.PMC5008585.pdf
Available at: https://en.wikipedia.org/w/index.php?title=Polyurethane&oldid=729335321.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/medi-95-e4701.PMC5008585.pdf
Medicine (2016) 95:35(e4702)Received: 8 April 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 28 July 2016 http://dx.doi.org/10.1097/MD.0000000000004702Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7d/2e/medi-95-e4702.PMC5008586.pdf
"The area under the receiver operating characteristic (ROC) curve according toADC thresholds (550 /C210–6, 600/C210–6, 650/C210–6, and 700 /C2 10–6mm2/s) for predicting clinical outcome was quite similar (supplement Table and Figure, http://links.lww.com/MD/B238).",OADS,/arxiv_data1/oa_pdf/7d/2e/medi-95-e4702.PMC5008586.pdf
Medicine (2016) 95:35(e4703)Received: 1 July 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 29 July 2016 http://dx.doi.org/10.1097/MD.0000000000004703Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/02/5e/medi-95-e4703.PMC5008587.pdf
"Methods This study was approved by the Institutional Review Board at Seoul National University Bundang Hospital (Seongnam-si, South Korea, approval on December 15, 2015, B-1512/326- 301), this observational study was registered in the ClinicalResearch Information Service (CRiS, http://cris.nih.go.kr, KCT0001749).",Non-OADS,/arxiv_data1/oa_pdf/02/5e/medi-95-e4703.PMC5008587.pdf
Medicine (2016) 95:35(e4705) Received: 14 June 2016 / Received in ﬁnal form: 2 August 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004705Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/medi-95-e4705.PMC5008588.pdf
Medicine (2016) 95:35(e4706)Received: 12 January 2016 / Received in ﬁnal form: 2 August 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004706Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/58/b0/medi-95-e4706.PMC5008589.pdf
Medicine (2016) 95:35(e4707)Received: 22 December 2015 / Received in ﬁnal form: 4 August 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004707Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4a/89/medi-95-e4707.PMC5008590.pdf
Medicine (2016) 95:35(e4708)Received: 7 April 2016 / Received in ﬁnal form: 2 August 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004708Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/71/67/medi-95-e4708.PMC5008591.pdf
"Independent risk factors associated with MRSA, P aeruginosa , and CfRE are shown in Table 4, con ﬁrming the associations observed in the univariable analyses for P aeruginosa and CfRE (see Supplemental Tables 1 through 4 for the univariate analyses,http://links.lww.com/MD/B237).",Non-OADS,/arxiv_data1/oa_pdf/71/67/medi-95-e4708.PMC5008591.pdf
Available at: http://ncipd.org/control/images/NCIPD_docs/CLSI_M100-S24.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/67/medi-95-e4708.PMC5008591.pdf
Medicine (2016) 95:35(e4715)Received: 8 June 2016 / Received in ﬁnal form: 3 August 2016 / Accepted: 3 August 2016 http://dx.doi.org/10.1097/MD.0000000000004715Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7f/cc/medi-95-e4715.PMC5008593.pdf
Medicine (2016) 95:35(e4719)Received: 2 April 2016 / Received in ﬁnal form: 21 July 2016 / Accepted: 3 August 2016 http://dx.doi.org/10.1097/MD.0000000000004719Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/82/fa/medi-95-e4719.PMC5008594.pdf
7132209; http://www.bjnsf.org/nsf_xmsq/nsf_zzxm/).,Non-OADS,/arxiv_data1/oa_pdf/e5/00/medi-95-e4730.PMC5008598.pdf
Medicine (2016) 95:35(e4730)Received: 13 January 2016 / Received in ﬁnal form: 30 July 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004730Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e5/00/medi-95-e4730.PMC5008598.pdf
"In the present study, female patients with higher BMIs showed higher serum total cholesterol levels (Tables S1 and S2, http://links.lww.com/MD/B231).",Non-OADS,/arxiv_data1/oa_pdf/e5/00/medi-95-e4730.PMC5008598.pdf
Medicine (2016) 95:35(e4742)Received: 22 May 2016 / Received in ﬁnal form: 22 July 2016 / Accepted: 5 August 2016 http://dx.doi.org/10.1097/MD.0000000000004742Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/05/65/medi-95-e4742.PMC5008603.pdf
"[13] To date, 5189 CYP19A1 polymorphisms have been identi ﬁed (http://www.ncbi.nlm.nih.gov/snp, accessed: December 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/05/65/medi-95-e4742.PMC5008603.pdf
"Two CYP19A1 and 2 APOE e4polymorphisms sites were selected using publicdatabases (http://www.ncbi.n lm.nih.gov/snp/), including CYP19A1 rs1065778 and rs3751592 and APOE e4 rs429358 and rs7412 .",OADS,/arxiv_data1/oa_pdf/05/65/medi-95-e4742.PMC5008603.pdf
"Acknowledgment The authors would like to thank Editage (http://online.editage.cn/ dashboard) for English language editing.References [1] Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/05/65/medi-95-e4742.PMC5008603.pdf
Medicine (2016) 95:35(e4743)Received: 22 May 2016 / Received in ﬁnal form: 4 August 2016 / Accepted: 5 August 2016 http://dx.doi.org/10.1097/MD.0000000000004743Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7d/8f/medi-95-e4743.PMC5008604.pdf
Medicine (2016) 95:35(e4749)Received: 3 June 2016 / Received in ﬁnal form: 18 July 2016 / Accepted: 8 August 2016 http://dx.doi.org/10.1097/MD.0000000000004749Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
In: British and World English ; 2015. http://www.oxforddictionaries.com/de ﬁnition/english/ sleep.,Non-OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
"Washington, DC: National Academies Press (US); 2006. http://www.ncbi.nlm.nih.gov/books/NBK19960/.Accessed January 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
"Unhealthy Sleep-Related Behaviors, Morbidity and Mortality Weekly Report; 2011. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6008a2.htm.",Non-OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
"Effect of Short Sleep Duration on Daily Activities, Morbidity and Mortality Weekly Report; 2011. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6008a3.htm.",Non-OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
https://data.gov.sg/dataset/mobile-penetration-rate/ resource/26e9766b-a42d-468c-9c25-88d89b850823/view/3fed45d7-7f86-4422-872a-e6d0a0154b06.,OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
Census of Population 2010Statistical Release 2: Households and Housing; 2015. http://www.singstat.gov.sg/publications/publications-and-papers/cop2010/census10_ stat_release2.,OADS,/arxiv_data1/oa_pdf/9f/e8/medi-95-e4749.PMC5008607.pdf
Medicine (2016) 95:35(e4750)Received: 13 May 2016 / Received in ﬁnal form: 12 July 2016 / Accepted: 8 August 2016 http://dx.doi.org/10.1097/MD.0000000000004750Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
"Search strategies, study selection, and data extraction PubMed/MEDLINE (i.e., Medical Literature Analysis and Retrieval System Online) was searched (April 13, 2016) using search terms generated by adding the key words to Falck-Ytterﬁlter, [7]as described in the Online Supplementary Methods, http://links.lww.com/MD/B235.",OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
"This was the case for the results in all groupssubjected to subgroup analysis (Table S1, http://links.lww.com/ MD/B235).",Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
"of femur length, the formulas of Campbell, Hadlock, and Shepard, or uterine artery blood ﬂow ( P=0.18, 0.15, or 0.53, respectively) (Figure S1, http://links.lww.com/MD/B235).",Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
"This meta-analysis involved 38,601 participants in 16 counties in Asia, Europe, Latin America, the Middle East, North America, and Oceania by including 7, 4, 4, and 5 articlesevaluating crown –rump and femur lengths; the formulas of Campbell, Hadlock, and Shepard; and uterine artery blood ﬂow, respectively (Table 1 and Online Supplementary Results, http://links.lww.com/MD/B235).",OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
"As statistical signi ﬁcance in differences of sensitivity or speci ﬁcity depending on possible cofounders may have been due to a threshold effect (i.e., ecological fallacy), it is also unclear whether possible cofounders were truly confounders.Based on the slope of funnel plots (Figure S1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
"2).However, the present meta-analysis had some limitations, including extrapolation of the results to groups that were notsubjected to subgroup or meta-regression analysis, for example, Africa versus other regions, males versus females, full-term versus preterm births, and intrauterine growth retardation versus allnewborns except those with intrauterine growth retardation(Table S1, http://links.lww.com/MD/B235).",Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
2016. http://www.who.int/nutrition/topics/feto_maternal/en/.,Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
2008. http://fmwww.bc.edu/repec/bocode/m/meta ndi_postestimation.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
2009. http://fmwww.bc.edu/repec/bocode/m/mi das.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/52/medi-95-e4750.PMC5008608.pdf
Medicine (2016) 95:35(e4751)Received: 6 March 2016 / Received in ﬁnal form: 19 July 2016 / Accepted: 8 August 2016 http://dx.doi.org/10.1097/MD.0000000000004751Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/24/d3/medi-95-e4751.PMC5008609.pdf
Medicine (2016) 95:35(e4752)Received: 19 April 2016 / Received in ﬁnal form: 8 August 2016 / Accepted: 9 August 2016 http://dx.doi.org/10.1097/MD.0000000000004752Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ef/13/medi-95-e4752.PMC5008610.pdf
Medicine (2016) 95:35(e4753)Received: 26 December 2015 / Received in ﬁnal form: 26 July 2016 / Accepted: 9 August 2016 http://dx.doi.org/10.1097/MD.0000000000004753Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6a/4e/medi-95-e4753.PMC5008611.pdf
"; 2011 (Available from: http://www.goldstandardsframework.org.uk/cd-content/uploads/ ﬁles/General%20Files/Prognostic%20Indicator% 20Guidance%20October%202011.pdf) [Accessed July 18, 2016].",Non-OADS,/arxiv_data1/oa_pdf/6a/4e/medi-95-e4753.PMC5008611.pdf
Medicine (2016) 95:35(e4761)Received: 24 May 2016 / Received in ﬁnal form: 8 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004761Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b8/b8/medi-95-e4761.PMC5008613.pdf
Medicine (2016) 95:35(e4769)Received: 4 August 2016 / Received in ﬁnal form: 6 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004769Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/13/83/medi-95-e4769.PMC5008615.pdf
Medicine (2016) 95:35(e4777)Received: 21 February 2016 / Received in ﬁnal form: 29 July 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004777Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9d/09/medi-95-e4777.PMC5008616.pdf
Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford_web.ppt.,Non-OADS,/arxiv_data1/oa_pdf/9d/09/medi-95-e4777.PMC5008616.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/33/ppa-10-1639.PMC5008635.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1639–1645Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1639OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11346 6 Impact of fixed orthodontic appliance or   clear-aligner on daily performance, in adult  patients with moderate need for treatment Feiou lin1 linjie Yao2 chandradev Bhikoo1 Jing guo3 1Department of Orthodontics,   2Department of Pedodontics, school  of stomatology, Wenzhou Medical  University, Wenzhou, 3Department  of Orthodontics, school and hospital  of stomatology, shandong University,   Jinan, People’s republic of chinaObjective:  To assess the impact of wearing fixed orthodontic appliance (FOA) or clear-aligner,  on daily performance in adult patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/33/ppa-10-1639.PMC5008635.pdf
"Ceramic bracket, lingual bracket, and clear-aligner have been invented to  improve esthetics during treatment.5,6 Over the past few decades, researchers have developed a questionnaire on oral  health-related quality of life (OHRQoL) to evaluate orthodontic treatment needs and  outcomes.7 Discomfort and concern with a fixed orthodontic appliance (FOA) will  affect the attitudes and compliance of patients with therapy.8–10 Understanding the  discomfort associated with and consequences of wearing an orthodontic appliance in correspondence: Jing guo Department of Orthodontics, school  and hospital of stomatology, shandong  University, no 44-1 Wenhua West  road, Jinan 250012, shandong, People’s  republic of china Tel +86 531 8838 2070 email guojing@sdu.edu.c n Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lin et al Running head recto: Impacts of FOA and clear-aligner on daily performance DOI: http://dx.doi.org/10.2147/PPA.S113466",Non-OADS,/arxiv_data1/oa_pdf/9d/33/ppa-10-1639.PMC5008635.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9d/33/ppa-10-1639.PMC5008635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2016:9 145–154Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 145 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S111170Historical cohort study examining comparative  effectiveness of albuterol inhalers with and  without integrated dose counter for patients with  asthma or chronic obstructive pulmonary disease David B Price1,2 Anna Rigazio2 Mary Buatti Small3 Thomas J Ferro3 1Academic Primary Care, Institute of  Applied Health Sciences, University of  Aberdeen, Aberdeen, UK; 2Research  in Real-Life Ltd, Cambridge, UK; 3Tev a  Pharmaceuticals, Frazer, PA, USABackground: Using a metered-dose inhaler (MDI) beyond the labeled number of actuations  may result in inadequate dosing of medication, which can lead to poor clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
"In one study, only 8% of patients reported counting the number of actuations Correspondence: David B Price Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UKTel +44 1224 554 588Fax +44 1224 550 683Email dprice@rirl.orgJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Price et alRunning head recto: Albuterol dose counter in asthma and COPDDOI: http://dx.doi.org/10.2147/JAA.S111170",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
"Journal of Asthma and Allergy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
Available from: http://www.lung.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/5b/jaa-9-145.PMC5008637.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/18/ppa-10-1647.PMC5008638.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1647–1656Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1647OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10952 0 self-reported quality of life in multiple sclerosis  patients: preliminary results based on the Polish  Ms registry Waldemar Brola1 Piotr sobolewski2 Małgorzata Fudala1 Stanisław Flaga3 Konrad Jantarski4 Danuta Ryglewicz5 Andrzej Potemkowski6 1Department of n eurology, specialist  Hospital, Końskie, 2Department of  neurology, holy spirit specialist  Hospital, Sandomierz, 3Agh  University of science and T echnology,   Krakow, 4Swietokrzyski Regional  Branch of the Polish national health  Fund (n FZ), Kielce, 5First Department  of neurology, institute of Psychiatry  and neurology, Warsaw, 6Department  of Psychology, University of Szczecin,   Szczecin, PolandBackground:  The aim of the study was to analyze selected clinical and sociodemographic  factors and their effects on the quality of life (QoL) of multiple sclerosis (MS) patients registered  in the Polish MS Registry.",Non-OADS,/arxiv_data1/oa_pdf/cb/18/ppa-10-1647.PMC5008638.pdf
"Keywords:  multiple sclerosis, patient-reported outcomes, quality of life, Poland Introduction Multiple sclerosis (MS) is a progressive, inflammatory demyelinating disease of the  central nervous system and represents one of the major causes of neurological dis - ability in young people.1 The estimated prevalence of MS in Europe over the past three  decades is 83 cases per 100,000 people, with higher rates in northern countries, and  the mean annual incidence is 4.3 per 100,000 people.2,3 The number of MS patients  worldwide exceeds 2.3 million of whom approximately 600,000 live in Europe.1–3 It is  estimated that there are 40,000–50,000 such patients in Poland, while the prevalence  of MS is estimated to be between 37 and 91 cases per 100,000 citizens.4 In Poland, no correspondence: Waldemar Brola Department of neurology, specialist  Hospital, ul Gimnazjalna 41B, 26-200  Konskie, Poland Tel +48 60 131 3415 Fax +48 41 390 2364 email wbrola@wp.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Brola et al Running head recto: Self-reported quality of life in MS patients DOI: http://dx.doi.org/10.2147/PPA.S109520",Non-OADS,/arxiv_data1/oa_pdf/cb/18/ppa-10-1647.PMC5008638.pdf
"Methods The survey was conducted in several dozen neurological  centers in Poland, dealing with the treatment of MS. study design All relevant data were gathered via the web portal of the  Rejestr Chorych na Stwardnienie Rozsiane ([Registry of  Multiple Sclerosis Patients] RejSM) ( http://www.rejsm.p l).",OADS,/arxiv_data1/oa_pdf/cb/18/ppa-10-1647.PMC5008638.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cb/18/ppa-10-1647.PMC5008638.pdf
Avail - able from: http://www.emsp.org/projects/ms-barometer/.,Non-OADS,/arxiv_data1/oa_pdf/cb/18/ppa-10-1647.PMC5008638.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/ndt-12-2181.PMC5008640.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2181–2187Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2181OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10909 4 Diffusion tensor imaging in the characterization  of multiple system atrophy aaron Michael rulseh1–3 Jiri Keller1,4 Jan rusz5,6 Michael syka1 hana Brozova6 robert rusina6,7 Petra havrankova6 Katerina Zarubova8 hana Malikova1 robert Jech6 Josef Vymazal1 1Department of radiology, Na  homolce hospital, Prague, czech  republic; 2Department of radiology,   1st Faculty of Medicine, general  University hospital, charles  University in Prague, Prague, czech  republic; 3National institute of  Mental health, Klecany, czech  republic; 43rd Faculty of Medicine,   charles University in Prague, Prague,   czech republic; 5Department of  circuit Theory, Faculty of electrical  engineering, czech T echnical  University in Prague, Prague, czech  republic; 6Department of Neurology  and centre of clinical Neuroscience,   First Faculty of Medicine, charles  University in Prague, Prague, czech  republic; 7Thomayer hospital, Prague,   czech republic; 8Department of  Neurology, 2nd Faculty of Medicine,   charles University in Prague, Prague,   czech republicPurpose:  Multiple system atrophy (MSA) is a rare neurodegenerative disease that remains  poorly understood, and the diagnosis of MSA continues to be challenging.",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/ndt-12-2181.PMC5008640.pdf
"A purely autonomic form of MSA (MSA-A,  or Shy–Drager syndrome) was once considered as a possible separate entity but is not  included in the current consensus criteria.1 MSA-A likely represents MSA-P/MSA-C at  an early stage of development as autonomic dysfunction is common to both.correspondence: aaron Michael rulseh Department of radiology, Na homolce  hospital, roentgenova 2, 15030 Prague,  czech republic Tel +420 257 273 200 Fax +420 257 272 604 email aarulseh@gmail.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Rulseh et al Running head recto: Diffusion imaging in multiple system atrophy DOI: http://dx.doi.org/10.2147/NDT.S109094",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/ndt-12-2181.PMC5008640.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/ndt-12-2181.PMC5008640.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/d2/ndt-12-2181.PMC5008640.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/ac/opth-10-1653.PMC5008643.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1653–1661Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1653Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9855 5 The outcomes and prognostic factors of  vitrectomy in chronic diabetic traction macular  detachment Muneera a abunajma1 hassan al-Dhibi1 emad B abboud1 Yahya al Zahrani1 essam alharthi2 abdullah alkharashi3 nicola g ghazi1,4 1Vitreoretinal Division, King Khaled  eye specialist hospital, riyadh, saudi  arabia; 2al hokama eye Center,   riyadh, saudi arabia; 3Department  of Ophthalmology, College of  Medicine, King saud University  riyadh, saudi arabia; 4Department of  Ophthalmology, University of Virginia,   Charlottesville, V a, UsaPurpose:  To investigate the outcomes of pars plana vitrectomy (PPV) for chronic diabetic  traction macular detachment (CTMD).",Non-OADS,/arxiv_data1/oa_pdf/86/ac/opth-10-1653.PMC5008643.pdf
"Currently, the most common indications include severe nonclearing vitreous hemor - rhage, traction retinal detachment recently involving the macula, combined traction  and rhegmatogenous retinal detachment,6–9 dense premacular hemorrhage,10 ghost  cell glaucoma,11 macular edema with premacular hyaloid traction,12 and cataract with  severe proliferative diabetic retinopathy.13,14 Although the majority of diabetic vitrec - tomies were performed for nonresolving vitreous hemorrhage in the 1970s,7 traction  macular detachment (TMD) became the most common indication, accounting for 40%  of diabetic vitrectomies in the late 1980s.15 Vitrectomy is not traditionally performed for extramacular traction detachment  since the incidence of progression to involve the macula was reported to be about 15% Correspondence: nicola g ghazi Vitreo-retinal Division, Cleveland Clinic  abu Dhabi, PO Box 112412, abu Dhabi, Uae email nicola.ghazi@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Abunajma et al Running head recto: The outcomes of PPV for chronic diabetic TMD DOI: http://dx.doi.org/10.2147/OPTH.S98555",Non-OADS,/arxiv_data1/oa_pdf/86/ac/opth-10-1653.PMC5008643.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/86/ac/opth-10-1653.PMC5008643.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/ac/opth-10-1653.PMC5008643.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 219–235Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 219 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S108322 The relationship between emotion regulation  capacity, heart rate variability, and quality of life in  individuals with alcohol-related brain damage Jean-Paul Steinmetz1,2 Claus Vögele3,4 Christiane Theisen-Flies5 Carine Federspiel1,2 Stefan Sütterlin6,7 1Department of Research and  Development, ZithaSenior, 2Centre  for Memory and Mobility, ZithaSenior,   3Institute for Health and Behaviour,   Integrative Research Unit on  Social and Individual Development (INSIDE), University of Luxembourg,  Luxembourg;  4Research Group  Health Psychology, University of Leuven, Leuven, Belgium;  5Home St  Joseph, ZithaSenior, Luxembourg;   6Department of Psychology,   Lillehammer University College,  Lillehammer,  7Division of Surgery and  Clinical Neuroscience, Department of Psychosomatic Medicine, Oslo University Hospital – Rikshospitalet,  Oslo, NorwayAbstract: The reliable measurement of quality of life (QoL) presents a challenge in individuals  with alcohol-related brain damage.",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
"In a recent study Correspondence: Jean-Paul Steinmetz Department of Research and Development, ZithaSenior, 30, rue Ste Zithe, L-2763 LuxembourgTel +352 4 0144 2060Fax +352 4 0144 2952Email jean-paul.steinmetz@zitha.luJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Steinmetz et alRunning head recto: Alcohol and quality of lifeDOI: http://dx.doi.org/10.2147/PRBM.S108322",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
"By Luxembourg law, legally authorized representatives are not competent in provid-ing written informed consent for the participant to participate in a study [Luxembourg Law of August 11, 1982; see external link {only available in French language}: http://www.legilux.public.lu/leg/a/archives/1982/0072/a072.pdf].)",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/prbm-9-219.PMC5008645.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/ab/ijn-11-4187.PMC5008646.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4187–4197International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4187OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10954 7 The influence of different long-circulating  materials on the pharmacokinetics of liposomal  vincristine sulfate Jing Zhang1,* Yingchong Chen1,* Xiang Li1,2 Xinli Liang1 Xiaojian luo2 1Key laboratory of Modern  Preparation of T cM, Ministry of  education, 2state Key laboratory  of Innovative Drug and Efficient  Energy-Saving Pharmaceutical  Equipment, Jiangxi University of  Traditional chinese Medicine,   Nanchang, People’s Republic of China *These authors contributed equally  to this workPurpose:  This study was designed to improve the in vivo pharmacokinetics of long-circulating  vincristine sulfate (VS)-loaded liposomes; three different long-circulating materials, chitosan,  poly(ethylene glycol)-1,2-distearoyl sn-glycero-3-phosphatidylethanolamine (PEG-DSPE),  and poly(ethylene glycol)-poly-lactide- co-glycolide (PEG-PLGA), were evaluated at the same  coating molar ratio with the commercial product Marqibo® (vincristine sulfate liposome injec - tion [VSLI]).",Non-OADS,/arxiv_data1/oa_pdf/07/ab/ijn-11-4187.PMC5008646.pdf
"The  enhanced permeation and retention effect, which makes use of the difference in capil - lary structure between normal and cancerous tissues, is responsible for the achievement  of targeting delivery.2 Neoplastic tissues usually have “leaky” vasculature and limited  lymphatic drainage, which will lead to enhanced permeation for nanoparticles to across Correspondence: Xiang Li state Key laboratory of Innovative  Drug and Efficient Energy-Saving  Pharmaceutical Equipment, Jiangxi  University of Traditional Chinese  Medicine, 818 Xingwan Road, Wanli  District, Jiangxi Nanchang 330004,  People’s Republic of China Tel +86 791 8711 9661 Fax +86 791 8711 8658 email sterlinghawk@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: The influence of different long-circulating materials DOI: http://dx.doi.org/10.2147/IJN.S109547",Non-OADS,/arxiv_data1/oa_pdf/07/ab/ijn-11-4187.PMC5008646.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/07/ab/ijn-11-4187.PMC5008646.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/ab/ijn-11-4187.PMC5008646.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/e9/ott-9-5339.PMC5008647.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5339–5347submit your manuscript | www.dovepress.co m Dove press  5339 http: //dx.doi.org/10.2147/OTT .S7782 8Dove press Original researchopen access to scientific and medical research Open access Full T ext article The clinicopathological significance of RUNX3   hypermethylation and mrna expression in  human breast cancer, a meta-analysis Xiao-yun song1,* Bo-yan li2,* en-xiang Zhou3 Feng-xia Wu4 1Department of Thoracic Surgery,   Beijing chest hospital, capital  Medical University, Beijing, People’s  Republic of China; 2Department  of Breast Surgery, Inner Mongolia  Forestry general hospital, inner  Mongolia, People’s Republic of China;   3Department of General Surgery,   the Second Xiangya Hospital of  central south University, changsha,   Hunan, People’s Republic of China;   4Department of Breast Surgery,   Beijing luhe hospital, capital Medical  University, Beijing, People’s republic  of China *These authors contributed equally  to this workAbstract:  Aberrant promoter methylation of RUNX3  has been reported in several tumors  including human breast cancer (BC).",Non-OADS,/arxiv_data1/oa_pdf/2f/e9/ott-9-5339.PMC5008647.pdf
"The activation of the Wnt/CTNNB1 pathway was observed following correspondence: Feng-xia Wu Department of Breast Surgery,  Beijing luhe hospital, capital  Medical University, 82 Xinhuananlu,  Tongzhou District, Beijing 101100,  People’s Republic of China Email f engxiawu@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Song et al Running head recto: RUNX3  hypermethylation in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S77828",Non-OADS,/arxiv_data1/oa_pdf/2f/e9/ott-9-5339.PMC5008647.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2f/e9/ott-9-5339.PMC5008647.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/e9/ott-9-5339.PMC5008647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 401–410Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 401 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S111688Attributes of innovations and approaches to  scalability – lessons from a national program  to extend the scope of practice of health  professionals Malcolm Masso Cristina Thompson Centre for Health Service  Development, Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW,  AustraliaAbstract: The context for the paper was the evaluation of a national program in Australia  to investigate extended scopes of practice for health professionals (paramedics, physio- therapists, and nurses).",Non-OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
"The focus of the program was to investigate the extent to which each role could be implemented on a national scale and the conditions under which the roles would be most likely to succeed.Correspondence: Malcolm Masso  Centre for Health Service Development, Australian Health Services Research Institute, iC Enterprise 1, Innovation Campus, University of Wollongong, Wollongong, NSW 2522, AustraliaTel +61 2 4221 4411Fax +61 2 4221 4679Email mmasso@uow.edu.auJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCH Y ear: 2016V olume: 9Running head verso: Masso and ThompsonRunning head recto: Attributes of innovations and approaches to scalabilityDOI: http://dx.doi.org/10.2147/JMDH.S111688",Non-OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 410 Masso and Thompson,Non-OADS,/arxiv_data1/oa_pdf/69/a0/jmdh-9-401.PMC5008649.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijn-11-4199.PMC5008656.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4199–4211International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4199OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10775 2 an integrated study on antimicrobial activity and  ecotoxicity of quantum dots and quantum dots  coated with the antimicrobial peptide indolicidin emilia galdiero1 antonietta siciliano1 Valeria Maselli1 renato gesuele1 Marco guida1 Domenico Fulgione1 stefania galdiero2 lucia lombardi3 annarita Falanga2 1Department of Biology, University  of Naples “Federico II”, Naples,   Italy; 2Department of Pharmacy  and cirpeb, University of Naples  “Federico II”, Naples, Italy;   3Department of experimental  Medicine, second University of  Naples, Naples, ItalyAbstract:  This study attempts to evaluate the antimicrobial activity and the ecotoxicity of  quantum dots (QDs) alone and coated with indolicidin.",Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijn-11-4199.PMC5008656.pdf
Y ear: 2016 Volume: 11 Running head verso: Galdiero et al Running head recto: Ecotoxicity of QDs with indolicidin DOI: http://dx.doi.org/10.2147/IJN.S107752,Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijn-11-4199.PMC5008656.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijn-11-4199.PMC5008656.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijn-11-4199.PMC5008656.pdf
"Psychol Rev 2014; 121:225 –47; PMID: 24730599; http:dx:doi.org10.1037/a0035942 Keywords: homeostasis, allostasis, sign reversal, addiction, obesity, regulation,thermoregulation, nitrous oxide © Douglas S Ramsay, Karl J Kaiyala, and Stephen C Woods *Correspondence to: Douglas S Ramsay; Email: ramsay@uw.edu Submitted: 09/25/2014Revised: 10/23/2014Accepted: 10/27/2014 http://dx.doi.org/10.4161/23328940.2014.982048 This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (h ttp://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/32/2f/ktmp-01-03-982048.PMC5008704.pdf
"All of them used similar experimental paradigm – induction of MS by means of pseudo-Coriolis intervention (rotation of a subject sitting in a chair © Eugene Nalivaiko, John A Rudd, and Richard HY So *Correspondence to: Eugene Nalivaiko; Email: Eugene.nalivaiko@newcastle.edu.auSubmitted: 09/30/2014; Revised: 10/23/2014; Accepted: 10/27/2014 http://dx.doi.org/10.4161/23328940.2014.982047 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Int J Aviat Psy 1993; 3:203-220; http://dx.doi.org/10.1207/s15327108ijap0303_3.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Jpn J Physiol 1963; 13:84-96; PMID:13939555; http://dx.doi.org/10.2170/jjphysiol.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
J Physiol 2001; 535:619-623; PMID:11533150; http://dx.doi.org/10.1111/j.1469- 7793.2001.00619.x 9.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Brain Res Bull 2001; 54:609-618; PMID:11403987; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Eur J Appl Physiol 2006; 98:48-55; PMID:16847677; http://dx.doi.org/10.1007/s00421- 006-0217-6 11.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Brain Res Bull 2010; 82:193-200; PMID:20394809; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Aviat Space Environ Med 2011; 82:409-415; PMID:21485398; http://dx.doi.org/10.3357/ASEM.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Physiol Behav 1994; 56:319-324; PMID:7938244; http://dx.doi.org/ 10.1016/0031-9384(94)90201-1 15.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Exp Brain Res 2014;232:2591-9; PMID:24658633; http://dx.doi.org/ 10.1007/s00221-014-3899-8 17.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Br J Clin Pharmacol 1997; 43:633-637;PMID:9205824; http://dx.doi.org/10.1046/j.1365- 2125.1997.00606.x 21.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Percept Mot Skills 2003; 97:1051-1057; PMID:15002846; http://dx.doi.org/10.2466/pms.2003.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Auton Neurosci 2004; 116:46-53; PMID:15556837; http://dx.doi.org/10.1016/j.autneu.2004.08.008 23.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Psychophysiol ogy 1986; 23:542-551; PMID:3809361; http://dx.doi.org/10.1111/j.1469- 8986.1986.tb00671.x 24.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
J Gen Psychol 1971; 85:87-92; PMID:5099582; http://dx.doi.org/10.1080/00221309.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Aviat Space Environ Med 2011; 82:424-433; PMID:21485400; http://dx.doi.org/10.3357/ASEM.2932.2011 30.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Comp Methods Progr Biomed 2014; 113:882-893; http://dx.doi.org/10.1016/j.cmpb.2013.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Applied ergonomics 2004; 35:549-556; PMID:15374762; http://dx.doi.org/ 10.1016/j.apergo.2004.06.002 34.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Can J Physiol Pharmavol 1964; 62:199-207; http://dx.doi.org/10.1139/y64-023 36.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Anticancer Drugs 2013; 24:99-111; PMID:23165435; http://dx.doi.org/10.1097/CAD.0b013e328359d7ba 39.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Exp Physiol 2002; 87:563-574; PMID:12481931; http://dx.doi.org/10.1113/eph8702424 40.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Cereb Cortex 2013; 23:806-813; PMID:22473843; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Auton Neurosci 2009; 148:76-82; PMID:19362521; http://dx.doi.org/10.1016/j.autneu.2009.03.008 44.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
PloS one 2014; 9:e86730; PMID:24466215; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Eur J Appl Physiol 2010; 109:27-33;PMID:19949811; http://dx.doi.org/10.1007/s00421- 009-1295-z 47.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Infection 2004; 32:59-64; PMID:15057568; http://dx.doi.org/10.1007/s15010- 004-3064-6 51.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Intensive Care Med 2000; 26:716-721; PMID:10945388; http://dx.doi.org/ 10.1007/s001340051237 52.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
PloS One 2006; 1:e1; PMID:17183631;http://dx.doi.org/10.1371/journal.pone.0000001 54.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Ann N Y Acad Sci 1997; 813:733-737; PMID:9100963; http://dx.doi.org/ 10.1111/j.1749-6632.1997.tb51775.x 56.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Med Hypotheses 1998; 50:219-226; PMID:9578327; http://dx.doi.org/10.1016/S0306- 9877(98)90022-6 57.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Am J Med 2001; 111 Suppl 8A:106S-112S; PMID:11749934; http://dx.doi.org/10.1016/S0002- 9343(01)00849-X 59.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Science 1977; 197:493-495; PMID:301659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Kidney Int 1979; 16:729-735; PMID:548611; http://dx.doi.org/10.1038/ki.1979.189 63.,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
Physiol Behav 1985; 35:151-156; PMID:4070378; http://dx.doi.org/ 10.1016/0031-9384(85)90329-4 www.landesbioscience.com 171 Temperature,Non-OADS,/arxiv_data1/oa_pdf/14/95/ktmp-01-03-982047.PMC5008705.pdf
"Other laboratory studies have also found signiﬁcant increases in core body temperature in sedentary human volunteers.20In a review of these laboratory studies, it was concluded that the © Andrew C Parrott and Lucy Young *Correspondence to: Andrew C Parrott; Email:a.c.parrott@swansea.ac.ukSubmitted: 09/05/2014; Revised: 09/30/2014; Accepted: 09/30/2014 http://dx.doi.org/10.4161/23328940.2014.977182 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Drug Alcohol Depend 1999; 55:105-15; PMID:10402155; http://dx.doi.org/10.1016/S0376- 8716(99)00002-2 2.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Neuropsy- chobiology 2004a; 50:329-35; PMID:15539865; http://dx.doi.org/10.1159/000080961 3.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Drug Alcohol Depend 2012a; 121:1-9; PMID:21924843; http://dx.doi.org/10.1016/j.drugalcdep.2011.08.012 4.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psychopharmacology 2005; 183:248-56; PMID:16163516; http://dx.doi.org/10.1007/s00213-005-0149-6 5.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Ecstasy in recreational users: self-reported psychological and physiological effects.Hum Psychopharmacol 1997; 12:91-97; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Eur J Emerg Med 1999; 6:249-54; PMID:10622392; http://dx.doi.org/ 10.1097/00063110-199909000-00014 9.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Drug Alcohol Depend 2001; 64:9-17;PMID:11470336; http://dx.doi.org/10.1016/S0376- 8716(00)00215-5 10.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Eur J Neurosci 2004; 20:51-8; PMID:15245478; http://dx.doi.org/10.1111/j.0953- 816X.2004.03453.x 11.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Curr Neurovasc Res 2004; 1:77-90; PMID:16181068; http://dx.doi.org/10.2174/1567202043480233 12.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psychopharmacology 2013; 225:765-80; PMID:23274506; http://dx.doi.org/10.1007/s00213-012-2957-9 13.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Med Clin North Am 2005; 89:1277-96;PMID:16227063; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Prog Brain Res 2007; 162:63-79; PMID:17645915;http://dx.doi.org/10.1016/S0079-6123(06)62005-0 15.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psychopharmacology 2004; 173:264-9;PMID:14726996; http://dx.doi.org/10.1007/s00213- 003-1725-2 16.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Behav Brain Res 1996; 73:103-07; PMID:8788485; http://dx.doi.org/10.1016/0166-4328(96)00078-2 18.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Clin Psychopharmacol 2008; 28:432- 40; PMID:18626271; http://dx.doi.org/10.1097/ JCP.0b013e31817ef470 21.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Addiction 2002; 97:1531-6; PMID:12472637; http://dx.doi.org/ 10.1046/j.1360-0443.2002.00222.x 22.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psycho- pharmacology 2004b; 173:234-41; PMID:15007594; http://dx.doi.org/10.1007/s00213-003-1712-7 23.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Plasma drug concentrations and physiological measures in ’dance party’ participants.Neuropsychopharmacology 2006; 31:424-30; PMID:16192986; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Neuropsychobiology 2008; 57:165-80; PMID:18654086; http://dx.doi.org/10.1159/000147470 25.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Psychopharmacol 2007; 21:a35; http://dx.doi.org/ 10.1177/0269881107077377 27.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Psychopharmacol 2005; 19:a26; http://dx.doi.org/10.1177/0269881105048900 28.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psychopharmacology 2001; 159:77-82;PMID:11797073; http://dx.doi.org/10.1007/ s002130100897 29.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psychopharmacology 1998; 139:261- 8; PMID:9784083; http://dx.doi.org/10.1007/ s002130050714 30.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Pharma-col Biochem Behav 2002; 71:837-44; PMID:11888574; http://dx.doi.org/10.1016/S0091- 3057(01)00711-0 32.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Ann Emerg Med 2007; 49:164-71; PMID:17084942; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Nephrol Dial Transplant 2013;28:2277-83; PMID:23476039; http://dx.doi.org/ 10.1093/ndt/gft023 34.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Ann N Y Acad Sci 2008; 1139:242-58; PMID:18991870; http://dx.doi.org/ 10.1196/annals.1432.052 35.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Neurosci 2014; 34:7754-62;PMID:24899699; http://dx.doi.org/10.1523/ JNEUROSCI.0506-14.2014 36.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Hum Exp Toxicol 2011; 30:259-266;PMID:20488845; http://dx.doi.org/10.1177/ 0960327110370984 37.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Open Addiction J2011; 4:36-37; http://dx.doi.org/10.2174/ 1874941001104010036 38.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Psychopharmacology 2008; 196:63-70; PMID:17899019; http://dx.doi.org/10.1007/s00213-007-0932-7 40.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Eur J Pharmacol 2003; 482:339-41; PMID:14660042; http://dx.doi.org/ 10.1016/j.ejphar.2003.09.060 218 Volume 1 Issue 3 Temperature,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Psychopharmacol 2005; 19:71-83; PMID:15671132; http://dx.doi.org/10.1177/0269881105048900 42.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Hum Psychopharmacol 2006;21:285-98; PMID:16856221; http://dx.doi.org/ 10.1002/hup.773 43.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Hum Psychopharmacol 2001; 16:557-77; PMID:12404536; http://dx.doi.org/10.1002/hup.351 44.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Br J Pharmacol 2012b; 166:1518- 20; http://dx.doi.org/10.1111/j.1476- 5381.2012.01941.x 45.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Neurosci Biobehav Revs 2013a; 37:1466-84;PMID:3660456; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Hum Psychopharmacol 2013b; 28:289-307; http://dx.doi.org/10.1002/hup.2318 47.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
HumPsychopharmacol 2007; 22:381-8; PMID:17621368; http://dx.doi.org/10.1002/hup.857 48.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Neural Transmiss 1997; 104:771-794; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Accid Emerg Med 1998; 15:322-6; PMID:9785160; http://dx.doi.org/10.1136/emj.15.5.322 51.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Br J Anaesthes 2005; 96:678-85; http://dx.doi.org/10.1093/bja/ael078 52.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Emerg Med 2005; 29:451-4; PMID:16243206; http://dx.doi.org/ 10.1016/j.jemermed.2005.05.007 53.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Eur Neuropsychophar- macol 2014; 24:369-74; PMID:24333019; http://dx.doi.org/10.1016/j.euroneuro.2013.11.006 56.,OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
Neuropsychobiology 2009; 60:148-58; PMID:19893332; http://dx.doi.org/10.1159/000253551 58.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Psychopharma- col 2006; 20:147-63; PMID:16510474; http://dx.doi.org/ 10.1177/0269881106063268 59.,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
J Psychopharmacol 2006; 20:456-63; PMID:16574720;http://dx.doi.org/10.1177/0269881106060147 www.landesbioscience.com 219 Temperature,Non-OADS,/arxiv_data1/oa_pdf/15/61/ktmp-01-03-977182.PMC5008707.pdf
"Two Special Issues dedicated to the Keywords: adherens junctions, blood ﬂow, cell-cell adhesions, permeability, temperature, tight junctions © Andrei I Ivanov *Correspondence to: Andrei I Ivanov;Email: aivanov2@vcu.edu Submitted: 10/07/2014 Revised: 10/16/2014Accepted: 10/16/2014http://dx.doi.org/10.4161/23328940.2014.978716 This is an Open Access article distributed under the terms of the Creative Commons Attribution- Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which per- mits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, providedthe original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000125; PMID:20182611; http://dx.doi.org/10.1101/cshperspect.a000125 2.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Annu Rev Cell Dev Biol 2002; 18:463-493; PMID:12142280; http://dx.doi.org/ 10.1146/annurev.cellbio.18.022602.131838 3.,OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Annu Rev Physiol 2010; 72:463-493;PMID:20148685; http://dx.doi.org/10.1146/annurev- physiol-021909-135833 4.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Int Rev Cell Mol Biol 2013; 303:27-99; PMID:23445808; http://dx.doi.org/10.1016/B978-0- 12-407697-6.00002-76.,OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition, Bioessays 2001; 23:912-923; PMID: 11598958; http://dx.doi.org/10.1002/bies.1132 7.",OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
J Invest Dermatol 2007; 127:654-659; PMID:17068482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Int J Pharmaceut 2008; 359:94-103; http://dx.doi.org/10.1016/j.ijpharm.2008.,OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Commun Integr Biol 2010; 3:619-621; PMID: 21331258; http://dx.doi.org/10.4161/cib.3.6.13461 11.,OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Am J Physiol Reg Integr Comp Physiol 2012; 302:R1372-1383; http://dx.doi.org/10.1152/ajpregu.00023.2012 13.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Ann N Y Acad Sci 1997; 813:733-737; PMID:9100963; http://dx.doi.org/ 10.1111/j.1749-6632.1997.tb51775.x 14.,OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Physiologically rele- vant increase in temperature causes an increase in intes- tinal epithelial tight junction permeability, Am J Physiol Gastrointest Liver Physiol 2006; 290:G204- 212; PMID:16407590; http://dx.doi.org/10.1152/ajpgi.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
J Animal Sci 2009; 87:E101-108; http://dx.doi.org/10.2527/jas.2008-1339 17.,OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Platelet-activating factor: a previously unrecognizedmediator of fever; J Physiol 2003; 553:221-228; PMID: 14565987; http://dx.doi.org/10.1113/jphysiol.2003.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Furuse M, Izumi Y, Oda Y, Higashi T, Iwamoto N. Molecular organization of tricellular tight junctions.Tissue barriers 2014; 2:e28960; PMID:25097825; http://dx.doi.org/10.4161/tisb.28960 20.",OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e26845; PMID:24868495; http://dx.doi.org/10.4161/tisb.26845 21.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e25231; PMID:24665409; http://dx.doi.org/10.4161/tisb.25231 22.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Emerging roles of Sem- aphorins in the regulation of epithelial and endothelial junctions, Tissue barriers 2013, 1:e23272; PMID: 24665374; http://dx.doi.org/10.4161/tisb.23272 23.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Tissue barriers 2013, 1:e24783; PMID:24665393; http://dx.doi.org/10.4161/tisb.24783 24.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Afadin con- trols cadherin cluster stability using clathrin-indepen- dent mechanism, Tissue barriers 2014; 2:e28687; PMID:25045601; http://dx.doi.org/10.4161/tisb.28687 25.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e27425;PMID:24665413; http://dx.doi.org/10.4161/tisb.27425 26.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e26713; PMID:24868494; http://dx.doi.org/10.4161/tisb.2671327.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e26938; PMID: 24868497; http://dx.doi.org/10.4161/tisb.26938 28.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e24518; PMID:24665398; http://dx.doi.org/10.4161/tisb.24518 29.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"Tissue barriers 2013, 1:e24978; PMID: 24478939; http://dx.doi.org/10.4161/tisb.24978 30.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1: e25247; PMID:24665401; http://dx.doi.org/10.4161/tisb.25247 31.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e27321; PMID: 24868498; http://dx.doi.org/10.4161/tisb.27321 33.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1:e25718; PMID:24665411; http://dx.doi.org/10.4161/tisb.25718 34.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2013; 1: e24894; PMID:24665406; http://dx.doi.org/10.4161/ tisb.24894 35.,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
Tissue barriers 2014; 2:e28426; PMID:25045600; http://dx.doi.org/10.4161/tisb.28426 www.landesbioscience.com 153 Temperature,Non-OADS,/arxiv_data1/oa_pdf/1c/ca/ktmp-01-03-978716.PMC5008708.pdf
"13-16Using dynamic infra- red thermography (DIRT) skin perfusion dynamics can be © Ina Isabella H øiland, Louis de Weerd, and James B Mercer *Correspondence to: James B Mercer; Email: james.mercer@uit.noSubmitted: 10/06/2014; Revised: 10/31/2014; Accepted: 10/31/2014 http://dx.doi.org/10.4161/23328940.2014.984553 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Tobb Control 2003; 12:349-59; http://dx.doi.org/10.1136/tc.12.4.349 4. WHO International Agency for Research on Cancer (IARC) Monograph on the Evaluation of Carcinogenic Risks to Humans.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Smokeless Tobacco and Some Tobacco-speciﬁc N-Nitrosamines 2007; 89:PP626; Available from: http://monographs.iarc.fr/ENG/recent-pub/mono89.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Directive 2001/37/EC http://ec.europa.eu/health/ tobacco/docs/dir_201440_en.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Trends Pharmacol Sci1992; 13:177-84; PMID:1604710; http://dx.doi.org/ 10.1016/0165-6147(92)90060-J 9.,OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Prog Cardiovasc Dis 2003; 46:91-111; PMID:12920702; http://dx.doi.org/10.1016/S0033- 0620(03)00087-2 12.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Ann Intern Med 1989;111:112-16; PMID:2742246; http://dx.doi.org/ 10.7326/0003-4819-111-2-112 13.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Microvasc Res 2010; 80:54-7; PMID:20144625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Br J Plast Surg 1983;36:373-82; PMID:6860870; http://dx.doi.org/ 10.1016/S0007-1226(83)90064-4 15.,OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Intraoperative Dynamic infrared thermography and free-ﬂap surgery.Ann Plastic Surg 2006; 57:279-84; PMID:16929195; http://dx.doi.org/10.1097/01.sap.0000218579.17185.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Eur J Appl Physiol 2006; 98:161-8; PMID:16874507; http://dx.doi.org/ 10.1007/s00421-006-0261-2 19.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Am Heart J 1988; 115:263-67;PMID:3276115; http://dx.doi.org/10.1016/0002- 8703(88)90647-3 21.,OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
J Auton Nerv Syst 1995; 53:215-22; PMID:7560758; http://dx.doi.org/10.1016/0165- 1838(94)00178-M 23.,OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Clin Pharmacol Ther 1982; 32:769-80;PMID:7140141; http://dx.doi.org/10.1038/clpt.1982.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Psychopharmacology (Berl) 1992; 108:507- 11; PMID:1410167; http://dx.doi.org/10.1007/ BF02247429 26.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Clin Physiol 1998; 18:103-7; PMID:9568348; http://dx.doi.org/10.1046/j.1365- 2281.1998.00082.x 27.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
PhotochemPhotobiol 2007; 83:1144-8; http://dx.doi.org/ 10.1111/j.1751-1097.2007.00074.x 29.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
Eur J Surg Oncol2002; 28: 815-20; PMID:12477471; http://dx.doi.org/ 10.1053/ejso.2002.1308 226 Volume 1 Issue 3 Temperature,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/ktmp-01-03-984553.PMC5008709.pdf
"*Correspondence should be addressed to Eugene A. Kiyatkin MD, PhD; Email: ekiyatki@intra.nida.nih.gov Submitted: 08/29/2014; Revised: 09/19/2014; Accepted: 09/22/2014http://dx.doi.org/10.4161/23328940.2014.969074 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/5f/ktmp-01-03-969074.PMC5008710.pdf
"*Correspondence to: John F Bowyer; Email: john.bowyer@fda.hhs.govSubmitted: 09/29/2014; Revised: 10/22/2014; Accepted: 10/27/2014 http://dx.doi.org/10.4161/23328940.2014.982049 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann NYAcad Sci 2008; 1139:127-39; PMID:18991857; http://dx.doi.org/10.1196/annals.1432.005 2.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neurotoxicol Teratol 2012;34:253-62; PMID:22289608; http://dx.doi.org/ 10.1016/j.ntt.2012.01.007 178 Volume 1 Issue 3 Temperature,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Arch Intern Med 1963; 112:822-6;PMID:14056847; http://dx.doi.org/10.1001/ archinte.1963.03860060060004 6.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Toxicol Appl Pharmacol 1978; 45:49-62; PMID:99845; http://dx.doi.org/10.1016/0041-008X(78)90027-3 7.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Psychopharmacologia 1968; 13:394-407; PMID:5706269; http://dx.doi.org/10.1007/ BF00404954 9.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Eur J Pharmacol1971; 16:176-80; PMID:4405780; http://dx.doi.org/ 10.1016/0014-2999(71)90008-2 10.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Eur J Pharmacol 1974; 26:30-4;PMID:4151642; http://dx.doi.org/10.1016/0014- 2999(74)90070-3 12.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
"Pharma- col, Biochem, Behav 1993; 44:87-98; PMID:8094252; http://dx.doi.org/10.1016/0091- 3057(93)90284-Z 16.",OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Synapse 2006; 60:521- 32; PMID:16952162; http://dx.doi.org/10.1002/ syn.20324 20.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neurotoxicology 2004; 25:555-72;PMID:15183010; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 2001; 919:179-83; PMID:11689178; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neuroscience 2007; 144:66-76; PMID:17049170; http://dx.doi.org/10.1016/j.neuroscience.2006.08.076 23.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Pharmacol Exp Ther 2006; 316:1210-8; PMID:16293712; http://dx.doi.org/ 10.1124/jpet.105.096503 26.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurochem 1997; 69:1185-95; PMID:9282942; http://dx.doi.org/10.1046/j.1471-4159.1997.69031185.x 28.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Synapse 2009; 63:147-51; PMID:19021208; http://dx.doi.org/ 10.1002/syn.20580 30.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
JNeurochem 2005; 95:429-36; PMID:16086684; http://dx.doi.org/10.1111/j.1471-4159.2005.03379.x 31.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res1992; 581:237-43; PMID:1356579; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Science 1989; 243:398-400; PMID:2563176; http://dx.doi.org/10.1126/science.256317633.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Pharmacol Exp Ther 2011; 336:900-7; PMID:21159748; http://dx.doi.org/10.1124/jpet.110.177287 35.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann New York Acad Sci1999; 890:495-504; PMID:10668455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
ToxicolSci 2001; 60:103-11; PMID:11222877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 2006; 1075:236-9; PMID:16458862; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neurotoxicity Res 2007; 11:183-202; PMID:17449459; http://dx.doi.org/10.1007/ BF03033567 40.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neuroscience 2001; 107:265-74; PMID:11731100; http://dx.doi.org/10.1016/S0306-4522(01)00351-7 41.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neurochem Int1998; 32:117-31; PMID:9542724; http://dx.doi.org/ 10.1016/S0197-0186(97)00031-4 42.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann New York Acad Sci 2001; 939:366-80; PMID:11462792; http://dx.doi.org/10.1111/j.1749-6632.2001.tb03646.x 43.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
BMC Genomics 2013; 14:147; PMID:23497014; http://dx.doi.org/10.1186/1471-2164-14-147 44.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
"Int J Hyperther: Off J Eur Soc Hyperther Oncol, North Am Hyperther Group 1995; 11:459-88; PMID:7594802; http://dx.doi.org/10.3109/ 02656739509022483 46.",OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
PloS One 2013; 8:e75044; PMID:24023970; http://dx.doi.org/ 10.1371/journal.pone.0075044 47.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Physiol 2013; 591:3063-80; PMID:23613528; http://dx.doi.org/10.1113/ jphysiol.2012.249060 48.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann Neurol 2009; 66:219-26; PMID:19743470; http://dx.doi.org/10.1002/ana.21712 49.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Eur J Neurosci 2010; 31:1252-60; PMID:20345922; http://dx.doi.org/10.1111/j.1460-9568.2010.07159.x 50.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurosci: Off J Soc Neurosci 2010; 30:5744- 53; PMID:20410126; http://dx.doi.org/10.1523/ JNEUROSCI.3360-09.2010 51.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Eur J Pharmacol 2013; 716:61-76; PMID:23500195; http://dx.doi.org/10.1016/j.ejphar.2013.03.003 52.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Exp Neurol 2012; 237:199-206; PMID:22735490; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res1998; 809:77-90; PMID:9795148; http://dx.doi.org/ 10.1016/S0006-8993(98)00846-4 55.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 1997; 759:135-40; PMID:9219871; http://dx.doi.org/10.1016/S0006- 8993(97)00173-X 56.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 2005; 1035:24-31; PMID:15713273; http://dx.doi.org/10.1016/j.brainres.2004.11.054 57.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Synapse 1998; 30:329-33; PMID:9776136; http://dx.doi.org/10.1002/(SICI)1098-2396(199811)30:3%3c329:: AID-SYN10%3e3.0.CO;2-V 58.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurosci: Off J Soc Neurosci 2008; 28:5756-61; PMID:18509037; http://dx.doi.org/10.1523/JNEUROSCI.1179-08.2008 59.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurosci: Off J Soc Neurosci 2004; 24:6028-36; PMID:15229250;http://dx.doi.org/10.1523/JNEUROSCI.0713- 04.2004 60.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Synapse 2008; 62:91-100; PMID:17992686; http://dx.doi.org/10.1002/syn.20471 61.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Psychiatry Res 2000; 98:93-102; PMID:10762735; http://dx.doi.org/10.1016/S0925- 4927(99)00052-9 62.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Am J Psychiat 2001; 158:383-9; PMID:11229978; http://dx.doi.org/ 10.1176/appi.ajp.158.3.383 64.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Am J Psychiat 2001; 158:377-82; PMID:11229977; http://dx.doi.org/ 10.1176/appi.ajp.158.3.377 65.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 1986; 365:15-20; PMID:3947981; http://dx.doi.org/ 10.1016/0006-8993(86)90717-1 66.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Prog Brain Res 1990; 86:37-51;PMID:1982368; http://dx.doi.org/10.1016/S0079- 6123(08)63165-9 68.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neurotoxicol Teratol 2005; 27:745-52; PMID:16203121; http://dx.doi.org/10.1016/j.ntt.2005.06.018 69.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Acta Neuropathol 1987; 72:286-97; PMID: 3564909; http://dx.doi.org/10.1007/BF00691103 72.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res Mol Brain Res 2001; 93:64-9; PMID:11532339; http://dx.doi.org/10.1016/S0169-328X(01)00184-X 73.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Eur J Neurosci 2007; 26:1242-53; PMID:17767502; http://dx.doi.org/10.1111/j.1460-9568.2007.05741.x74.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann New York Acad Sci 2006; 1074:198-224; PMID: 17105918; http://dx.doi.org/10.1196/annals.1369.020 75.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Curr Pharm Des 2007; 13:1903-23; PMID:17584116; http://dx.doi.org/10.2174/138161207780858375 76.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Curr Neurovasc Res 2014;11:31-47; PMID:24274907; http://dx.doi.org/ 10.2174/1567202610666131124235011 78.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Appl Physiol 2006; 100:1059- 64; PMID:16467392; http://dx.doi.org/10.1152/japplphysiol.00954.2005 80.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neuropharmacology 2008; 55:281-8; PMID:18541276; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 1997; 17:894-904;PMID:9290587; http://dx.doi.org/10.1097/ 00004647-199708000-00008 84. de la Torre JC.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neuroscience 1976; 1:455-7; PMID:11370237; http://dx.doi.org/10.1016/0306-4522(76)90096-8 85.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 1989;476:71-7; PMID:2914215; http://dx.doi.org/ 10.1016/0006-8993(89)91537-0 86.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Proc Nat Acad Sci US A 1975; 72:3726-30; PMID:810805; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurosci: Off J Soc Neurosci 2013; 33:3390-401; PMID:23426667; http://dx.doi.org/10.1523/ JNEUROSCI.3346-12.2013 88.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 2011; 1373:91-100; PMID:21156163; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurointerventional Surg 2014; PMID:24780822; http://dx.doi.org/10.1136/ neurintsurg-2014-011161 90.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurosurg 2012; 117:781-6; PMID:22920957; http://dx.doi.org/10.3171/2012.7.JNS12396 91.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Neu- roreport 2011; 22:923-8; PMID:21979424; http://dx.doi.org/10.1097/WNR.0b013e32834d0bc8 92.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Toxicol Appl Pharmacol 2014; 275:73-8; PMID:24412707; http://dx.doi.org/10.1016/j.taap.2013.12.023 93.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Synapse 2009; 63:881-94; PMID:19582783; http://dx.doi.org/ 10.1002/syn.20661 94.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Forensic Sci 2013; 58:1088-91; PMID:23601243; http://dx.doi.org/ 10.1111/1556-4029.12176 95.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Exp Mol Med 2013; 45: e66; PMID:24310172; http://dx.doi.org/10.1038/emm.2013.97 96.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Biochem Soc Trans 2011; 39:989-93; PMID:21787335; http://dx.doi.org/10.1042/BST0390989 97.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Prog Brain Res 2007;162:459-78; PMID:17645933; http://dx.doi.org/ 10.1016/S0079-6123(06)62023-2 98.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 1985; 5:401-12; PMID: 3928638; http://dx.doi.org/10.1038/jcbfm.1985.55 99.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Arch Neurol 1972; 26:336-43; PMID:5015592; http://dx.doi.org/10.1001/archneur.1972.00490100066006 100.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann Internal Med 1977; 86:381-7; PMID:848798; http://dx.doi.org/10.7326/0003-4819-86-4-381 101.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Toxicol Clin Toxicol 1994; 32:147-55; PMID:8145354; http://dx.doi.org/10.3109/ 15563659409000444 102.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
"Serum myoglo- bin, but not lipopolysaccharides, is predictive ofAMPH-induced striatal neurotoxicity.Neurotoxicology 2013; 37C:40-50; PMID:23608161; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Legal Med 2003; 5:42-8; PMID:12935649; http://dx.doi.org/10.1016/S1344- 6223(03)00005-1 105.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Exp Nephrol 2000; 8:72-6; PMID:10729745; http://dx.doi.org/10.1159/000020651 106.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Antioxidants Redox Signaling 2010; 13:1087-123; PMID:20170402; http://dx.doi.org/10.1089/ars.2009.2974 107.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Oxidative Med Cell Longevity 2013; 2013:396527; PMID:23781294; http://dx.doi.org/10.1155/2013/396527 108.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neu- rosci: Off J Soc Neurosci 2012; 32:13155-63; PMID:22993432; http://dx.doi.org/10.1523/JNEUROSCI.2530-12.2012 109.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Front Cell Neurosci 2014; 8:271; PMID:25232304; http://dx.doi.org/10.3389/fncel.2014.00271 111.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Acta Neurologica Scandinavica 2014; PMID:25208981; http://dx.doi.org/10.1111/ ane.12294 112.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Autoimmun 2014; S0896-8411:00101-2; PMID:25175979;http://dx.doi.org/10.1016/j.jaut.2014.06.004 114.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Biochem Phar- macol 2014; 88:594-604; PMID:24445162; http://dx.doi.org/10.1016/j.bcp.2014.01.008 116.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Nat Rev Immunol2013; 13:621-34; PMID:23928573; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurol 2014; 261:2037-42; PMID:25182699; http://dx.doi.org/10.1007/s00415- 014-7473-x 118.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Parkinson’s Dis 2013; 3:493-514;PMID:24275605; http://dx.doi.org/10.3233/ JPD-130250 119.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neuroimmu- nol 2014; 269:1-8; PMID:24161471; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neuroinﬂammation 2012; 9:94; PMID:22594666; http://dx.doi.org/ 10.1186/1742-2094-9-94 121.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurocytol 1990; 19:338-42; PMID: 1975269; http://dx.doi.org/10.1007/BF01188403 122.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Ann New York Acad Sci 2008;1139:318-30; PMID:18991877; http://dx.doi.org/ 10.1196/annals.1432.032 124.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neurochem 2006; 96:706-18; PMID:16405514; http://dx.doi.org/10.1111/j.1471- 4159.2005.03566.x 125.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 2005; 1050:190-8; PMID:15987631; http://dx.doi.org/10.1016/j.brainres.2005.05.049 126.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Pharmacol Exp Ther 2004; 311:1-7; PMID:15163680; http://dx.doi.org/ 10.1124/jpet.104.070961 127.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Mol Diagn Ther 2006; 10:257-69; PMID:16884330;http://dx.doi.org/10.1007/BF03256465 128.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Clin Immunol 2008; 28:528-41; PMID:18574677; http://dx.doi.org/10.1007/s10875- 008-9208-1 129.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Brain Res 2008; 1203:133-48; PMID:18329007; http://dx.doi.org/ 10.1016/j.brainres.2008.01.093 130.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
PloS One 2014; 9:e102003; PMID:Can’t; http://dx.doi.org/10.1371/journal.pone.0102003 131.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Immunobiology 2013; 218:1063-8; PMID:23518444; http://dx.doi.org/ 10.1016/j.imbio.2013.02.001 132.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
2012:315941; PMID:22778496; http://dx.doi.org/ 10.1155/2012/315941 133.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Immunol Rev 2012; 249:158-75; PMID:22889221; http://dx.doi.org/10.1111/j.1600- 065X.2012.01146.x 134.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Mol Med2014; PMID:25105302; http://dx.doi.org/10.2119/ molmed.2014.00117 135.,OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
J Neural Trans 2009; 116:405-15; PMID:19271121; http://dx.doi.org/10.1007/s00702-009-0204-2 136.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
BMC Psychiat 2012; 12:221; PMID:23216941; http://dx.doi.org/10.1186/1471- 244X-12-221137.,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
Lancet 2012; 379:55-70; PMID:22225671; http://dx.doi.org/10.1016/S0140-6736(11)61138-0 182 Volume 1 Issue 3 Temperature,Non-OADS,/arxiv_data1/oa_pdf/3e/9e/ktmp-01-03-982049.PMC5008711.pdf
"Am J Physiol Regul Integr Comp Physiol 2014; 306: R552-66; PMID: 24500434; http://dx.doi.org/10.1152/ajpregu.00365.2013 Keywords: body temperature, metham- phetamine, modeling, neural control © Yaroslav I Molkov and Dmitry V Zaretsky *Correspondence to: Yaroslav I Molkov;Email: ymolkov@iupui.edu Submitted: 09/15/2014 Accepted: 09/18/2014http://dx.doi.org/10.4161/2167549X.2014.968483 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distri- bution, and reproduction in any medium, pro-vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
Meth math: modeling temperature responses to methamphetamine.Am J Physiol Regul Integr Comp Physiol 2014; 306: R552-66; PMID:24500434; http://dx.doi.org/10.1152/ ajpregu.00365.2013 2.,Non-OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
Am J PhysiolRegul Integr Comp Physiol 2007; 292:R47-63; PMID:16959861; http://dx.doi.org/10.1152/ajpregu.,OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
Brain Res 2008; 1226:116-23; PMID:18586013; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
Am J Physiol Regul Integr Comp Physiol2010; 298:R130-40; PMID:19923355; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
J Pharmacol Exp Ther 2007; 323:477-87; PMID:17702902; http://dx.doi.org/10.1124/jpet.107.,Non-OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
J Phys- iol 2002; 538:941-6; PMID:11826177; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/42/ktmp-01-03-968483.PMC5008712.pdf
"Hyperther-mia typically coincides with devastating medical complications,including hyperkalemia, renal failure, metabolic acidosis, liver © Christine K Dao, Sara M Nowinski, and Edward M Mills *Correspondence to: Edward M Mills; Email: tedmills@austin.utexas.eduSubmitted: 10/31/2014; Revised: 11/05/2014; Accepted: 11/06/2014 http://dx.doi.org/10.4161/23328940.2014.985953 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Crit Care Clin 1997; 13:785-808; PMID:9330841; http://dx.doi.org/10.1016/S0749- 0704(05)70369-9 3.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Am J Health Syst Pharm 2013; 70:34-42; PMID:23261898; http://dx.doi.org/ 10.2146/ajhp110543 4.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Physiol Rev 2006; 86:435-64;PMID:16601266; http://dx.doi.org/10.1152/physrev.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Front Biosci (Landmark Ed) 2011; 16:74-104; PMID:21196160; http://dx.doi.org/10.2741/3677 11.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Med Clin North America 2005; 89:1277-96; PMID:16227063; http://dx.doi.org/ 10.1016/j.mcna.2005.06.002 12.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Physiol Rev 2006; 86:435-64; PMID:16601266; http://dx.doi.org/10.1152/physrev.00009.200513.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
FEBS Lett 1980; 113:299-303; PMID:7389900; http://dx.doi.org/10.1016/0014-5793(80)80613-2 14.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Biochem Biophys Res Commun106:582-9; PMID:6285923; http://dx.doi.org/ 10.1016/0006-291X(82)91150-0 15.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Obes Rev 2001; 2:255-65;PMID:12119996; http://dx.doi.org/10.1046/j.1467- 789X.2001.00043.x 16.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Cell Metabolism 2007; 6:181-94; PMID:17767905;http://dx.doi.org/10.1016/j.cmet.2007.08.003 18.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
FEBS Lett 1994; 343:22-6; PMID:8163011; http://dx.doi.org/10.1016/0014-5793(94)80599-7 21.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Physiol Rev 2004; 84:277-359; PMID:14715917; http://dx.doi.org/ 10.1152/physrev.00015.2003 22.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Clin Invest 1998; 102:1724-31; PMID:9802886;http://dx.doi.org/10.1172/JCI453223.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Biol Chem 1997; 272:32847-56; PMID:9407062; http://dx.doi.org/10.1074/jbc.272.52.32847 24.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Crit Care Med 2005; 33:1311-6; PMID:15942349; http://dx.doi.org/10.1097/01.CCM.0000165969.29002.70 26.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Biol Chem 2000; 275:25073-81; PMID:10825155; http://dx.doi.org/10.1074/jbc.M000547200 27.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Cell 151:400-13; PMID:23063128; http://dx.doi.org/10.1016/j.cell.2012.09.010 28.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
N Engl J Med 2009; 360:1509- 17; PMID:19357406; http://dx.doi.org/10.1056/NEJMoa0810780 www.landesbioscience.com 189 Temperature,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
FASEB J 2009; 23: 3113-20; PMID:19417078; http://dx.doi.org/ 10.1096/fj.09-133546 31.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Eur J Nucl Med Mol Imaging 2007; 34:1018-22; PMID:17225118; http://dx.doi.org/10.1007/s00259-006-0318-9 32.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Clin Nucl Med 2006; 31:193-6; PMID:16550009; http://dx.doi.org/10.1097/01.rlu.0000204199.33136.05 33.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Comp Biochem Physiol A Comp Physiol 1972;41:409-19; PMID:4404317; http://dx.doi.org/ 10.1016/0300-9629(72)90071-0 37.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Cell Biol 1988; 107:1099-112;PMID:3417775; http://dx.doi.org/10.1083/jcb.107.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Nat Med 2012; 18:1575-9; PMID:22961106; http://dx.doi.org/10.1038/nm.2897 42.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Clin Lab Med 2006; 26:165-84; PMID:16567230; http://dx.doi.org/10.1016/j.cll.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Nature 1990;343:559-61; PMID:1967823; http://dx.doi.org/ 10.1038/343559a0 45.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Nature 2003; 426:403-4; PMID:14647371; http://dx.doi.org/10.1038/426403a 46.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Thyroid 1995; 5:481-92;PMID:8808101; http://dx.doi.org/10.1089/thy.1995.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
FEBS Lett 2003;543:5-10; PMID:12753895; http://dx.doi.org/ 10.1016/S0014-5793(03)00320-X 48.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Biol Chem 1999; 274:26003-7; PMID:10473545; http://dx.doi.org/ 10.1074/jbc.274.37.26003 49.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Diabetes 2000; 49:143-56; PMID:10868929; http://dx.doi.org/10.2337/diabetes.49.2.143 50.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Biochem BiophysRes Commun 1997; 235:79-82; PMID:9196039; http://dx.doi.org/10.1006/bbrc.1997.6740 51.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Biol Chem 2000; 275: 16251-7; PMID:10748195; http://dx.doi.org/10.1074/jbc.M910177199 53.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Biol Chem 1997; 272:24129-32;PMID:9305858; http://dx.doi.org/10.1074/jbc.272.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Bio- chem Biophys Res Commun 1997; 240:222-7; PMID:9367914; http://dx.doi.org/10.1006/bbrc.1997.7636 59.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Pharmacol Ther 2003; 99:45-53; PMID:12804698; http://dx.doi.org/10.1016/S0163-7258(03)00052-461.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Biochem Pharmacol 1987; 36:2297-303; PMID:2886126; http://dx.doi.org/10.1016/0006-2952(87)90594-6 62.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Br J Pharmacol 2010; 160: 1029-44; PMID:20590597; http://dx.doi.org/10.1111/j.1476-5381.2010.00722.x 63.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Nat Rev Neurosci 2003; 4:13-25; PMID:12511858; http://dx.doi.org/10.1038/nrn1008 64.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Pharmacol Rev 2003; 55: 463-508; PMID:12869661; http://dx.doi.org/ 10.1124/pr.55.3.3 65.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Neuropsychobiology 2008; 57:165-80; PMID:18654086; http://dx.doi.org/10.1159/000147470 66.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Toxicology 2005; 206:349-58; PMID:15588925; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Environ Res 2003; 92:48-53; PMID:12706754; http://dx.doi.org/10.1016/S0013-9351(02)00051-8 71.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Brain Res 1994; 658:33-8; PMID:7530580; http://dx.doi.org/10.1016/S0006-8993(09)90007-5 72.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Neuropharmacology 2002; 42:697-705; PMID:11985828; http://dx.doi.org/10.1016/S0028- 3908(02)00016-3 76.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Neuroscience 1999; 92:1011-23; PMID:10426541; http://dx.doi.org/10.1016/S0306-4522(99)00049-4 77.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Br J Pharmacol 2001; 133:429-37; PMID:11375260; http://dx.doi.org/10.1038/sj.bjp.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Neuropsycho- pharmacology 1994; 10:231-8; PMID:7945733; http://dx.doi.org/10.1038/npp.1994.26 79.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Eur J Pharmacol 2003; 476:31-4; PMID:12969746; http://dx.doi.org/10.1016/S0014- 2999(03)02173-3 80.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Pharm Pharmacol1994; 46:826-32; PMID:7699571; http://dx.doi.org/ 10.1111/j.2042-7158.1994.tb03738.x 81.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Neuroscience 2006; 141:2067-73; PMID:16814930; http://dx.doi.org/ 10.1016/j.neuroscience.2006.05.050 82.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
"The preservation of in vivo phosphorylated and activated uncoupling protein 3(UCP3) in isolated skeletal muscle mitochondria fol- lowing administration of 3,4-methylenedioxyme- thamphetamine (MDMA aka ecstasy) to ratsmice.Mitochondrion 2012; 12:110-9; PMID:21453795; http://dx.doi.org/10.1016/j.mito.2011.03.011 84.",Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Pharmacol Exp Ther 2003; 305:159-66; PMID:12649364; http://dx.doi.org/10.1124/jpet.102.044982 85.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Forensic Sci 2007; 52:951-3; PMID:17524054; http://dx.doi.org/10.1111/j.1556- 4029.2007.00463.x 86.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Br J Pharmacol 2007; 151:1103-08; PMID:17533413; http://dx.doi.org/ 10.1038/sj.bjp.0707312 88.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Br J Pharmacol 1993; 109:1157-63; PMID:8104645; http://dx.doi.org/ 10.1111/j.1476-5381.1993.tb13743.x 90.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Int J Obes Relat Metab Disord 1999; 23:1057-65; PMID:10557026; http://dx.doi.org/ 10.1038/sj.ijo.0801039 91.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Obes Res 1995; 3 Suppl 4:537S-540S; PMID:8697055; http://dx.doi.org/10.1002/j.1550- 8528.1995.tb00224.x 92.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Br J Pharmacol 2012; 166: 2277-88; PMID:22404145; http://dx.doi.org/ 10.1111/j.1476-5381.2012.01936.x 94.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Biochem Pharma- col 2004; 68:1339-43; PMID:15345323; http://dx.doi.org/10.1016/j.bcp.2004.03.049 95.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
"J Emerg Med 2014; 46:632-42; PMID:24565885; http://dx.doi.org/ 10.1016/j.jemermed.2013.11.104 96 Iqbal MM, Basil MJ, Kaplan J, Iqbal T. Overview of serotonin syndrome.",Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Lancet 1993; 342:1419; PMID:7901695; http://dx.doi.org/10.1016/0140-6736(93)92774-N 99.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Med Baltimore 2000; 79:201-9; PMID:10941349; http://dx.doi.org/10.1097/ 00005792-200007000-00001 100.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
2000; 150:9-14; PMID:10867971; http://dx.doi.org/10.1007/s002130000397 101.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Neurochem Int 2003; 43:155-64;PMID:12620284; http://dx.doi.org/10.1016/S0197- 0186(02)00213-9 102.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Pharmacol Biochem Behav 1993; 45:629-37; PMID:8392732; http://dx.doi.org/ 10.1016/0091-3057(93)90518-X103.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Anesthesiol- ogy 2004; 101:263-author reply 264;PMID:15220816; http://dx.doi.org/10.1097/ 00000542-200407000-00053 105.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Science 1991; 253:448-51; PMID:1862346; http://dx.doi.org/ 10.1126/science.1862346 106.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Anes- thesiology 2003; 99:1132-36; PMID:14576550; http://dx.doi.org/10.1097/00000542-200311000-00020 107.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Acta Anaesthesiologica Scandinavica 1990; 34: 677-82; PMID:24843434; http://dx.doi.org/10.1111/j.1399-6576.1990.tb03172.x 108.,OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Br J Anaesth 1978; 50:241-6; PMID:637997; http://dx.doi.org/10.1093/bja/50.3.241 110.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Eur J Anaesthesiol 2013; 30:29- 37; PMID:23138574; http://dx.doi.org/10.1097/ EJA.0b013e32835a1127 112.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
J Pharmacol Exp Ther 2005; 314:1267-73;PMID:15947037; http://dx.doi.org/10.1124/jpet.,Non-OADS,/arxiv_data1/oa_pdf/df/28/ktmp-01-03-985953.PMC5008714.pdf
Am J Physiol Regul IntegrComp Physiol 2007; 292:R37-46; PMID:17008453; http://dx.doi.org/10.1152/ajpregu.00668.2006.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/ktmp-01-03-980138.PMC5008715.pdf
"Temperature2014; 1(3):267-74; http://dx.doi.org/10.4161/23328940.2014.944811 Keywords: calorimetry, comparator, heat regulation, homeostasis, nitrousoxide, null zone, set point, thermoeffec-tor responses, thermoregulatorythreshold © Andreas D Flouris *Correspondence to: Andreas D Flouris; Email: andreas ﬂouris@gmail.com Submitted: 10/11/2014Revised: 10/21/2014Accepted: 10/21/2014 http://dx.doi.org/10.4161/23328940.2014.980138 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/a5/00/ktmp-01-03-980138.PMC5008715.pdf
Am J Physiol Regul Integr Comp Physiol 2007; 292:R37-46; PMID:17008453; http://dx.doi.org/ 10.1152/ajpregu.00668.2006 3.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/ktmp-01-03-980138.PMC5008715.pdf
Temperature 2014; 1(3):256-66; http://dx.doi.org/10.4161/23328940.2014.944809 5.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/ktmp-01-03-980138.PMC5008715.pdf
Temperature 2014; 1(3):247-55; http://dx.doi.org/10.4161/23328940.2014.944802 6.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/ktmp-01-03-980138.PMC5008715.pdf
Eur J Appl Physiol 2011; 111:1-8; PMID:20711785; http://dx.doi.org/10.1007/s00421-010-1602-8 9.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/ktmp-01-03-980138.PMC5008715.pdf
"16Neuroleptic malignant © Matthias E Liechti *Correspondence to: Matthias E Liechti; Email: matthias.liechti@usb.chSubmitted: 07/12/2014; Revised: 07/12/2014; Accepted: 07/28/2014 http://dx.doi.org/10.4161/23328940.2014.955433 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.or g/licenses/ by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Pharmacol Rev 2003; 55:463- 508; PMID:12869661; http://dx.doi.org/10.1124/ pr.55.3.3.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Hum Exp Toxicol 2011; 30:259-66; PMID:20488845; http://dx.doi.org/ 10.1177/0960327110370984.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Lancet 1992; 340:384-7;PMID:1353554; http://dx.doi.org/10.1016/0140- 6736(92)91469-O.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
JAccid Emerg Med 1998; 15:322-6; PMID:9785160; http://dx.doi.org/10.1136/emj.15.5.322.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Br J Anaesth 2006; 96:678-85; PMID:16595612; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Pharmacol Exp Ther 2005; 313:629-39; PMID:15644431; http://dx.doi.org/10.1124/jpet.104.079236.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Med Clin North Am 2005; 89:1277-96; PMID:16227063; http://dx.doi.org/ 10.1016/j.mcna.2005.06.002.14.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Eur J Pharmacol 2004; 500:3-13; PMID:15464016; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharmacology (Berl) 2013; 225:765-80; PMID:23274506; http://dx.doi.org/10.1007/s00213- 012-2957-9.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
N Engl J Med 2005; 352:1112-20; PMID:15784664; http://dx.doi.org/10.1056/NEJMra041867.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Aust N Z J Psychiatry 2007; 41:649-55; PMID:17620161; http://dx.doi.org/10.1080/00048670701449237.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Nature 2003; 426:403-4; PMID:14647371; http://dx.doi.org/10.1038/426403a.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Mol Med 2004; 82:787-99; PMID:15602689; http://dx.doi.org/10.1007/ s00109-004-0591-7.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
The role of 5-HT in the impairment of thermo- regulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature.Psychopharmacology (Berl) 2005; 179:884-90; PMID:15650843; http://dx.doi.org/B10.1007/ s00213-004-2106-1.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Eur J Anaesthesiol 2013; 30:29- 37; PMID:23138574; http://dx.doi.org/10.1097/EJA.0b013e32835a1127.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Physiol Behav 1995; 58:877-82; PMID:8577883; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Neurosci 2014; 34:7754-62;PMID:24899699; http://dx.doi.org/10.1523/ JNEUROSCI.0506-14.2014.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Eur J Neurosci 2004; 20:51-8;PMID:15245478; http://dx.doi.org/10.1111/j.0953- 816X.2004.03453.x.26.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Emerg Med 2005; 29:451-4; PMID:16243206; http://dx.doi.org/ 10.1016/j.jemermed.2005.05.007.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Clin Pharmacol Ther 2011; 90:246-55;PMID:21677639; http://dx.doi.org/10.1038/clpt.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
PLoS One 2012; 7:e36476; PMID:22574166; http://dx.doi.org/10.1371/journal.pone.0036476.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Pharmacol Exp Ther 2012; 340:286-94; PMID:22034656; http://dx.doi.org/10.1124/jpet.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Clin Psychopharmacol 2013; 33:658-666; PMID:23857311; http://dx.doi.org/10.1097/JCP.0b013e3182979d32.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharmacology (Berl) 2012; 224:363- 76; PMID:22700038; http://dx.doi.org/10.1007/ s00213-012-2761-6.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Int J Neuropsychopharmacol 2014; 17:371-81; PMID:24103254; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psy- chopharmacology (Berl) 2001; 154:161-8; PMID:11314678; http://dx.doi.org/10.1007/ s002130000648.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Drug Alco-hol Depend 2003; 72:33-44; PMID:14563541; http://dx.doi.org/10.1016/S0376-8716(03)00172-8.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharmacol (Berl) 2002; 162:396-405; PMID:12172693; http://dx.doi.org/10.1007/ s00213-002-1131-1.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharmacol (Berl) 2004; 173:364-75; PMID:15071716; http://dx.doi.org/10.1007/s00213-004-1789-7.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Behav Brain Res 1996;73:103-7; PMID:8788485; http://dx.doi.org/ 10.1016/0166-4328(96)00078-2.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Clin Pharmacol Ther 2009; 86:160-6; PMID:19440186; http://dx.doi.org/10.1038/clpt.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Ann N Y Acad Sci 2000; 914:225-37; PMID:11085324; http://dx.doi.org/10.1111/j.1749-6632.2000.tb05199.x.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neuropsychopharmacology1998; 19:241-51; PMID:9718588; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Psychopharmacol 2000; 14:269-74; PMID:11106307; http://dx.doi.org/10.1177/026988110001400313.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neu- ropsychopharmacology 2000; 23:396-404; PMID:10989266; http://dx.doi.org/10.1016/S0893-133X (00)00126-3.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neuropsychopharmacology 2000; 23:388- 95; PMID:10989265; http://dx.doi.org/10.1016/S0893-133X(00)00130-5.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Eur Neuropsychopharmacol 2000; 10:289-295;PMID:10871712; http://dx.doi.org/10.1016/S0924- 977X(00)00086-9.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Psychopharmacol 2014; 28:847-56; PMID:25052243; http://dx.doi.org/10.1177/ 0269881114542454 48.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharmacol (Berl) 2012; 219:109-22; PMID:21713605; http://dx.doi.org/10.1007/s00213-011-2383-4.49.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J ClinPsychopharmacol 2008; 28:432-40; PMID: 18626271; http://dx.doi.org/10.1097/JCP.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharma- cology 2007; 189:489-503; PMID:16220332; http://dx.doi.org/10.1007/s00213-005-0174-5.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Eur J Pharmacol 1988; 149:159-63; PMID:2899513; http://dx.doi.org/10.1016/0014-2999(88)90056-8.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neuropsychopharmacology 2000; 22:513-21; PMID:10731626; http://dx.doi.org/10.1016/S0893- 133X(99)00148-7.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Pharmacol Exp Ther 2007; 323:954-62; PMID:17890444; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psy- chopharmacology 2007; 189:565-73;PMID:17047932; http://dx.doi.org/10.1007/s00213- 006-0576-z.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neuropharmacology 2001; 40:65-74; PMID:11077072; http://dx.doi.org/10.1016/S0028-3908(00)00106-4.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Drugs 1990; 40:903-49; PMID:2079001; http://dx.doi.org/10.2165/00003495-199040060-00010.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Emerg Med J 2010; 27:586-9; PMID:20378736; http://dx.doi.org/10.1136/emj.2009.079905.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
BMC Res Notes2013; 6:220; PMID:23734766; http://dx.doi.org/ 10.1186/1756-0500-6-220.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Pharmacol Exp Ther 2003; 305:159-66;PMID:12649364; http://dx.doi.org/10.1124/ jpet.102.044982.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Pharmacol Exp Ther 2002; 303:395-402; PMID:12235276; http://dx.doi.org/10.1124/ jpet.102.037473.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Neural Transm 2007; 114:959-68;PMID:17520319; http://dx.doi.org/10.1007/ s00702-007-0715-7.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychophar- macology (Berl) 2012; 220:751-62; PMID:21993879; http://dx.doi.org/10.1007/s00213-011-2529-4.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Clin Toxicol (Phila) 2012; 50:39- 43; PMID:22148985; http://dx.doi.org/10.3109/15563650.2011.635148.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Acta Anaesthe-siol Scand 2003; 47:1298-9; PMID:14616331; http://dx.doi.org/10.1046/j.1399-6576.2003.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Anal Toxicol 2003; 27:253-6; PMID:12820749; http://dx.doi.org/ 10.1093/jat/27.4.253.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neuro- pharmacology 2014; 79:152-60; PMID:24275046; http://dx.doi.org/10.1016/j.neuropharm.2013.11.008.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Int J Legal Med 2001; 114:352-6; PMID:11508803; http://dx.doi.org/10.1007/s004140100204.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Ann Emerg Med 2012; 60:103-5; PMID:22387085; http://dx.doi.org/10.1016/j.annemergmed.2012.01.005.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Clin Psy- chopharmacol 2012; 32:299-300; PMID:22388166; http://dx.doi.org/10.1097/JCP.0b013e3182499677.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Am J Emerg Med 1989; 7:313-20;PMID:2565724; http://dx.doi.org/10.1016/0735- 6757(89)90179-4.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Psychopharmacology 1995; 119:247-60;PMID:7675958; http://dx.doi.org/10.1007/ BF02246288.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Anesthesiol-ogy 2004; 101:263; author reply 264; PMID: 15220814; http://dx.doi.org/10.1097/00000542- 200407000-00053.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Neuroreport 1998; 9:3897-902; PMID:9875725; http://dx.doi.org/10.1097/00001756-199812010-00024.82.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Ann Emerg Med 1985; 14:1112-3; PMID:4051280; http://dx.doi.org/10.1016/S0196-0644(85)80934-3.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Am J Med 1993; 94:608-10; PMID:8506886; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Effects of labetalol treatment on the physi- ological and subjective response to smoked cocaine.Pharmacol Biochem Behav 2000; 65:255-9; PMID:10672977; http://dx.doi.org/10.1016/S0091- 3057(99)00201-4.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Drug Alcohol Depend 2000; 60:69-76; PMID:10821991; http://dx.doi.org/10.1016/S0376-8716(99)00143-X.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Clin Toxicol (Phila) 2014; 52:406; http://dx.doi.org/10.3109/15563650.2014.906213.89.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Lancet 1996; 347:1052; PMID:8606600; http://dx.doi.org/10.1016/S0140-6736(96)90196-8.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
QJM 2002; 95:431-437; PMID:12096147; http://dx.doi.org/10.1093/qjmed/95.7.431.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
J Clin Endocrinol Metab 2011;96:2844-50; PMID:21715530; http://dx.doi.org/ 10.1210/jc.2011-1143.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Ann Emerg Med 2007; 49:164-71;PMID:17084942; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Am J Med Sci 2003; 326:89-93; PMID:12920440; http://dx.doi.org/10.1097/00000441-200308000-00006.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Dtsch Med Wochenschr 2001; 126:809-11; PMID:11499262; http://dx.doi.org/10.1055/s-2001-15702.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Ann N Y Acad Sci 2008; 1139:242-58; PMID:18991870; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/63/ktmp-01-03-955433.PMC5008716.pdf
Temperature 2014; 1(3):213-18; http://dx.doi.org/10.4161/23328940.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
"*Correspondence to: Eugene A Kiyatkin; Email: ekiyatki@intra.nida.nih.gov Submitted: 10/17/2014Revised: 10/20/2014Accepted: 10/20/2014http://dx.doi.org/10.4161/23328940.2014.980137 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
Temperature 2014; 1(13):213-18; http://dx.doi.org/10.4161/23328940.2014.977182 2.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
Temperature 2014; 1(3):191-99; http://dx.doi.org/10.4161/23328940.2014.955433 3.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
Eur J Neurosci 2004; 20:51-8; PMID:15245478; http://dx.doi.org/10.1111/j.0953-816X.2004.03453.x 4.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
J. Neurosci 2014; 34:7754-62; PMID:24899699; http://dx.doi.org/ 10.1523/JNEUROSCI.0506-14.2014 5.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
Pharmacol Res Perspect 2014 Apr 1; 2(2):e00031;PMID:24765530; http://dx.doi.org/10.1002/prp2.31 6.,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
Ann NY Acad Sci 2008; 1139:242-58; PMID:18991870; http://dx.doi.org/10.1196/annals.1432.052 7.,OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
Eur J Neurosci 2007; 26:1242-53; PMID:17767502; http://dx.doi.org/ 10.1111/j.1460-9568.2007.05741.x www.landesbioscience.com 161 Temperature,Non-OADS,/arxiv_data1/oa_pdf/77/1c/ktmp-01-03-980137.PMC5008718.pdf
"The method developed in this study offers a cheap and effective alternative for immediateenzyme isolation from the production medium and its stabilization, compared to other carriers used for the immobilization.Received: 27 January 2016 Revised: 16 July 2016 Accepted: 17 August 2016 Heliyon 2 (2016) e00146 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
It is a Article No~e00146 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Thecollected supernatant was stored in the fridge at 4 °C and represents a cellulase Article No~e00146 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Column height (cm) Immobilization yield (%) Avicelase activity (U/g) 1 11.86 ± 2.14 0.43 ± 2.77 2 14.75 ± 2.21 0.54 ± 2.53 3 15.41 ± 2.33 0.57 ± 2.17 Article No~e00146 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
"Parameters Pseudo-first order kinetic model Pseudo-second order kinetic model Temperature ( °C) q e,exp(U/g) k 1 (1/min)qe,cal (U/g)R2k2 (g/U min)qe,cal (U/g)R2 30 2.8501 0.0059 0.7789 0.0653 0.0581 2.7785 0.9742 40 3.3246 0.0672 1.5018 0.4679 0.0191 3.9404 0.9834 45 5.4813 0.0116 1.0481 0.0783 0.0123 5.5788 0.9872 50 4.1725 0.0233 3.1737 0.9429 0.0148 5.0123 0.9881 Article No~e00146 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
"Dimitrijevi ć -Brankovi ć, Rapid cationic dye Article No~e00146 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
Article No~e00146 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00146 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC5008956.pdf
"This system was designed to generate a robust immune response by stimulating IL-1 βproduction through Toll-like receptor 4 (TLR4), a potent mechanism for mucosal immunity.Received: 1 June 2016 Revised: 25 July 2016 Accepted: 19 August 2016 Heliyon 2 (2016) e00147 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
"We believe that a nicotine vaccine will be most effective when antibodies are available to block nicotine at two levels: A) in mucussecretions of the respiratory tract to block nicotine absorption into the blood, and Article No~e00147 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Nicotinewas also quantified by using UV adsorption of derived nicotine as a standard at Article No~e00147 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
The cell suspension Article No~e00147 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Unless otherwise Article No~e00147 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
We chose to use LPS as a Article No~e00147 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
"Total anti-nicotine IgG titers further indicate increasing levels of IgG, which peaked at day 56 Article No~e00147 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Last accessed on 24 August 2016 http://www.who.int/mediacentre/factsheets/fs339/en/ .,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Last accessed on 24 August 2016 http://www.tobaccoreport.ca/2012/ .,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
http://www.ncbi.nlm.nih.gov/pubmed/12538044 .,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
Article No~e00147 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00147 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/59/main.PMC5008958.pdf
"The evolution of species may appear to be a self-organized critical phenomenon, the size distribution of extinction events possibly following a power law [ 4,5,7,8,9].Received: 5 April 2016 Revised: 25 July 2016 Accepted: 16 August 2016 Heliyon 2 (2016) e00144 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
We hope the present study with evolution models Article No~e00144 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
"Species with fitness in the active phase may trigger mutations, whereas Article No~e00144 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
"Interestingly, Article No~e00144 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
x Abundancy Vector (Configuration Vector) z Asymmetric Interaction Matrixu Self-Interaction Vector u Mean Value of Self-Interaction C Matrix of Connectivity Parameters Γ Symmetry Parameter K Interaction MatrixF Fitness Vector I Inheritance Parameter Article No~e00144 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
"(7)simply results from the first species appearing at unit abundance, and the Article No~e00144 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
Article No~e00144 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00144 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/7f/main.PMC5008959.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)Correlated INSIG1 and triglyceride statin response E Theusch et al 229 The Pharmacogenomics Journal (2017), 222 –229",Non-OADS,/arxiv_data1/oa_pdf/d6/47/tpj201612a.PMC5008997.pdf
"In addition, pneumatic tourniquets are utilized by most TKA  surgeon due to the advantages of preventing intraoperative Editorial  Knee Surg Relat Res 2016;28(3):177-178 http://dx.doi.org/10.5792/ksrr.2016.28.3.177pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research 177Copyright © 2016 KOREAN KNEE SOCIETY www.jksrr.orgBlood Management in Total Knee Arthroplasty:  Updates and Debates Kang-Il Kim, MD, PhD Department of Orthopaedic Surgery, Kyung Hee University School of Medicine, Seoul, Korea Correspondence to: Kang-Il Kim, MD, PhD Department of Orthopaedic Surgery, Center for Joint Diseases, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, KoreaTel: +82-2-440-6151, Fax: +82-2-440-7468E-mail: kneedr@hotmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/0f/ksrr-28-177.PMC5009040.pdf
"Keywords: Knee, a rthroplasty, Blood, c onservation strategiesReview Article Knee Surg Relat Res 2016;28(3):179-187http://dx.doi.org/10.5792/ksrr.2016.28.3.179pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 22, 2015; Revised December 21, 2015;  Accepted January 18, 2016Correspondence to: David Liu, FRACSGold Coast Centre for Bone and Joint Surgery, Suite 8A Fred McKay House, Tugun, Queensland 4224, AustraliaTel: +61-7-5598-0205, Fax: +61-7-5598-0294E-mail: dliu01@bigpond.com 179This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/24/ksrr-28-179.PMC5009041.pdf
Available from: https://www.aoa.org.au/.,Non-OADS,/arxiv_data1/oa_pdf/49/24/ksrr-28-179.PMC5009041.pdf
"Keywords: Knee, a rthroplasty, t ransexamic acid, Blood loss, t ransfusionOriginal Article Knee Surg Relat Res 2016;28(3):188-193http://dx.doi.org/10.5792/ksrr.2016.28.3.188pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received February 2, 2016; Revised (1st) March 28, 2016;  (2nd) May 18, 2016; Accepted May 18, 2016Correspondence to: Eun-Kyoo Song, MDDepartment of Orthopaedic Surgery, Chonnam National University Bitgoeul Hospital, 80 Deongnam-gil, Nam-gu, Gwangju 61748, KoreaTel: +82-62-670-9475, Fax: +82-62-670-9476E-mail: eksong@jnu.ac.kr 188This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/d5/ksrr-28-188.PMC5009042.pdf
"Keywords: Knee, a rthroplasty, Blood loss, t ransexamic acid, n eutral drainageOriginal Article Knee Surg Relat Res 2016;28(3):194-200http://dx.doi.org/10.5792/ksrr.2016.28.3.194pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research 194This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/ksrr-28-194.PMC5009043.pdf
"Keywords: Knee, a rthroplasty, Bilateral, Blood loss, t ransfusion, drainageOriginal Article Knee Surg Relat Res 2016;28(3):201-206http://dx.doi.org/10.5792/ksrr.2016.28.3.201pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received October 22, 2015; Revised (1st) November 30, 2015;  (2nd) January 11, 2016; Accepted February 10, 2016Correspondence to: Anoop Jhurani, MSDepartment of Orthopaedics, Fortis Escorts Hospital, Jawaharlal Nehru Marg, Near World Trade Park, Malviya Nagar, Jaipur, Rajasthan 302017, IndiaTel: +91-141-254-7000, Fax: +91-141-254-7002E-mail: anoopjhurani@gmail.com 201This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/0d/ksrr-28-201.PMC5009044.pdf
"Keywords: Knee, a rthroplasty, thromboembolism, p rophylaxis, SurveyOriginal Article Knee Surg Relat Res 2016;28(3):207-212http://dx.doi.org/10.5792/ksrr.2016.28.3.207pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 11, 2016; Revised May 1, 2016; Accepted May 22, 2016Correspondence to: Churl Hong Chun, MDDepartment of Orthopaedic Surgery, Wonkwang University School of Medicine, 895 Muwang-ro, Iksan 54538, KoreaTel: +82-63-859-1363, Fax: +82-63-852-9329E-mail: cch@wonkwang.ac.kr 207This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/6a/ksrr-28-207.PMC5009045.pdf
"Keywords: Knee, a rthroplasty, thromboembolism, p rophylaxis, Mechanical, i ntermittent pneumatic compression deviceOriginal Article Knee Surg Relat Res 2016;28(3):213-218http://dx.doi.org/10.5792/ksrr.2016.28.3.213pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 26, 2016; Revised (1st) March 28, 2016; (2nd) May 27, 2016;  (3rd) June 30, 2016; Accepted July 16, 2016Correspondence to: Soo Jae Yim, MDDepartment of Orthopaedic Surgery, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, KoreaTel: +82-32-621-5260, Fax: +82-32-621-5018E-mail: yims@chol.com 213This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/2d/ksrr-28-213.PMC5009046.pdf
"Keywords: Knee, o steoarthritis, f unction, Quality of lifeOriginal Article Knee Surg Relat Res 2016;28(3):219-224 http://dx.doi.org/10.5792/ksrr.2016.28.3.219pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 3, 2015; Revised (1st) July 9, 2015; (2nd) September 21, 2015; (3rd) November 3, 2015; (4th) November 30, 2015; (5th) January 14, 2016; (6th) January 21, 2016; Accepted January 21, 2016Correspondence to: Marcos Almeida Matos, PhDDepartment of Post-Graduation, Bahiana School of Medicine and Public Health, Rua da Ilha, 378, Itapua, 41620-620 Salvador, Bahia, BrazilTel: +55-71-8719-0773, Fax: +55-71-3358-8886E-mail: marcos.almeida@hotmail.com 219This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/d0/ksrr-28-219.PMC5009047.pdf
"Keywords: Knee, Medial meniscus, h orizontal tear, a rthroscopy, MeniscectomyOriginal Article Knee Surg Relat Res 2016;28(3):225-232http://dx.doi.org/10.5792/ksrr.2016.28.3.225pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 3, 2015; Revised March 10, 2016; Accepted June 22, 2016Correspondence to: Ji-Hoon Bae, MDDepartment of Orthopedic Surgery, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, KoreaTel: +82-2-2626-3296, Fax: +82-2-2626-1164E-mail: osman@korea.ac.kr  225This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/70/ksrr-28-225.PMC5009048.pdf
"Keywords: Knee, a rthroplasty, f emoral nerve block, l ocal infiltration analgesia, f lexion contractureOriginal Article Knee Surg Relat Res 2016;28(3):233-238 http://dx.doi.org/10.5792/ksrr.2016.28.3.233pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 5, 2016; Revised (1st) February 8, 2016;  (2nd) March 14, 2016; Accepted March 27, 2016Correspondence to: Yuji Arai, MDDepartment of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanTel: +81-75-251-5549, Fax: +81-75-251-5841E-mail: yarai89046@nike.eonet.ne.jp 233This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/28/ksrr-28-233.PMC5009049.pdf
"Keywords: Knee, a rthroplasty, i nfection, r evision, t wo-stage, a rticulating spacer, n ew prosthesisOriginal Article Knee Surg Relat Res 2016;28(3):239-244http://dx.doi.org/10.5792/ksrr.2016.28.3.239pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received February 18, 2015; Revised (1st) June 17, 2015;  (2nd) October 11, 2015; (3rd) February 3, 2016; (4th) February 17, 2016 Accepted March 4, 2016Correspondence to: Rasmus Juul, MDDepartment of Orthopaedic Surgery, Zealand University Hospital, Lykkebækvej 1, Koge 4600, DenmarkTel: +45-4076-4590, Fax: +45-56-63-15-39E-mail: rasmusjuul@dadlnet.dk 239This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/48/ksrr-28-239.PMC5009050.pdf
"Keywords: Knee, l ateral meniscus, Meniscofemoral ligament Case Report Knee Surg Relat Res 2016;28(3):245-248http://dx.doi.org/10.5792/ksrr.2016.28.3.245pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 17, 2015; Revised August 10, 2015;  Accepted August 11, 2015Correspondence to: Y ong-Bum Joo, MDDepartment of Orthopedic Surgery, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, KoreaTel: +82-42-338-2412, Fax: +82-42-252-7098E-mail: longman76@hanmail.net 245This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/5b/ksrr-28-245.PMC5009051.pdf
"Keywords: f emur, Synovial sarcoma, Myositis ossificans, Soft tissue, i njury, n eoplasmCase Report Knee Surg Relat Res 2016;28(3):249-252http://dx.doi.org/10.5792/ksrr.2016.28.3.249pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 12, 2015; Revised March 5, 2016;  Accepted March 21, 2016Correspondence to: Mehmet Sabri Balik, MDDepartment of Orthopaedic and Traumatology, Recep Tayyip Erdogan University, Islampasa Mahallesi, Sehitler Caddesi, No.",Non-OADS,/arxiv_data1/oa_pdf/5e/eb/ksrr-28-249.PMC5009052.pdf
"74, 53100 Rize, TurkeyTel: +90-464-213-0491, Fax: +90-464-212-3015E-mail: sabribalik@yahoo.com 249This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/eb/ksrr-28-249.PMC5009052.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdEDITORIAL Hsu and Sheu http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/8d/42/JDI-7-649.PMC5009124.pdf
5 September 2016 651EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Editorial,Non-OADS,/arxiv_data1/oa_pdf/8d/42/JDI-7-649.PMC5009124.pdf
5 September 2016 653REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neutrophils in type 1 diabetes,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
5 September 2016 655REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neutrophils in type 1 diabetes,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
5 September 2016 657REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neutrophils in type 1 diabetes,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
5 September 2016 659REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neutrophils in type 1 diabetes,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
5 September 2016 661REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neutrophils in type 1 diabetes,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
5 September 2016 663REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neutrophils in type 1 diabetes,Non-OADS,/arxiv_data1/oa_pdf/31/7a/JDI-7-652.PMC5009125.pdf
5 September 2016 665REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Japanese American Diabetes Study,Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Fujimoto http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
5 September 2016 667REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Japanese American Diabetes Study,Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Fujimoto http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
5 September 2016 669REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Japanese American Diabetes Study,Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Fujimoto http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
5 September 2016 671REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Japanese American Diabetes Study,Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdREVIEW ARTICLE Fujimoto http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
5 September 2016 673REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Japanese American Diabetes Study,Non-OADS,/arxiv_data1/oa_pdf/15/89/JDI-7-664.PMC5009126.pdf
5 September 2016 675COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Relationship between SU and CV events,Non-OADS,/arxiv_data1/oa_pdf/2d/03/JDI-7-674.PMC5009127.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdCOMMENTARY Shimoda and Kaku http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/2d/03/JDI-7-674.PMC5009127.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdCOMMENTARY Matsuzaka and Shimano http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/6f/64/JDI-7-677.PMC5009128.pdf
5 September 2016 679COMMENTARY http://onlinelibrary.wiley.com/journal/jdi CRTC2 regulates SREBP-1 processing,Non-OADS,/arxiv_data1/oa_pdf/6f/64/JDI-7-677.PMC5009128.pdf
5 September 2016 681ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi VD regulates podocytes via NF- jB pathway,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
5 September 2016 683ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi VD regulates podocytes via NF- jB pathway,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
5 September 2016 685ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi VD regulates podocytes via NF- jB pathway,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
5 September 2016 687ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi VD regulates podocytes via NF- jB pathway,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/09/39/JDI-7-680.PMC5009129.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3a/31/JDI-7-689.PMC5009130.pdf
5 September 2016 691ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Hypertriglyceridemic waist and T2DM,Non-OADS,/arxiv_data1/oa_pdf/3a/31/JDI-7-689.PMC5009130.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3a/31/JDI-7-689.PMC5009130.pdf
5 September 2016 693ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Hypertriglyceridemic waist and T2DM,Non-OADS,/arxiv_data1/oa_pdf/3a/31/JDI-7-689.PMC5009130.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3a/31/JDI-7-689.PMC5009130.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
5 September 2016 697ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi To screen DM and pre-DM in China,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
5 September 2016 699ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi To screen DM and pre-DM in China,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
5 September 2016 701ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi To screen DM and pre-DM in China,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0a/49/JDI-7-695.PMC5009131.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
5 September 2016 705CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Insulin degludec in T1D and T2D-BBT,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
5 September 2016 707CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Insulin degludec in T1D and T2D-BBT,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
5 September 2016 709CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Insulin degludec in T1D and T2D-BBT,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/45/55/JDI-7-703.PMC5009132.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
5 September 2016 713CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Flexible IDeg dosing in Japanese adults,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
5 September 2016 715CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Flexible IDeg dosing in Japanese adults,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
Available at: https://www.pmda.go.jp/index.html.,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
5 September 2016 717CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Flexible IDeg dosing in Japanese adults,Non-OADS,/arxiv_data1/oa_pdf/8f/28/JDI-7-711.PMC5009133.pdf
5 September 2016 719CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Long-term phase 3 study of trelagliptin,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
5 September 2016 721CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Long-term phase 3 study of trelagliptin,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
5 September 2016 723CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Long-term phase 3 study of trelagliptin,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
5 September 2016 725CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Long-term phase 3 study of trelagliptin,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/98/c5/JDI-7-718.PMC5009134.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
5 September 2016 729CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin +metformin initial treatment,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
5 September 2016 731CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin +metformin initial treatment,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
5 September 2016 733CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin +metformin initial treatment,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
5 September 2016 735CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin +metformin initial treatment,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9a/06/JDI-7-727.PMC5009135.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
5 September 2016 739ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi DPP-4i adherence in Japan,Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
5 September 2016 741ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi DPP-4i adherence in Japan,Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
"Available from: http://www.idf.org/diabetesatlasAccessed January 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
"from: http://www.mhlw.go.jp/stf/houdou/0000032074.html Accessed January 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
"Availablefrom: http://www.jds.or.jp/modules/en/ index.php?content_id=44 Accessed January 15, 2014.",OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
5 September 2016 743ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi DPP-4i adherence in Japan,Non-OADS,/arxiv_data1/oa_pdf/a8/28/JDI-7-737.PMC5009136.pdf
5 September 2016 745ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi No race in ﬂuence on linagliptin effects,Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
5 September 2016 747ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi No race in ﬂuence on linagliptin effects,Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
"Available from: http://bidocs.boehringer-ingel heim.com/BIWebAccess/ ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Tradjenta/Tradjenta.pdf.Accessed 31 July, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
5 September 2016 749ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi No race in ﬂuence on linagliptin effects,Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b4/ab/JDI-7-744.PMC5009137.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a7/f8/JDI-7-751.PMC5009138.pdf
5 September 2016 753SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi SGLT2 inhibition and HbA1c improvement,Non-OADS,/arxiv_data1/oa_pdf/a7/f8/JDI-7-751.PMC5009138.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a7/f8/JDI-7-751.PMC5009138.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
5 September 2016 757ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Tofogli ﬂozin PMS study in the elderly,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
5 September 2016 759ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Tofogli ﬂozin PMS study in the elderly,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
5 September 2016 761ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Tofogli ﬂozin PMS study in the elderly,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
"Available from:http://www.mhlw.go.jp/stf/houdou/0000032074.htmlAccessed October 17, 2015 (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
Available from: http://www.mhlw.go.jp/english/database/db-hss/sp s_2011.html.,OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
5 September 2016 763ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Tofogli ﬂozin PMS study in the elderly,Non-OADS,/arxiv_data1/oa_pdf/f5/4c/JDI-7-755.PMC5009139.pdf
5 September 2016 765ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi CYP2C93 variant and gliclazide ef ﬁcacy,Non-OADS,/arxiv_data1/oa_pdf/b8/7f/JDI-7-764.PMC5009140.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b8/7f/JDI-7-764.PMC5009140.pdf
5 September 2016 767ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi CYP2C93 variant and gliclazide ef ﬁcacy,Non-OADS,/arxiv_data1/oa_pdf/b8/7f/JDI-7-764.PMC5009140.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b8/7f/JDI-7-764.PMC5009140.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
5 September 2016 771ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Pitavastatin on glucose metabolism,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
5 September 2016 773ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Pitavastatin on glucose metabolism,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
5 September 2016 775ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Pitavastatin on glucose metabolism,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ac/f1/JDI-7-769.PMC5009141.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
5 September 2016 779CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi ALC and MC in DPN,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
5 September 2016 781CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi ALC and MC in DPN,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
5 September 2016 783CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi ALC and MC in DPN,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
5 September 2016 785CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi ALC and MC in DPN,Non-OADS,/arxiv_data1/oa_pdf/2f/9a/JDI-7-777.PMC5009142.pdf
5 September 2016 787ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Nocturia and ED in DM,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/JDI-7-786.PMC5009143.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/JDI-7-786.PMC5009143.pdf
5 September 2016 789ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Nocturia and ED in DM,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/JDI-7-786.PMC5009143.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/JDI-7-786.PMC5009143.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c7/4a/JDI-7-791.PMC5009144.pdf
5 September 2016 793ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes and atrial ﬁbrillation,Non-OADS,/arxiv_data1/oa_pdf/c7/4a/JDI-7-791.PMC5009144.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c7/4a/JDI-7-791.PMC5009144.pdf
5 September 2016 795ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes and atrial ﬁbrillation,Non-OADS,/arxiv_data1/oa_pdf/c7/4a/JDI-7-791.PMC5009144.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c7/4a/JDI-7-791.PMC5009144.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
5 September 2016 799ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi AFABP in GDM women,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
5 September 2016 801ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi AFABP in GDM women,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
5 September 2016 803ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi AFABP in GDM women,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/ca/JDI-7-797.PMC5009145.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdLETTER TO THE EDITOR http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/5d/85/JDI-7-805.PMC5009146.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"(a) Couscous, (b) ﬁsh, (c) fresh vegetables, (d) apples.Food consumption estimation Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"4 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"(a) Meat, (b) vegetables, (c) fruits.Food consumption estimation Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"6 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"(a) Protein, (b) fat, (c) carbohydrate.Food consumption estimation Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"8 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
"2015; 115: 64 /C177.Food consumption estimation Citation: Libyan Journal of Medicine 2016, 11: 32676 - http://dx.doi.org/10.3402/ljm.v11.32676 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/26/ce/LJM-11-32676.PMC5009147.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/32/main.PMC5009187.pdf
"In  rare  cases,  however,  HCC  response  may  result  in  increased density  because  of  the  intratumoral  hemorrhage,  which  is  a  rare effect  observed  during  sorafenib  therapy  [15] ,  thus  result  mislead http://dx.doi.org/10.1016/j.ejro.2016.08.002 2352-0477/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d0/32/main.PMC5009187.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/32/main.PMC5009187.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/7b/main.PMC5009188.pdf
"While  the  commonly  known  “blooming  sign”  is  a  strong  indica- tor  for  malignant  lesions  [4],  the  diagnostic  value  of  the  CS  has  not http://dx.doi.org/10.1016/j.ejro.2016.08.004 2352-0477/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/79/7b/main.PMC5009188.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/7b/main.PMC5009188.pdf
"EDITORIAL Won Lee Dental Clinic, Uijeongbu St. Mary’s Hospital, 271 Cheonbo-ro, Uijeongbu  11765, Korea TEL: +82-31-820-3574   FAX: +82-31-847-2894 E-mail: cmfs21@catholic.ac.kr ORCID: http://orcid.org/0000-0002-6383-8754    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC An important Supreme Court decision for the dental field Won Lee, D.D.S., M.S.D., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/53/61/jkaoms-42-173.PMC5009189.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.173 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/53/61/jkaoms-42-173.PMC5009189.pdf
"The ORIGINAL ARTICLE Mohanavalli Singaram Department of Dentistry, ESIC Medical College and Post Graduate Institute of  Medical Sciences and Research, K. K. Nagar, Chennai 6000078, India TEL: +91-044-24748959   FAX: +91-044-24742825 E-mail: mona13omfs@gmail.com ORCID: http://orcid.org/0000-0003-2905-2966    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Prevalence, pattern, etiology, and management of maxillofacial trauma  in a developing country: a retrospective study Mohanavalli Singaram, Sree Vijayabala G, Rajesh Kumar Udhayakumar Department of Dentistry, ESIC Medical College and Post Graduate Institute of Medical Sciences and Research, Chennai, India Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:174-181) Objectives:  This retrospective study aims to evaluate the prevalence of maxillofacial trauma in a developing country, along with its pattern, etiology  and management.",Non-OADS,/arxiv_data1/oa_pdf/41/c6/jkaoms-42-174.PMC5009190.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.174 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/41/c6/jkaoms-42-174.PMC5009190.pdf
"J Korean Assoc Oral Maxillofac Surg 2016;42:174-181 180ORCID Mohanavalli Singaram, http://orcid.org/0000-0003-2905-2966 Sree Vijayabala G, http://orcid.org/0000-0001-9582-2186 References 1.",Non-OADS,/arxiv_data1/oa_pdf/41/c6/jkaoms-42-174.PMC5009190.pdf
"However, there have been various reports of complications,  such as metal toxicity and allergy, stress shielding, metal-ORIGINAL ARTICLE Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 303 Pilmun-daero, Dong-gu, Gwangju 61452, Korea TEL: +82-62-220-3815   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr ORCID: http://orcid.org/0000-0002-0424-9984    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Mini-plate removal in maxillofacial trauma patients   during a five-year retrospective study Hyun-Chun Park, Su-Gwan Kim, Ji-Su Oh, Jae-Seek You, Won-Gi Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:182-186) Objectives:  The purpose of this study was to analyze the incidence of indications for the removal of mini-plates over a five-year period in maxillofa- cial trauma patients.",Non-OADS,/arxiv_data1/oa_pdf/22/32/jkaoms-42-182.PMC5009191.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.182 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/22/32/jkaoms-42-182.PMC5009191.pdf
"ORCID Hyun-Chun Park, http://orcid.org/0000-0003-1937-075X Su-Gwan Kim, http://orcid.org/0000-0002-0424-9984 Ji-Su Oh, http://orcid.org/0000-0002-8369-5025 Jae-Seek You, http://orcid.org/0000-0001-7638-9583 Won-Gi Kim, http://orcid.org/0000-0002-2653-1550 References 1.",Non-OADS,/arxiv_data1/oa_pdf/22/32/jkaoms-42-182.PMC5009191.pdf
"In a  hyperlipidemic condition, protein-bound lipid particles pass  through the endothelial wall into the subendothelial field,  where they are caught and oxidatively modified by reactive ORIGINAL ARTICLE Serkan Dündar Department of Periodontology, Faculty of Dentistry, Firat University, Campus,  Elazig 231119, Turkey TEL: +90-424-237-00-00-6497   FAX: +90-424-2122717 E-mail: dtserkandundar@gmail.com ORCID: http://orcid.org/0000-0003-3944-1957    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC The effects of high-fat diet on implant osseointegration:   an experimental study Serkan Dündar1, Ferhan Yaman2, Muhammed Fatih Ozupek3, Arif Saybak4, Mehmet Gul5,   Fatih Asutay6, Mustafa Kirtay3, Ibrahim Hanifi Ozercan7 1Department of Periodontology, Faculty of Dentistry, Firat University, Elazig,   2Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Dicle University, Diyarbakir,   3Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Inonu University, Malatya,   4Periodontists, Private Practice, Adana,   5Department of Periodontology, Faculty of Dentistry, Dicle University, Diyarbakir,   6Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Afyon Kocatepe University, Afyonkarahisar,   7Department of Medical Pathology, Faculty of Medicine, Firat University, Elazig, Turkey Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:187-192) Objectives:  In this study, we investigated whether a high-fat diet (HFD) affected the bone implant connection (BIC) in peri-implant bone.",Non-OADS,/arxiv_data1/oa_pdf/9a/85/jkaoms-42-187.PMC5009192.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.187 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/9a/85/jkaoms-42-187.PMC5009192.pdf
"High-fat diet and osseointegration 191Mehmet Gul, http://orcid.org/0000-0002-5721-8778 Fatih Asutay, http://orcid.org/0000-0002-5056-8193 Mustafa Kirtay, http://orcid.org/0000-0001-6598-2541 Ibrahim Hanifi Ozercan, http://orcid.org/0000-0002-8781- 8838 References 1.",Non-OADS,/arxiv_data1/oa_pdf/9a/85/jkaoms-42-187.PMC5009192.pdf
"ORCID Serkan Dündar, http://orcid.org/0000-0003-3944-1957 Ferhan Yaman, http://orcid.org/0000-0002-7583-2341 Muhammed Fatih Ozupek, http://orcid.org/0000-0001- 8922-3646 Arif Saybak, http://orcid.org/0000-0003-4566-7282",Non-OADS,/arxiv_data1/oa_pdf/9a/85/jkaoms-42-187.PMC5009192.pdf
"BPs can also counteract the hyper- calcemia of malignancies and carcinomas metastatic to the ORIGINAL ARTICLE Jae-Hoon Lee Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook  University, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea TEL: +82-41-550-0271   FAX: +82-41-551-8988 E-mail: lee201@dankook.ac.kr ORCID: http://orcid.org/0000-0002-9959-4632    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Evaluation of the predisposing factors and involved outcome of surgical  treatment in bisphosphonate-related osteonecrosis of the jaw cases  including bone biopsies Tae-Hwan Kim, Won-Gyo Seo, Chul-Hong Koo, Jae-Hoon Lee Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Cheonan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:193-204) Objectives:  This study examined the statistical relevance of whether the systemic predisposing factors affect the prognosis of surgical treatment of  bisphosphonate-related osteonecrosis of the jaw (BRONJ).",Non-OADS,/arxiv_data1/oa_pdf/95/87/jkaoms-42-193.PMC5009193.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.193 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/95/87/jkaoms-42-193.PMC5009193.pdf
"ORCID Tae-Hwan Kim, http://orcid.org/0000-0001-6226-2733 Won-Gyo Seo, http://orcid.org/0000-0002-6097-1322 Chul-Hong Koo, http://orcid.org/0000-0001-9904-0798 Jae-Hoon Lee, http://orcid.org/0000-0002-9959-4632 References 1.",Non-OADS,/arxiv_data1/oa_pdf/95/87/jkaoms-42-193.PMC5009193.pdf
"In addition, although antimicrobial  treatment is effective, the treatment occurs over a long time CASE REPORT Ju Yeon Cho Department of Dentistry, Dongsan Medical Center, Keimyung University  School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea TEL: +82-53-250-7805   FAX: +82-53-250-7802 E-mail: vice01@hanmail.net ORCID: http://orcid.org/0000-0001-8338-9493    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC The treatment of actinomycosis mimicking a retained root tip:   a confusing case Ju Yeon Cho Department of Dentistry, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:205-208) Actinomycosis is an infection caused by the actinomyces genus and is associated with trauma or previous infection.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/jkaoms-42-205.PMC5009194.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.205 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/a1/48/jkaoms-42-205.PMC5009194.pdf
"Histologically, it is not considered a genuine CASE REPORT Jong-Ki Huh Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital,  Yonsei University College of Dentistry, 211 Eonju-ro, Gangnam-gu, Seoul  06273, Korea TEL: +82-2-2019-4560   FAX: +82-2-3463-4052 E-mail: omshuh@yuhs.ac ORCID: http://orcid.org/0000-0002-7381-3972    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Bony window approach for a traumatic bone cyst on the mandibular  condyle: a case report with long-term follow-up Hyoung Keun Kim1, Jae-Hyung Lim2, Kug-Jin Jeon3, Jong-Ki Huh1 1Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital, Yonsei University College of Dentistry, Seoul,   2Department of Dentistry, Korea University Ansan Hospital, Ansan,   3Department of Oral and Maxillofacial Radiology, Yongin Severance Hospital, Yonsei University College of Dentistry, Yongin, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:209-214) Traumatic bone cyst (TBC) occurs preferentially on the mandibular symphysis and body, but rarely on the mandibular condyle.",Non-OADS,/arxiv_data1/oa_pdf/25/c4/jkaoms-42-209.PMC5009195.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.209 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/25/c4/jkaoms-42-209.PMC5009195.pdf
"ORCID Hyoung Keun Kim, http://orcid.org/0000-0001-6622-7636 Jae-Hyung Lim, http://orcid.org/0000-0001-5874-1918 Kug-Jin Jeon, http://orcid.org/0000-0002-5862-2975 Jong-Ki Huh, http://orcid.org/0000-0002-7381-3972 References 1.",Non-OADS,/arxiv_data1/oa_pdf/25/c4/jkaoms-42-209.PMC5009195.pdf
"Osteomyelitis of the mandible due to an impacted third CASE REPORT Hoon Myoung Department of Oral and Maxillofacial Surgery, Dental Research Institute,  School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea TEL: +82-2-2072-3059   FAX: +82-2-766-4948 E-mail: myoungh@snu.ac.kr ORCID: http://orcid.org/0000-0002-9984-8479    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Chronic suppurative osteomyelitis with proliferative periostitis related to  a fully impacted third molar germ: a report of two cases Joonhyoung Park1, Hoon Myoung1,2 1Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University,   2Dental Research Institute, Seoul National University, Seoul, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:215-220) In prolonged chronic osteomyelitis, chronic inflammation and low-grade infections can result in new periosteal bone formation.",Non-OADS,/arxiv_data1/oa_pdf/a4/ea/jkaoms-42-215.PMC5009196.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.215 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/a4/ea/jkaoms-42-215.PMC5009196.pdf
"ORCID Joonhyoung Park, http://orcid.org/0000-0003-1017-4285 Hoon Myoung, http://orcid.org/0000-0002-9984-8479 References 1.",Non-OADS,/arxiv_data1/oa_pdf/a4/ea/jkaoms-42-215.PMC5009196.pdf
"Most SpCC cases in  the head and neck manifest in male patients between the sixth  and eighth decades of life and in patients who have habits CASE REPORT Chul-Hwan Kim Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook  University, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea TEL: +82-41-550-0271   FAX: +82-41-551-8988 E-mail: kchoms@dankook.ac.kr ORCID: http://orcid.org/0000-0002-5199-2420    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Spindle cell carcinoma of the tongue combined with double primary  cancer of the thyroid gland: a case report Tae-Hwan Kim, Chul-Hwan Kim Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Cheonan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:221-226) Spindle cell carcinoma (SpCC) is referred to as a variant of oral squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/03/63/jkaoms-42-221.PMC5009197.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.221 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/03/63/jkaoms-42-221.PMC5009197.pdf
"ORCID Tae-Hwan Kim, http://orcid.org/0000-0001-6226-2733 Chul-Hwan Kim, http://orcid.org/0000-0002-5199-2420 References 1.",Non-OADS,/arxiv_data1/oa_pdf/03/63/jkaoms-42-221.PMC5009197.pdf
"Therefore, we describe   the importance of early diagnosis and appropriate treatment  of TMJ septic arthritis.CASE REPORT Jin-Yong Cho Department of Oral and Maxillofacial Surgery, Gachon University Gil Medical  Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, Korea TEL: +82-32-460-3372   FAX: +82-32-460-3101 E-mail: omslips@hotmail.com ORCID: http://orcid.org/0000-0001-7945-3923    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Septic arthritis of the temporomandibular joint: a case report Sung-Won Yang, Jin-Yong Cho, Hyeon-Min Kim Department of Oral and Maxillofacial Surgery, Gachon University Gil Medical Center, Incheon, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:227-230) Septic arthritis of the temporomandibular joint (TMJ) is a rare disease.",Non-OADS,/arxiv_data1/oa_pdf/1d/b4/jkaoms-42-227.PMC5009198.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.227 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/1d/b4/jkaoms-42-227.PMC5009198.pdf
"ORCID Sung-Won Yang, http://orcid.org/0000-0002-7265-800X Jin-Yong Cho, http://orcid.org/0000-0001-7945-3923 Hyeon-Min Kim, http://orcid.org/0000-0002-5963-6543 References 1.",Non-OADS,/arxiv_data1/oa_pdf/1d/b4/jkaoms-42-227.PMC5009198.pdf
"The neoplasm  exhibits a slow but limitless growth pattern, and the mandible CASE REPORT Armağan Çalışkan Department of Dentomaxillofacial Radiology, Faculty of Dentistry, Ondokuz  Mayis University, Atakum, Samsun 55139, Turkey TEL: +90-362-312-1919   FAX: +90-362-457-6032 E-mail: armagan.caliskan@omu.edu.tr ORCID: http://orcid.org/0000-0002-8948-2178    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Benign cementoblastoma of the anterior mandible: an unusual case report Armağan Çalışkan1, Tuğçe Berre Karöz2, Mahmut Sumer2, Aydan Açıkgöz1, Yurdanur Süllü3 Departments of 1Dentomaxillofacial Radiology and 2Oral and Maxillofacial Surgery, Faculty of Dentistry,   3Department of Pathology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:231-235) A benign cementoblastoma, which is another name for a true cementoma, is a rare neoplasm that develops from odontogenic ectomesenchyme.",Non-OADS,/arxiv_data1/oa_pdf/21/9f/jkaoms-42-231.PMC5009199.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.231 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/21/9f/jkaoms-42-231.PMC5009199.pdf
"This relatively new term can be found  in PubMed (https://www.ncbi.nlm.nih.gov/pubmed/) in a  total four articles1,4-6, including Park et al.’s article1, using  the keywords “extracorporeal” and “condylar fracture.” This  terminology was used by several authors to describe fixation  of a fragment intentionally detached from the surrounding  hard and soft tissue.",Non-OADS,/arxiv_data1/oa_pdf/d2/bc/jkaoms-42-236.PMC5009200.pdf
"Box 27, Sunyani, Brong Ahafo, Ghana TEL: +233-249-681-906 E-mail: smin5@snu.ac.kr ORCID: h ttp://orcid.org/0000-0002-6916-0489    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Commentary to “A follow-up study on extracorporeal fixation of  condylar fractures using vertical ramus osteotomy” Soung Min Kim1,2, Ji Hyuck Kim2 1Oral and Maxillofacial Microvascular Reconstruction Lab, Brong Ahafo Regional Hospital, Sunyani, Ghana,   2Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea Copyright ⃆ 2016 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d2/bc/jkaoms-42-236.PMC5009200.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.236 pISSN 2234-7550 ·eISSN 2234-5930 This research was supported by grant no 04-2010-0040 from Seoul National University Dental Hospital Research Fund.BRIEF COMMUNICATION,Non-OADS,/arxiv_data1/oa_pdf/d2/bc/jkaoms-42-236.PMC5009200.pdf
"ORCID Soung Min Kim, http://orcid.org/0000-0002-6916-0489 Ji Hyuck Kim, http://orcid.org/0000-0003-1825-1839 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d2/bc/jkaoms-42-236.PMC5009200.pdf
"Cidade Universitária, Recife 50740-521, Brazil TEL: +55-81-2126-8342   FAX: +55-81-2126-8817 E-mail: danyel.perez@ufpe.br ORCID: http://orcid.org/0000-0002-4591-4645    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Multiple pericoronal radiolucencies affecting the four dental quadrants:  dentigerous cysts?",Non-OADS,/arxiv_data1/oa_pdf/15/84/jkaoms-42-238.PMC5009201.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.4.238 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/15/84/jkaoms-42-238.PMC5009201.pdf
"ORCID Amanda Almeida Leite, http://orcid.org/0000-0003-1908- 8009 Maria Eduarda Pérez de Oliveira, http://orcid.org/0000- 0003-3265-2671 Carla Isabelly Rodrigues Fernandes, http://orcid.org/0000- 0002-1290-6235 Danyel Elias da Cruz Perez, http://orcid.org/0000-0002- 4591-4645",Non-OADS,/arxiv_data1/oa_pdf/15/84/jkaoms-42-238.PMC5009201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/aa/dav011.PMC5009217.pdf
Retrieved 19 September 2014. http://www.ncsl.org/research/ human-services/healthy-hunger -free-kids-act-of-2010-summary.,Non-OADS,/arxiv_data1/oa_pdf/b8/aa/dav011.PMC5009217.pdf
"Retrieved 26July 2014, from http://www.health.gov.au/internet/main/ publishing.nsf/Content/phd-prevention-np .",Non-OADS,/arxiv_data1/oa_pdf/96/46/dav024.PMC5009218.pdf
"Retrieved November 2014, from http://www.strobe-statement.",Non-OADS,/arxiv_data1/oa_pdf/96/46/dav024.PMC5009218.pdf
"Retrieved November 2014, from http://www.healthytogether.vic.gov.au/ .",Non-OADS,/arxiv_data1/oa_pdf/96/46/dav024.PMC5009218.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.009,Non-OADS,/arxiv_data1/oa_pdf/df/a5/main.PMC5009225.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 3 –18 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/df/a5/main.PMC5009225.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 3 –18 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/df/a5/main.PMC5009225.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 3 –18 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/df/a5/main.PMC5009225.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 3 –18 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/df/a5/main.PMC5009225.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 3 –18 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/df/a5/main.PMC5009225.pdf
massiliensis ’is available at http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database .,Non-OADS,/arxiv_data1/oa_pdf/86/91/main.PMC5009226.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.011,Non-OADS,/arxiv_data1/oa_pdf/86/91/main.PMC5009226.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,8–9 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/86/91/main.PMC5009226.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.006,Non-OADS,/arxiv_data1/oa_pdf/cd/49/main.PMC5009227.pdf
Available from: http://www.gabrielbirgand.fr/2011/09/dynamique- des-souches-de-clostridium-dif ﬁcile-en-europe/ .,Non-OADS,/arxiv_data1/oa_pdf/cd/49/main.PMC5009227.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,6–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/cd/49/main.PMC5009227.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Schizophrenia spectrum disorderAcross tasksTask-positive networkDefault mode network Functional magnetic resonance imaging Independent component analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC5009228.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.0122213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC5009228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC5009228.pdf
"MRI processing and voxel-wise analysis FreeSurfer ( http://surfer.nmr.mgh.harvard.edu ) was used to process the T1-weighted images, including surface reconstruction and full brain segmentation ( Fischl et al., 2002 ) to obtain precise brain extracted vol- umes for registration.",OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC5009228.pdf
"Functional images were processed using FEAT, part of FSL (FMRIB's Software Library, http://www.fmrib.ox.ac.uk/fsl; (Jenkinson et al., 2012 )).",OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC5009228.pdf
http://dx.doi.org/10.1093/schbul/sbv013 .,Non-OADS,/arxiv_data1/oa_pdf/aa/a3/main.PMC5009228.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.012,Non-OADS,/arxiv_data1/oa_pdf/09/00/main.PMC5009229.pdf
massiliensis ’is available at: http://mediterranee-infection.com/article.php?laref=256&titre= urms-database Nucleotide sequence accession number.,Non-OADS,/arxiv_data1/oa_pdf/09/00/main.PMC5009229.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 0 –12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/09/00/main.PMC5009229.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 0 –12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/09/00/main.PMC5009229.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BurdenCaregiverDietPhenylalaninePhenylketonuriaPediatric 1.,Non-OADS,/arxiv_data1/oa_pdf/26/a5/main.PMC5009233.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.08.0082214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/26/a5/main.PMC5009233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/a5/main.PMC5009233.pdf
Available from: http://www.nhs.uk/conditions/Phenylketon- uria/Pages/Introduction.aspx [accessed October 2015].,Non-OADS,/arxiv_data1/oa_pdf/26/a5/main.PMC5009233.pdf
Available from: http://www.nspku.org/sites/default/ ﬁles/publications/Dietary%20Information%20Booklet%202013_0.pdf [accessed Sep- tember 2015].,Non-OADS,/arxiv_data1/oa_pdf/26/a5/main.PMC5009233.pdf
Available from: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/26/a5/main.PMC5009233.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/d0/main.PMC5009234.pdf
"While  TWIST  has  been  reported  to yield excellent image  quality  and  to  be  accurate  in  the  diagnosis  of peripheral  arterial  stenosis  [11] ,  its  value  in  the  assessment  of  lower http://dx.doi.org/10.1016/j.ejro.2016.08.006 2352-0477/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/main.PMC5009234.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/ce/d0/main.PMC5009234.pdf
"[http://dx.doi.org/10.1002/gps.3967 ] [PMID: 23606378 ] [2] Conde-Sala JL, Garre-Olmo J, Turró-Garriga O, Vilalta-Franch J, López-Pousa S. Differential features of burden between spouse and adult- child caregivers of patients with Alzheimer’s disease: an exploratory comparative design.",OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1016/j.ijnurstu.2010.03.001 ] [PMID: 20374966 ] [3] Høgsnes L, Melin-Johansson C, Norbergh KG, Danielson E. The existential life situations of spouses of persons with dementia before and after relocating to a nursing home.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1080/13607863.2013.818100 ] [PMID: 23869816 ] [4] Savundranayagam  MY,  Montgomery  RJ,  Kosloski  K.  A  dimensional  analysis  of  caregiver  burden  among  spouses  and  adult  children.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1093/geront/gnq102 ] [PMID: 21135026 ] [5] Springate BA, Tremont G. Dimensions of caregiver burden in dementia: impact of demographic, mood, and care recipient variables.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1016/j.jagp.2012.09.006 ] [PMID: 23567422 ] [6] Kasuya RT, Polgar-Bailey P, Takeuchi R. Caregiver burden and burnout.",OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.3810/pgm.2000.12.1324 ] [PMID: 11126138 ] [7] Albinsson L, Strang P. Existential concerns of families of late-stage dementia patients: questions of freedom, choices, isolation, death, and meaning.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1089/109662103764978470 ] [PMID: 12854939 ] [8] Levine NB, Gendron CE, Dastoor DP, et al.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1111/opn.12044 ] [PMID: 24433340 ] [10] Bramble M, Moyle W, McAllister M. Seeking connection: family care experiences following long-term dementia care placement.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1111/j.1365-2702.2009.02878.x ] [PMID: 19825115 ] [11] Kjällman-Alm A, Norbergh KG, Hellzen O.",OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.3402/qhw.v8i0.21676 ] [PMID: 24152431 ] [12] Habermann B, Hines D, Davis L. Caring for parents with neurodegenerative disease: a qualitative description.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1097/NUR.0b013e318295576b ] [PMID: 23748990 ] [13] Kwon SH, Tae YS.",OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1016/j.anr.2012.10.005 ] [PMID: 25031116 ] [14] Garity J. Caring for a family member with Alzheimer’s disease: coping with caregiver burden post-nursing home placement.,Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1177/1054773805282356 ] [PMID: 16410621 ] [16] Ferrell BR.,OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.3322/canjclin.56.2.84 ] [PMID: 16514136 ] [18] Yalom ID.,OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1176/foc.5.4.foc451 ] [20] Krippendorff K. Content analysis: An introduction to its methodology.,Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G ] [PMID: 10940958 ] [24] McCarty EF.,OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1111/j.1365-2648.1996.tb00053.x ] [PMID: 8675899 ] [25] Ward-Griffin C, Oudshoorn A, Clark K, Bol N. Mother-adult daughter relationships within dementia care: a critical analysis.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1177/1074840706297424 ] [PMID: 17220380 ] [26] Farran CJ, Keane-Hagerty E, Salloway S, Kupferer S, Wilken CS.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1093/geront/31.4.483 ] [PMID: 1894152 ] [27] Pratt C, Schmall V, Wright S. Ethical concerns of family caregivers to dementia patients.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1093/geront/27.5.632 ] [PMID: 3678903 ] [28] Frankl V. Man’s search for meaning.,Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1080/13576270903537690 ] [30] Boss P. Insights: ambiguous loss: living with frozen grief.,Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"[http://dx.doi.org/10.1300/J083v37n02_08 ] [32] Shuter P, Beattie E, Edwards H. An exploratory study of grief and health-related quality of life for caregivers of people with dementia.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1177/1533317513517034 ] [PMID: 24381138 ] [33] Heidegger M. Being and Time.,Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1016/0895-4356(90)90060-3 ] [PMID: 2319285 ] © Høgsnes et al.,OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/cd/TONURSJ-10-122.PMC5009291.pdf
[http://dx.doi.org/10.1056/NEJMoa012407 ] [PMID: 12239256 ] [3] da Silva RM.,OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.3389/fphys.2014.00471 ] [PMID: 25538626 ] [4] Kapoor WN.,OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1161/01.CIR.0000031168.96232.BA ] [5] Tan MP, Parry SW. Vasovagal syncope in the older patient.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.jacc.2007.11.025 ] [PMID: 18261677 ] [6] Sheldon RS, Grubb BP II, Olshansky B, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1016/j.hrthm.2015.03.029 ] [PMID: 25980576 ] [7] Cannom DS.,OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.pcad.2012.11.013 ] [PMID: 23472768 ] [8] Lewis DA, Dhala A. Syncope in the pediatric patient.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/S0031-3955(05)70113-9 ] [PMID: 10218070 ] [9] Fu Q, Levine BD.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.autneu.2014.07.004 ] [PMID: 25081417 ] [10] Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1097/CRD.0b013e31815c8032 ] [PMID: 18091397 ],Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1093/eurheartj/ehq071 ] [PMID: 20304836 ] [12] Sumner GL, Rose MS, Koshman ML, Ritchie D, Sheldon RS.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1111/j.1540-8167.2010.01848.x ] [PMID: 20662990 ] [13] Sheldon R. Syncope outcomes in a national health database: low risk is not no risk.,Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.jacc.2012.10.019 ] [PMID: 23246387 ] [14] Brignole M, Menozzi C, Del Rosso A, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1053/eupc.1999.0064 ] [PMID: 11225598 ] [15] Barón-Esquivias G, Pedrote A, Cayuela A, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1053/euhj.2001.2900 ] [PMID: 11863351 ] [16] Kim PH, Ahn SJ, Kim JS.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2004.08.025 ] [PMID: 15589002 ] [17] Carvalho  MS,  Reis  Santos  K,  Carmo  P,  et  al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1111/pace.12656 ] [PMID: 25940375 ] [18] Dhala A, Natale A, Sra J, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/0002-9149(95)80030-V ] [PMID: 7832133 ] [19] Foglia-Manzillo G, Romanò M, Corrado G, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1053/eupc.2002.0260 ] [PMID: 12408255 ] [20] Brignole  M,  Moya  A,  Menozzi  C,  Garcia-Civera  R,  Sutton  R.  Proposed  electrocardiographic  classification  of  spontaneous  syncope documented by an implantable loop recorder.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1016/j.eupc.2004.11.001 ] [PMID: 15670961 ] [21] Brignole M. Different electrocardiographic manifestations of the cardioinhibitory vasovagal reflex.,Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1093/europace/eun390 ] [PMID: 19168495 ] [22] Lacroix D, Kouakam C, Klug D, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1111/j.1540-8159.1997.tb05432.x ] [PMID: 9392805 ] [23] Pérez-Paredes M, Picó Aracil F, Sánchez Villanueva JG, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1007/s10286-011-0153-3 ] [PMID: 22170295 ] [25] Deharo JC, Jego C, Lanteaume A, Djiane P. An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.jacc.2005.09.043 ] [PMID: 16458141 ] [26] Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1136/hrt.71.3.274 ] [PMID: 8142198 ] [27] Benditt  DG,  Sutton  R,  Gammage  MD,  et  al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1111/j.1540-8159.1997.tb03916.x ] [PMID: 9080522 ] [28] Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/S0002-9149(97)00891-6 ] [PMID: 9591898 ] [29] Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS).",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/S0735-1097(98)00549-X ] [PMID: 9935002 ] [30] Sutton R, Brignole M, Menozzi C, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1161/01.CIR.102.3.294 ] [PMID: 10899092 ] [31] Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus  medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1161/hc2601.091708 ] [PMID: 11435337 ] [32] Connolly SJ, Sheldon R, Thorpe KE, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1001/jama.289.17.2224 ] [PMID: 12734133 ] [33] Raviele A, Giada F, Menozzi C, et al.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.ehj.2004.06.031 ] [PMID: 15451153 ] [34] Occhetta E, Bortnik M, Audoglio R, Vassanelli C. Closed loop stimulation in prevention of vasovagal syncope.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.eupc.2004.08.009 ] [PMID: 15519257 ] [35] Sud S, Massel D, Klein GJ, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1016/j.amjmed.2006.05.046 ] [PMID: 17208080 ] [36] Brignole M. Pacing for neurally-mediated syncope: How to decide?,Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.5603/CJ.2014.0092 ] [PMID: 25524729 ] [37] Boersma L, Mont L, Sionis A, García E, Brugada J.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.eupc.2003.09.006 ] [PMID: 14697729 ] [38] Furukawa T, Maggi R, Bertolone C, Fontana D, Brignole M. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1111/j.1540-8167.2011.02133.x ] [PMID: 21777327 ] [39] Brignole M, Sutton R, Menozzi C, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1093/eurheartj/ehi842 ] [PMID: 16569653 ] [40] Brignole M, Menozzi C, Moya A, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.082313 ] [PMID: 22565936 ] [41] Sutton R, Ungar A, Sgobino P, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1093/europace/eut323 ] [PMID: 24406537 ] [42] Moya A.,Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.ccl.2015.04.015 ] [PMID: 26115833 ] [43] Ungar A, Sgobino P, Russo V, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1136/heartjnl-2013-304399 ] [PMID: 24153416 ] [44] Brignole  M,  Donateo  P,  Tomaino  M,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1161/CIRCEP.113.001103 ] [PMID: 24336948 ] [45] Sutton R, Brignole M. Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1093/eurheartj/ehu255 ] [PMID: 24980488 ] [46] Moya A, Roca-Luque I, Francisco-Pascual J, Perez-Rodón J, Rivas N. Pacemaker therapy in syncope.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.ccl.2012.10.001 ] [PMID: 23217694 ] [47] Zyśko D, Fedorowski A, Nilsson D, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1093/europace/euv262 ] [PMID: 26443446 ] [48] Davis S, Westby M, Petkar S, Pitcher D. Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal syncope that affect their quality of life or present a high risk of injury.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1136/heartjnl-2012-302851 ] [PMID: 23236029 ] [49] Brignole M, Ammirati F, Arabia F, et al.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
[http://dx.doi.org/10.1093/eurheartj/ehv069 ] [PMID: 25825044 ],Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1136/heartjnl-2013-303878 ] [PMID: 23723446 ] [51] Udo EO, Zuithoff NP, van Hemel NM, et al.",OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/j.hrthm.2011.12.014 ] [PMID: 22182495 ] © Rose Mary Ferreira Lisboa da Silva; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/80/TOCMJ-10-179.PMC5009292.pdf
"[http://dx.doi.org/10.1016/0039-6257(89)90125-2 ] [PMID: 2678549 ] [2] Sen HN, Nussenblatt RB.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1016/j.ajo.2009.07.024 ] [PMID: 19878754 ] [3] Kilmartin DJ, Dick AD, Forrester JV.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1136/bjo.84.3.259 ] [PMID: 10684834 ] [4] Chan CC, Roberge RG, Whitcup SM, Nussenblatt RB.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1001/archopht.1995.01100050065032 ] [PMID: 7748129 ] [5] Chu XK, Chan CC.",Non-OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1186/1869-5760-3-49 ] [PMID: 23724856 ] [6] Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia.",Non-OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1016/S0161-6420(80)35270-6 ] [PMID: 7383540 ] [7] Jennings T, Tessler HH.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1136/bjo.73.2.140 ] [PMID: 2930760 ] [8] Zaharia MA, Lamarche J, Laurin M. Sympathetic uveitis 66 years after injury.",Non-OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1016/j.ajo.2009.05.033 ] [PMID: 19665105 ] [10] Chang GC, Young LH.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.3109/08820538.2011.588658 ] [PMID: 21958181 ] [11] Hakin KN, Pearson RV, Lightman SL.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1038/eye.1992.95 ] [PMID: 1286704 ] [12] Serna-Ojeda JC, Pedroza-Seres M. Treatment with immunosuppressive therapy in patients with pars planitis: experience of a reference centre in Mexico.",Non-OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2014-304913 ] [PMID: 24985727 ] [13] Patel SS, Dodds EM, Echandi LV, et al.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2013.09.009 ] [PMID: 24572676 ] [14] Mahajan VB, Gehrs KM, Goldstein DA, Fischer DH, Lopez JS, Folk JC.",OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
[http://dx.doi.org/10.1016/j.ophtha.2008.10.024 ] [PMID: 19147232 ] © Guzman-Salas et al.,OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/95/TOOPHTJ-10-154.PMC5009293.pdf
"[http://dx.doi.org/10.1097/00001756-200502080-00004 ] [PMID: 15671854 ] [4] Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/S0079-6123(10)84013-0 ] [PMID: 20887879 ] [5] Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.2174/187152410793429719 ] [PMID: 20868359 ] [7] Li C, Guo Y, Xie W, Li X, Janokovic J, Le W. Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1007/s11064-010-0214-3 ] [PMID: 20635141 ] [8] Plowey ED, Chu CT. Synaptic dysfunction in genetic models of Parkinson’s disease: a role for autophagy?",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.nbd.2010.10.011 ] [PMID: 20969957 ] [9] Hickson-Bick DL, Jones C, Buja LM.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.1016/j.yjmcc.2007.10.013 ] [PMID: 18062988 ] [10] Cummings JL.,OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1006/brcg.1995.1257 ] [PMID: 8546854 ] [11] Chung YC, Ko HW, Bok E, et al.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.5483/BMBRep.2010.43.4.225 ] [PMID: 20423606 ] [12] Schiess M. Nonsteroidal anti-inflammatory drugs protect against Parkinson neurodegeneration: can an NSAID a day keep Parkinson disease away?,Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1001/archneur.60.8.1043 ] [PMID: 12925357 ] [13] Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G. Non-steroidal anti-inflammatory drugs in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.1016/j.expneurol.2007.02.008 ] [PMID: 17433296 ] [14] Whitton PS.,OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.brainres.2010.09.098 ] [PMID: 20888805 ] [16] Naoi M, Maruyama W. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.2174/138161210793176527 ] [PMID: 20698822 ] [17] Bick RJ, Poindexter BJ, Kott MM, et al.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.brainres.2008.03.081 ] [PMID: 18501880 ] [18] Dinh K, Poindexter BJ, Barnes JL, Schiess MC, Bick RJ.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.cyto.2008.12.004 ] [PMID: 19157893 ] [19] Broom L, Marinova-Mutafchieva L, Sadeghian M, Davis JB, Medhurst AD, Dexter DT.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.1016/j.freeradbiomed.2010.12.026 ] [PMID: 21185368 ] [20] Doherty GH.,OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1007/s12264-011-1530-6 ] [PMID: 22108814 ] [21] Nolano M, Provitera V, Estraneo A, et al.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1093/brain/awn102 ] [PMID: 18515869 ] [22] Scherder E, Wolters E, Polman C, Sergeant J, Swaab D. Pain in Parkinson’s disease and multiple sclerosis: its relation to the medial and lateral pain systems.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.1016/j.neubiorev.2005.03.001 ] [PMID: 16143170 ],OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.2353/ajpath.2007.060530 ] [PMID: 17200202 ] [26] Doursout MF, Oguchi T, Fischer UM, et al.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1097/NEN.0b013e31818e5e99 ] [PMID: 19018246 ] [30] Saija  A,  Princi  P,  Lanza  M,  Scalese  M,  Aramnejad  E,  De  Sarro  A.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/0024-3205(95)00008-T ] [PMID: 7885193 ] [31] Bardou I, Kaercher RM, Brothers HM, Hopp SC, Royer S, Wenk GL.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.neurobiolaging.2013.11.006 ] [PMID: 24315728 ] [32] Reinert KR, Umphlet CD, Quattlebaum A, Boger HA.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.brainres.2014.02.005 ] [PMID: 24513404 ] [33] Qin L, Wu X, Block ML, et al.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1002/glia.20467 ] [PMID: 17203472 ] [34] Hosoi T, Noguchi J, Takakuwa M, et al.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.brainres.2014.02.035 ] [PMID: 24576488 ] [35] Lee M, McGeer E, Kodela R, Kashfi K, McGeer PL.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1002/glia.22553 ] [PMID: 23918470 ] [36] Smith MP, Cass WA.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.neulet.2006.11.017 ] [PMID: 17125923 ] [37] Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.1016/j.freeradbiomed.2013.01.018 ] [PMID: 23380027 ] [38] Some Pain Relievers May Help Prevent Parkinson’s Disease.,Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"Available from: http://www.pbs.org/newshour/updates/ health-july-dec03- parkinsons_08-18/  2003 [39] Kordower JH, Bjorklund A. Trophic factor gene therapy for Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1002/mds.25344 ] [PMID: 23390096 ] [40] Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.pharmthera.2013.01.004 ] [PMID: 23348013 ] [41] Patel NK, Pavese N, Javed S, Hotton GR, Brooks DJ, Gill SS.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1212/WNL.0b013e3182a55ea5 ] [PMID: 23946313 ] [42] Diógenes MJ, Outeiro TF.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.2174/187152710793237449 ] [PMID: 20942787 ] [43] Youdim MB, Kupershmidt L, Amit T, Weinreb O.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
[http://dx.doi.org/10.1016/S1353-8020(13)70032-4 ] [PMID: 24262165 ],OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"[http://dx.doi.org/10.1016/j.pharmthera.2013.01.004 ] [PMID: 23348013 ] [45] Li JY, Ma SS, Huang QY, Li MT.",OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/6f/TONEUJ-10-67.PMC5009294.pdf
"ACKNOWLEDGEMENTS The Italian Association for ALS (AISLA; http://www.aisla.it/ ) and the resting home “San Pietro”- Cooperative “La Meridiana” (Monza, Italy).",Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.1111/j.1468-1331.2011.03540.x ] [PMID: 21972798 ] [2] Miller  RG,  Jackson  CE,  Kasarskis  EJ,  et  al.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.1212/WNL.0b013e3181bc01a4 ] [PMID: 19822873 ] [3] Wells MR, Giantinoto S, D’Agate D, et al.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.7556/jaoa.1999.99.2.92 ] [PMID: 10079641 ] [4] Rolle G, Tremolizzo L, Somalvico F, Ferrarese C, Bressan LC.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.7556/jaoa.2014.136 ] [PMID: 25170037 ] [5] Rivera-Martinez S, Wells MR, Capobianco JD.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"Available at: https://www.aacom.org/docs/default-source/insideome/got2011ed.pdf?sfvrsn=2 [7] Brooks BR, Miller RG, Swash M, Munsat TL.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.1080/146608200300079536 ] [PMID: 11464847 ] [8] Cedarbaum  JM,  Stambler  N,  Malta  E,  et  al.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.1016/S0022-510X(99)00210-5 ] [PMID: 10540002 ] [9] Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale.",Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.1159/000110176 ] [PMID: 2725806 ] [10] Norris FH Jr, Calanchini PR, Fallat RJ, Panchari S, Jewett B.",Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.1212/WNL.24.8.721 ] [PMID: 4858705 ] [11] Tremolizzo L, Ferrarese C, Appollonio I.",OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
[http://dx.doi.org/10.3109/21678421.2012.746990 ] [PMID: 23286758 ],Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"[http://dx.doi.org/10.3109/21678421.2013.764568 ] [PMID: 23421600 ] [15] Kiresuk TJ, Sherman RE.",Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
[http://dx.doi.org/10.1007/BF01530764 ] [PMID: 24185570 ] © Maggiani et al.,Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/41/TONEUJ-10-59.PMC5009295.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Pain, a supplement to  Surgical Neurology International S571Surgical variation of microvascular decompression for trigeminal  neuralgia: A  technical note and anatomical study Otávio T .",Non-OADS,/arxiv_data1/oa_pdf/75/4e/SNI-7-571.PMC5009571.pdf
"http://surgicalneurologyint.com/Surgical-variation-of-microvascular-decompression- for-trigeminal-neuralgia:-A-technical-note-and-anatomical-study/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/75/4e/SNI-7-571.PMC5009571.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: General Neurosurgery, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS581Abstract Background:  Lumbar puncture (LP) rarely results in complications such as spinal  hematomas.",Non-OADS,/arxiv_data1/oa_pdf/68/8f/SNI-7-581.PMC5009572.pdf
"http://surgicalneurologyint.com/Iatrogenic-spinal-hematoma-as-a-complication-of- lumbar-puncture:-What-is-the-risk-and-best-management-plan?/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/68/8f/SNI-7-581.PMC5009572.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: General Neurosurgery, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS577Abstract Background: External ventricular drainage (EVD) is an emergency process  intended to reduce intracranial hypertension resulting from the obstruction of  cerebrospinal fluid (CSF) flow.",Non-OADS,/arxiv_data1/oa_pdf/a8/39/SNI-7-577.PMC5009573.pdf
"http://surgicalneurologyint.com/Surface-anatomy-for-implantation-of-external- ventricular-drainage:-Some-surgical-remarks/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/a8/39/SNI-7-577.PMC5009573.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  The treatment of giant deep arteriovenous malformations (AVMs)  remains challenging.",Non-OADS,/arxiv_data1/oa_pdf/f6/34/SNI-7-79.PMC5009574.pdf
"Surg Neurol Int  2016;7:79. http://surgicalneurologyint.com/T otal-temporary-occlusion-of-blood-flow-for- several-hours-to-treat-a-giant-deep-arteriovenous-malformation:-A-series-of- multiple-operations-to-save-a-young-life/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/f6/34/SNI-7-79.PMC5009574.pdf
"Surgical Neurology International 2016, 7:79  http://www.surgicalneurologyint.com/content/7/1/79AVM is considered to be giant when nidus is 6 cm or  more in maximum diameter.",Non-OADS,/arxiv_data1/oa_pdf/f6/34/SNI-7-79.PMC5009574.pdf
"Surgical Neurology International 2016, 7:79  http://www.surgicalneurologyint.com/content/7/1/79for rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/f6/34/SNI-7-79.PMC5009574.pdf
"Surgical Neurology International 2016, 7:79  http://www.surgicalneurologyint.com/content/7/1/79of the lesion was 9.8% per patient per year, and among  those who suffered hemorrhage, 85.5% were hemiparetic  or hemiplegic.",Non-OADS,/arxiv_data1/oa_pdf/f6/34/SNI-7-79.PMC5009574.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Developing an algorithm for cost‑effective, clinically judicious  management of peripheral nerve tumors Harjus Birk1,2, Corinna C. Zygourakis2, Michel Kliot3 1School of Medicine, University of California, San Francisco, California, 2Department of Neurological Surgery, University of California, San Francisco, CA,  3Department of Neurological Surgery, Northwestern University, Chicago, Illinois, USA  E‑mail:  Harjus Birk ‑ harjus.Birk@ucsf.edu; Corinna C. Zygourakis ‑ ZygourakisC@neurosurg.ucsf.edu; *Michel Kliot ‑ Michelkliot@gmail.com   *Corresponding author Received: 10 April 16  Accepted: 20 July 16  Published: 26 August 16 Abstract Peripheral nerve tumors such as neurofibromas and schwannomas have become  increasingly identified secondary to improved imaging modalities including  magnetic resonance neurogram and ultrasound.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/SNI-7-80.PMC5009575.pdf
"Surg Neurol Int 2016;7:80. http://surgicalneurologyint.com/Developing-an-algorithm-for-cost-effective,- clinically-judicious-management-of-peripheral-nerve-tumors/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/SNI-7-80.PMC5009575.pdf
"Surgical Neurology International 2016, 7:80  http://www.surgicalneurologyint.com/content/7/1/80mutations.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/SNI-7-80.PMC5009575.pdf
"Surgical Neurology International 2016, 7:80  http://www.surgicalneurologyint.com/content/7/1/80For surgical patients, the actual total inpatient and  outpatient hospital costs were also determined from the  UCSF hospital cost accounting database.",OADS,/arxiv_data1/oa_pdf/5b/70/SNI-7-80.PMC5009575.pdf
"Surgical Neurology International 2016, 7:80  http://www.surgicalneurologyint.com/content/7/1/80CONCLUSION In summary, we propose the following paradigm  [Figure  1] to guide the management of symptomatic  and asymptomatic peripheral nerve tumors.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/SNI-7-80.PMC5009575.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Olfactory neuroblastoma (ONB) is a rare, aggressive tumor of the  nasal cavity.",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/SNI-7-77.PMC5009576.pdf
"Surg Neurol Int 2016;7:77. http://surgicalneurologyint.com/Olfactory-neuroblastoma-followed-by-emergency- surgery-for-symptomatic-intradural-spinal-metastasis:-A-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/SNI-7-77.PMC5009576.pdf
"Surgical Neurology International 2016, 7:77  http://www.surgicalneurologyint.com/content/7/1/77paralysis due to ISM.",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/SNI-7-77.PMC5009576.pdf
"Surgical Neurology International 2016, 7:77  http://www.surgicalneurologyint.com/content/7/1/77surgically relieve the compression by the tumor to avoid  complete tetraplegia.",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/SNI-7-77.PMC5009576.pdf
"Surgical Neurology International 2016, 7:77  http://www.surgicalneurologyint.com/content/7/1/77reported [ Table  2].",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/SNI-7-77.PMC5009576.pdf
"Surgical Neurology International 2016, 7:77  http://www.surgicalneurologyint.com/content/7/1/77REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/SNI-7-77.PMC5009576.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Commentary: Metabolic syndrome and the hepatorenal reflex Michael D. Wider Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan, USA E‑mail: *Michael D. Wider ‑ mdwider@yahoo.com   *Corresponding author Received: 28 July 16  Accepted: 28 July 16  Published: 26 August 16 EDITOR’S NOTE Surgical Neurology International (SNI) is publishing a  paper by Mike Wider, a physiologist, on the cause of the  metabolic syndrome, one of the major disease syndromes  affecting people around the world and associated with  the world epidemic of obesity.",Non-OADS,/arxiv_data1/oa_pdf/05/10/SNI-7-81.PMC5009577.pdf
Surg Neurol Int 2016;7:81. http://surgicalneurologyint.com/Commentary:-Metabolic-syndrome-and-the- hepatorenal-reflex/,Non-OADS,/arxiv_data1/oa_pdf/05/10/SNI-7-81.PMC5009577.pdf
"Surgical Neurology International 2016, 7:81  http://www.surgicalneurologyint.com/content/7/1/81underlying cause of MetS is still very unclear.",Non-OADS,/arxiv_data1/oa_pdf/05/10/SNI-7-81.PMC5009577.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Graphene has unique electrical, physical, and chemical properties  that may have great potential as a bioscaffold for neuronal regeneration after spinal  cord injury.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surg Neurol Int 2016;7:75. http://surgicalneurologyint.com/Biocompatibility-of-reduced-graphene-oxide-nanoscaffolds-following-acute-spinal-cord-injury-in-rats/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75INTRODUCTION Few options are available for the treatment of spinal cord  injury (SCI), despite years of research on the subject.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75and carprofen (analgesic tablets) was administered.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75surrounding nervous tissue.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75conduits fabricated from PLGA have been implanted into  completely transected rat spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75nanoscaffold [ Figure  3].",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75immunostaining methods could have been used; however,  there is precedent[27] for the staining techniques that we  employed.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Surgical Neurology International 2016, 7:75  http://www.surgicalneurologyint.com/content/7/1/75adult rats.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/SNI-7-75.PMC5009578.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Extradural spinal mass lesions are most commonly metastatic  tumors.",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surg Neurol Int 2016;7:76. http://surgicalneurologyint.com/Dorsal-extradural-meningioma:-Case-report-and- literature-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surgical Neurology International 2016, 7:76  http://www.surgicalneurologyint.com/content/7/1/76regions.",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surgical Neurology International 2016, 7:76  http://www.surgicalneurologyint.com/content/7/1/76However, because many reports used different criteria to  differentiate between partially and completely extradural  lesions, it is difficult to get their real frequency, which  may be lower than that already presented.",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surgical Neurology International 2016, 7:76  http://www.surgicalneurologyint.com/content/7/1/76Table 1: Review of cases of epidural meningiomas described in literature Article Author Epidural with  an intradural  component/totalExclusively  epiduralAge Gender Tumor  locationBony changes on Neuroimaging Tissier, 1898[62]1 14 M C2-C5 Soderbergh and Sundberg, 1916[56]1 59 M C3-C4 Mass, 1918[36]1 54 F D4-D6 Naffziger and Ha, 1933[42]4 54 M D8 60 F D9 55 M C6-D2 34 F C7-D2 Enderle, 1934[18]1 44 M L3-L4 Noisi, 1936[43]1 Ingraham, 1938[27]1 10 M C3-C5 Rasmussen, 1940[48]10/140 Elsberg, 1941[17]4/73 Oddsson, 1947[45] 1 32 M L/S Bull, 1953[9]6/59 Pedicle destruction (1 case) Henschen, 1955[26]3 42 F C5 17 F D1 31 M D5 Arseni, 1958[3]9/114 Rand, 1960[47]1 1 8 F dorsal Destruction of left D6-D7 hemilamina and  erosion of pedicle Lombardi, 1961[35]3/71 3 Widened intervertebral foramen Haft, 1963[25]1 1 24 M D5-D7 Normal Early, 1966[16]1 1 14 M D3-D5 Erosion of D4 body Soo, 1966[58]2 1 64 F D4-D6 Normal 0 7 M C1-D7 Widened pedicles Vakili, 1967[64]1 61 M D1 Pecker, 1967[46]3 25 F C2-C5 Normal 43 F C6-D1 Enlargement of C7-D1 foramen 65 F D4-D6 Erosion of D3-D5 pedicles Rath, 1967[49]1 1 20 F C3-C6 Normal Abbott, 1968[1]1 0 57 M D4 Hallpike, 1968[24]1 1 33 M D6-D7 Erosion of the right D6 pedicle Singh, 1968[55]1 35 F D4 Fortuna, 1969[19]4 1 53 F D7-D10 1 74 F D7-D8 1 40 F D4-D6 1 31 M D1-D2 Mittal, 1960[40]1 40 F D12 Balaparameswararao, 1970[5]3/14 40 F L3-L5 54 F L4-L5 30 F D3-D4 Calogero, 1972[10] 4 0 40 F D4 0 54 M L3 0 28 F D9-D11 0 33 M D7 Borghi, 1973[7]5 28 F C7-D2 Erosion of C7 and D1 pedicles 0 23 F D1 Normal 32 F C5-D1 Normal 0 28 F D5-D6 D6 pedicle thinned Contd...",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surgical Neurology International 2016, 7:76  http://www.surgicalneurologyint.com/content/7/1/76Table 1: Contd...",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surgical Neurology International 2016, 7:76  http://www.surgicalneurologyint.com/content/7/1/76CONCLUSION Purely extradural meningiomas are very infrequent but  they should be included in the differential diagnosis  of extradural lesions.",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Surgical Neurology International 2016, 7:76  http://www.surgicalneurologyint.com/content/7/1/7652.",Non-OADS,/arxiv_data1/oa_pdf/88/68/SNI-7-76.PMC5009579.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Previous reports have proposed an association between traumatic  brain injury (TBI) and subsequent glioblastoma (GBM) formation.",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Surg Neurol Int 2016;7:78. http://surgicalneurologyint.com/Traumatic-brain-injury-and-subsequent- glioblastoma-development:-Review-of-the-literature-and-case-reports/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Surgical Neurology International 2016, 7:78  http://www.surgicalneurologyint.com/content/7/1/78which is caused by mosaicism for a gain‑of‑function  mutation in the gene encoding isocitrate dehydrogenase  (IDH1 ), increases the risk for glioma formation, along with  enchondromas.",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Surgical Neurology International 2016, 7:78  http://www.surgicalneurologyint.com/content/7/1/78the overall study.",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Surgical Neurology International 2016, 7:78  http://www.surgicalneurologyint.com/content/7/1/78DISCUSSION Epidemiological studies are largely equivocal on the link  between TBI and subsequent formation of malignant  glioma.",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Surgical Neurology International 2016, 7:78  http://www.surgicalneurologyint.com/content/7/1/78zone of the lateral ventricles and the subgranular  zone of the hippocampal dentate gyrus (for review  see[33]).",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Surgical Neurology International 2016, 7:78  http://www.surgicalneurologyint.com/content/7/1/7816.",Non-OADS,/arxiv_data1/oa_pdf/07/30/SNI-7-78.PMC5009580.pdf
"Following the European Committee  on Antimicrobial Susceptibility Testing (EUCAST)  breakpoints (http://www.eucast.org/), isolates with a colistin  MIC of ≤2 μg/ml were categorized as susceptible, while  those with MICs of >2 μg/ml were considered to be resistant.",Non-OADS,/arxiv_data1/oa_pdf/e4/a9/CMJ-129-2033.PMC5009584.pdf
[17] Multilocus sequence typing (MLST) was performed  with primers listed in the online database for  K. pneumoniae  (http://bigsdb.web.pasteur.fr/klebsiella/ klebsiella.html).,OADS,/arxiv_data1/oa_pdf/e4/a9/CMJ-129-2033.PMC5009584.pdf
Sequence types (STs) were assigned using  online database tools (http://pubmlst.org/).,OADS,/arxiv_data1/oa_pdf/e4/a9/CMJ-129-2033.PMC5009584.pdf
"To determine  the clonal relatedness of the novel ST1883, the  eBURST  software eBURSTv3 (http://eburst.mlst.net/) was used to  compare the ST1883 strain with the K. pneumoniae  ST11  isolates and K. pneumoniae  ST strains with five or more of the  same housekeeping genes as that of the ST1883 strain type.",OADS,/arxiv_data1/oa_pdf/e4/a9/CMJ-129-2033.PMC5009584.pdf
"Trial Registration: Chinese Clinical Trial Register, ChiCTR‑IIR‑16007814; http://www.chictr.org.cn/showproj.aspx?proj=13183.",Non-OADS,/arxiv_data1/oa_pdf/30/04/CMJ-129-2045.PMC5009586.pdf
All data were analyzed using  PLINK v1.07 (http://pngu.mgh.harvard.edu/Bpurcell/plink/).,OADS,/arxiv_data1/oa_pdf/bf/2a/CMJ-129-2085.PMC5009593.pdf
Available from:  http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@ dh/@en/documents/digitalasset/dh_4098599.pdf.,OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.dh.gov.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.joannabriggs.edu.au/protocols/ Protocol237.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.bookshop.rcplondon.ac.uk/conten ts/6ad05aab‑8400‑494c‑8cf4‑9772d1d5301b.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from:  http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijmi/ vol3n2/info.xml.,OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.who.int/classifications/icf/site/beginners/bg.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
doi: http://dx.doi.org/10.1016/j.ajem.2003.12.009.,OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.healthy.net/Health/ Article/Stroke/853/1.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.statistics.gov.uk/StatBase/Product.,OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.ec.europa.eu/employment_ social/social_inclusion/docs/approb_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.guidelines.gov/content.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from: http://www.search.asksource.info/cf/ search/search.cfm?search=framework%20paper&db=biball.,OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available  from: http://www.gmc‑uk.org/static/documents/content/GMP_0910.,Non-OADS,/arxiv_data1/oa_pdf/53/11/CMJ-129-2115.PMC5009598.pdf
Available from:   http://www.cebm.net/index.aspx?o=5653.,Non-OADS,/arxiv_data1/oa_pdf/a4/d5/CMJ-129-2123.PMC5009599.pdf
"7230NucleicAcidsResearch,2016,Vol.44,No.15 Computational processing ofChIP-Seq data Raw reads were processed in the following way: adapters were trimmed using cutadapt ( 59) and subsequent sliding window-based adaptive trimming with sickle (https://github.com/najoshi/sickle ); reads shorter than 20 bps were discarded.",Non-OADS,/arxiv_data1/oa_pdf/37/c9/gkw371.PMC5009728.pdf
"To generate a DPB2 over-expression construct without adding a tag tothe protein, the cDNA was recombined in the pK7WG2 vector (https://gateway.psb.ugent.be/search ).",OADS,/arxiv_data1/oa_pdf/ec/32/gkw449.PMC5009731.pdf
"Forcyl2mu- tantcomplementation,the35SpromoterofthepH7FWG2(https://gateway.psb.ugent.be/search ) was replaced by the DPB2promoter described in ( 14) amplified with primers introducing a HindIII and a SpeI site at its 5 /primeand 3/prime ends respectively.",Non-OADS,/arxiv_data1/oa_pdf/ec/32/gkw449.PMC5009731.pdf
Statisticalanalysis All statistical analysis was performed using the R software (https://www.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/ec/32/gkw449.PMC5009731.pdf
"Overall, our work provides evidence for the exquisite complexityofDNAdamageandreplicationstressresponse in plants, and further questions the central role of SOG1 asthecentralintegratorofDNAdamageresponseinplantcells.Additionally,itrevealsthetissuespecificityofcellular responses, defects in pre-meiotic DNA replication trigger- ing a cell death response that does not occur in vegetativetissues in responseto Pol /H9280dysfunction.DATA DEPOSITION Microarray data from this article were deposited at Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/geo/ ), accession no.",OADS,/arxiv_data1/oa_pdf/ec/32/gkw449.PMC5009731.pdf
GSE71002) and at CATdb ( http://urgv.evry.,Non-OADS,/arxiv_data1/oa_pdf/ec/32/gkw449.PMC5009731.pdf
"The present work has benefited from the core facilities of Imagerie-Gif, ( http://www.i2bc.paris-saclay.fr ), member of IBiSA ( http://www.ibisa.net ), supported by the Labex‘Saclay PlantScience’(ANR-11-IDEX-0003-02).",Non-OADS,/arxiv_data1/oa_pdf/ec/32/gkw449.PMC5009731.pdf
"Identification ofcosRNAs using sRNA miner sRNA miner is implemented in R /Bioconductor ( 27), and isfreelyavailableatGitHubrepository( https://github.com/ MolGen/sRNAminer ).Thealgorithmcalculatesalignment end density at every genome position in a strand- and end- type-specific manner from a mapping file in bam format.Maxima in a sliding 31-nt window are retained for the de- tection of dominant 5 /prime- and 3/prime-ends.",OADS,/arxiv_data1/oa_pdf/32/da/gkw466.PMC5009733.pdf
sRNA mappings and identified cosRNAs are avail- able athttps://www.molgen.hu-berlin.de/projects-jbrowse- athaliana.php .,OADS,/arxiv_data1/oa_pdf/32/da/gkw466.PMC5009733.pdf
The sRNA mappings and identified cosR- NAscanbeviewedonlineat https://www.molgen.hu-berlin.,OADS,/arxiv_data1/oa_pdf/32/da/gkw466.PMC5009733.pdf
"AVAILABILITY sRNA miner is implemented in R /Bioconductor ( 27), and isfreelyavailableatGitHubrepository( https://github.com/ MolGen/sRNAminer ) for non-commercialuse.",OADS,/arxiv_data1/oa_pdf/32/da/gkw466.PMC5009733.pdf
"As shown in an independent comprehensive benchmark byBlueCollarBioinformatics( http://bcb.io )(3),andaswe demonstrateinourowncomparisonstudies,currentSVde-tectionmethodslacksensitivityforthedetectionofsmaller deletions, insertions and other complex variants.",OADS,/arxiv_data1/oa_pdf/64/c3/gkw481.PMC5009736.pdf
SWAN source code and manuals are available athttp://bitbucket.org/charade/swan .,OADS,/arxiv_data1/oa_pdf/64/c3/gkw481.PMC5009736.pdf
"We used SVEngine (http://bitbucket.org/charade/ svengine),BWA-MEM aligner (19)a n dSAMtools (20)t o simulatethedatasets.Onesetofdatahadaveragesequenc- ing coverage ranging from 5X to 50X with 100% SV allelic fraction.Theotherdatasethad50Xcoveragewithfrom5% to 100% in SVallele fractions with50X coverage.",OADS,/arxiv_data1/oa_pdf/64/c3/gkw481.PMC5009736.pdf
De- tails of the procedure details are described in Supplemen- tary Text S1 and the simulated data set is downloadable athttp://hamachi.stanford.edu/publication-material/swan/ swan-data.tgz ).,OADS,/arxiv_data1/oa_pdf/64/c3/gkw481.PMC5009736.pdf
Accession number All data are available at the Gene Expression Omnibus repository ( http://www.ncbi.nlm.nih.gov/geo ) with via ac-,OADS,/arxiv_data1/oa_pdf/d3/6a/gkw602.PMC5009749.pdf
"MATERIALS AND METHODS Analysisofpublicbreastcancerexpressionprofilingdatasets All genome-wide expression profiling datasets of breast cancerpatientswithasamplesize >80availableinthepub- lic domain ( n=20) were retrieved from the public Gene Expression Omnibus (GEO) dataset on the NCBI web- site (http://www.ncbi.nlm.nih.gov/geo/ ) ,a n da n a l y z e du s - ing R2: a genomics analysis and visualization platform de-",OADS,/arxiv_data1/oa_pdf/5e/7f/gkw606.PMC5009750.pdf
The Chin-124 set was uploaded from EMBL EBI (http://www.ebi.ac.uk/arrayexpress ) under E-TABM- 158.Expressiondata(CELfiles)wereanalyzedasdescribed previously ( 38).,OADS,/arxiv_data1/oa_pdf/5e/7f/gkw606.PMC5009750.pdf
The TranscriptView genomic analysis and visualization tool within R2 was used to check if probe-sets had an anti-sense position in an exon of the gene ( http://r2.amc.nl >genome browser).,OADS,/arxiv_data1/oa_pdf/5e/7f/gkw606.PMC5009750.pdf
"The constructs have unique, non-overlapping homology with all target gene transcripts describedin http://www.ncbi.nlm.nih.gov/gene .",Non-OADS,/arxiv_data1/oa_pdf/5e/7f/gkw606.PMC5009750.pdf
The intensity of the bands was quantified using ImageJ software ( http://imagej.nih.gov ) and the signal ob- tained for each Flag-HOXA1 fusion co-expressed with na-tive GST was subtracted from the signal obtained with that Flag fusion co-expressed with GST-RBCK1 or GST- TRAF2.,OADS,/arxiv_data1/oa_pdf/5e/7f/gkw606.PMC5009750.pdf
"Universityof Rochester,http://membrane.urmc.rochester.edu/content/wham .",Non-OADS,/arxiv_data1/oa_pdf/7f/5c/gkw607.PMC5009751.pdf
All parts and uses demonstrated or disclosed hereinhavebeencontributedtothepublicdomainviatheBioBrick publicagreement( https://biobricks.org/bpa ).,OADS,/arxiv_data1/oa_pdf/56/67/gkw624.PMC5009755.pdf
All se- quences and raw data are available in supplementary ma- terialsandsupplementarydatafiles.Alllibrarieshavebeen deposited and are available at the Bacillus Genetic StockCenter(http://www.bgsc.org/ ) FUNDING French Institut National de la Sant ´e et de la Recherche M´edicale (INSERM); Centre National pour la Recherche Scientifique (CNRS); Institut National de la Recherche Agronomique (INRA).,OADS,/arxiv_data1/oa_pdf/56/67/gkw624.PMC5009755.pdf
"ACCESSION NUMBERS Crystallographic models of the three complexes have been deposited in the PDB ( http://www.rcsb.org , PDB codes: 5HLT, 5HNF, 5HNH).",OADS,/arxiv_data1/oa_pdf/bb/ba/gkw644.PMC5009758.pdf
GRASPER is implemented as a JAVA program and is availableundertheGPLv3licenseasopen-sourcesoftwareathttps://github.com/COL-IU/GRASPER .,OADS,/arxiv_data1/oa_pdf/12/e1/gkw647.PMC5009759.pdf
": +91‑9443138800 Email: nelcon2016@gmail.com Website: http://www.isacontamilnadu2016.com/ 18th Annual Rajasthan State  Conference of Indian Society of  Anaesthesiologists 2016 ISACONRAJASTHAN2016September  3rd‑4th, 2016Government Medical  College Auditorium,  Kota, IndiaDr.",Non-OADS,/arxiv_data1/oa_pdf/9c/3b/JOACP-32-288.PMC5009832.pdf
"The Netherlandshttp://www.esra2016.com/ CONGRESS VENUE  MECC Maastricht Address: Forum 100, 6229 GV Maastricht Telephone: +31 (0)43 38 38 383 Email: info@mecc.nl Annual East Zone Conference of ISA ISACON EAST – 2016September  9th‑11th, 2016Puri, Odisha Dr. Debaprasad Mohanty Mobile No.",Non-OADS,/arxiv_data1/oa_pdf/78/22/JOACP-32-307.PMC5009834.pdf
": +91‑9826168747 Email: ashsethi64@yahoo.com Website: http://www.isampchapter.com Society For Airway Management  19th Annual Meeting 2016  (SAM 2016) September  15th‑18th 2016Atlanta, Georgia, USA http://samhq.com/2014‑sam‑meeting‑in‑seattle‑washington/ The Society for Airway Management is a 501(c)(3) organization   5753 Tanager Street | Schererville, IN 46375   PH: (773) 834‑3171 | FAX: (773) 834‑3166 Administrator: amprince@peds.bsd.uchicago.edu   Webmaster: webpagesam@gmail.com 7th National Airway Conference  NAC 2016 September  16th‑19th 2016Vadodara Dr. Amit Shah  Organizing Chairman   Dr. Apeksh Patwa   Organizing Secretary   Contact: Dr. Dinesh Patel Telephone : 9879925025 Email Id: nac2016vadodara@gmail.com Website: http://www.nac2016.in ISACON AP – 2016 25th Annual State Conference  of ISA AP State ChapterSeptember  16th‑18th 2016Tanish Function  Hall, Kurnool, APOrg Secretary: Dr. G. Shantiraju Mobile No.",Non-OADS,/arxiv_data1/oa_pdf/78/22/JOACP-32-307.PMC5009834.pdf
: +91 7702228107 9494491910 Email: gunnasraj@gmail.com Website: http://www.isaapcon2016.in/Conference Calendar July 2016,Non-OADS,/arxiv_data1/oa_pdf/78/22/JOACP-32-307.PMC5009834.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/49/22/JOACP-32-319.PMC5009836.pdf
Available from: http://www.rcoa.ac.uk/ system/files/TRG ‑CU‑CCT ‑ANAES2010_0.pdf.,OADS,/arxiv_data1/oa_pdf/29/5d/JOACP-32-333.PMC5009839.pdf
Appendix C. Available from: http://www.meded.ucsf.edu/sites/ meded.ucsf.edu/files/documents/graduate‑medical‑education/ appc.doc.,Non-OADS,/arxiv_data1/oa_pdf/29/5d/JOACP-32-333.PMC5009839.pdf
"Name of conference Dates Venue Name of organising Secretary with contact details 6th Annual Conference of the  Academy of Regional Anaesthesia  (AORA)  AORA INDIA 2016September  23rd‑24th 2016Hyderabad Dr. TVS Gopal Organising Chairperson Axon Anaesthesia Associates Pvt Ltd   302, Anjali Enclave, 6‑3‑596/24/1,   Venkataramana Colony, Khairatabad,   Hyderabad ‑ 500 004 Telangana India   Telefax : +91‑40‑66138808 Phone : 09030065456   Email : axongm@gmail.com, vinod_sagar2005@yahoo.com Telephone : 91 9030065456 Email Id : axongm@gmail.com Website : http://www.aoraindia.com/aora2016/index.html NYSORA 15th Annual Symposium  on Regional Anesthesia, Pain  and Perioperative Medicine 2016  (NYSORA 2016) September  23rd‑25th, 2016Hilton Midtown,  New Yorkhttp://nysorasymposium.com/ Vision Expo   2753 Broadway, Suite 183   New York, NY 10025, +44 1462 483 466   info@visionexpo.co www.nysora.com ISACON Bihar Jarkhand – 2016 Annual State Conference of ISA  Bihar Jarkhand State ChapterSeptember  23rd‑25th, 2016The Park, Jubba Sahni  Park Market, Club  Road, Mithanpura,  MuzaffarpurOrg Secretary: Dr. Narendra Kumar Mobile No.",Non-OADS,/arxiv_data1/oa_pdf/bd/d1/JOACP-32-349.PMC5009842.pdf
": +91‑9435031489 Email: dhruba_borgohain@yahoo.co.in American Society of  Anesthesiologists (ASA) Annual  Meeting ANESTHESIOLOGY® 2016October  22nd‑26th, 2016McCormick Place  Convention Center Chicago, Illinois  60616, United StatesURL: https://www.asahq.org/Annual%20Meeting/?utm_ source=asahq& utm_medium=landing‑page& utm_ campaign=Annual‑Meeting Difficult Airway Society Annual  Meeting 2016 (DAS 2016)November 16‑18th, 2016Riviera International  Centre, Torquayhttps://www.das.uk.com/meetings 64th Annual National  Conference of Indian Society of  Anaesthesiologists  ISACON 2016November,  25th‑29th, 2016Punjab Agricultural  University Campus,  LudhianaDr.",Non-OADS,/arxiv_data1/oa_pdf/13/38/JOACP-32-353.PMC5009843.pdf
"Sunil Katyal, Organizing Secretary 19‑H, Ashok Vihar, Rishi Nagar, Ludhiana ‑141001, Punjab, India   Mobile: +91 9814030552, Email ID: katyalsunilmd@gmail.com   Web: www.isacon2016.com Anaesthesiology 69th  Postgraduate Assembly 2016  (NYSSA 2016)December 9th‑13th, 2016Marriott Marquis,  New York, USAhttp://pganyc.weebly.com/ THE NEW YORK STATE SOCIETY OF ANESTHESIOLOGISTS,  INC.  110 East 40th Street, Suite 300, New York, NY 10016 USA   Telephone: 1‑212‑867‑7140 Fax: 1‑212‑867‑7153   International: +00 followed by number   HQ@nyssa‑pga.org 14th Conference of   Asian Society of Paediatric  Anaesthesiologists”   (ASPA 2017) with Preconference workshopsJune 3rd‑4th, 2017 2nd June 2017Grand Hyatt,  Mumbai, India.",Non-OADS,/arxiv_data1/oa_pdf/13/38/JOACP-32-353.PMC5009843.pdf
Available from: http://www.iata.org/ whatwedo/safety/health/Documents/medical‑manual‑2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/09/JOACP-32-359.PMC5009844.pdf
Available from: http://www.aai.aero/public_notices/ aaisite_test/policy.jsp#4.,Non-OADS,/arxiv_data1/oa_pdf/d8/09/JOACP-32-359.PMC5009844.pdf
": Recovery of bowel function after pediatric laparoscopyJournal of Anaesthesiology Clinical Pharmacology | July-September 2016 | Vol 32 | Issue 3 371For the purpose of analysis the surgery was classified as  local, regional or extensive according to its extent and  invasiveness defined by surgeons, and the predicted associated  postoperative pain as defined by the French Society of  Anesthesiology and Intensive Care (http://www.sfar.org/ article/21/prise-en-charge-de-la-douleur-post-operatoire-chez- l-adulte-et-l-enfant-cc-1997).",Non-OADS,/arxiv_data1/oa_pdf/24/0e/JOACP-32-369.PMC5009846.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/4e/15/JOACP-32-376.PMC5009847.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/4e/15/JOACP-32-376.PMC5009847.pdf
Available from: http://www.statista.,Non-OADS,/arxiv_data1/oa_pdf/68/ec/JOACP-32-385.PMC5009850.pdf
Available from: http://www.cpsbc.ca.,Non-OADS,/arxiv_data1/oa_pdf/68/ec/JOACP-32-385.PMC5009850.pdf
Available from:  http://www.policybase.cma.ca/dbtw ‑wpd/Policypdf/PD12‑ 03. pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/ec/JOACP-32-385.PMC5009850.pdf
Available from: http://www.epilepsynse.org.uk/AboutEpilepsy/ Whatisepilepsy.,Non-OADS,/arxiv_data1/oa_pdf/49/16/JOACP-32-404.PMC5009861.pdf
Available from: http://www.drugs.com/ pro/carbamazepine.html.,Non-OADS,/arxiv_data1/oa_pdf/49/16/JOACP-32-404.PMC5009861.pdf
Available from: http://www.drugs.com/ pro/carbamazepine.html.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/JOACP-32-405.PMC5009862.pdf
Available from: http://www.nfpa.org/~/media/Files/ Research/Research%20Foundation/rfsurgicalwetdrylocations.pdf.,OADS,/arxiv_data1/oa_pdf/26/de/JOACP-32-408.PMC5009865.pdf
@ERSpublications Comprehensive overview of compartment-specific microarray studies of material from pulmonaryhypertension patients http://ow.ly/YEFO2 Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/dc/2b/ERJ-02030-2015.PMC5009873.pdf
Available from:  http://www.richmond.gov.uk/risky_behaviour_programme.,Non-OADS,/arxiv_data1/oa_pdf/28/4d/JFCM-23-133.PMC5009881.pdf
Available from: http://www.carbuzz.com/news/2014/1/8/ Drifting‑Banned‑in‑Saudi‑Arabia‑as‑ More‑and‑More‑Die‑7718003.,Non-OADS,/arxiv_data1/oa_pdf/28/4d/JFCM-23-133.PMC5009881.pdf
Available from: http://www.iihs.org/iihs/topics/t/ teenagers/fatalityfacts/teenagers.,Non-OADS,/arxiv_data1/oa_pdf/28/4d/JFCM-23-133.PMC5009881.pdf
Available from: http://www.worldpopulationreview.com.,Non-OADS,/arxiv_data1/oa_pdf/28/4d/JFCM-23-133.PMC5009881.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs110/en/.,Non-OADS,/arxiv_data1/oa_pdf/75/d6/JFCM-23-145.PMC5009883.pdf
Available from: http://www.chs.,Non-OADS,/arxiv_data1/oa_pdf/75/d6/JFCM-23-145.PMC5009883.pdf
Available from: https://www.caregiver.,Non-OADS,/arxiv_data1/oa_pdf/84/67/JFCM-23-155.PMC5009885.pdf
Available from: http://www.journals.sbmu.ac.ir/jme/article/ view/1028/1141.,Non-OADS,/arxiv_data1/oa_pdf/3f/86/JFCM-23-166.PMC5009887.pdf
Available from: http://search.proquest.com.ezproxy.,Non-OADS,/arxiv_data1/oa_pdf/3c/70/JFCM-23-179.PMC5009889.pdf
Available from: http://www.sciencedirect.com/science/article/pii/ S209050681100056X.,Non-OADS,/arxiv_data1/oa_pdf/3c/70/JFCM-23-179.PMC5009889.pdf
Available from: http://www.saudijobesity.,Non-OADS,/arxiv_data1/oa_pdf/3c/70/JFCM-23-179.PMC5009889.pdf
Available from: http://www.omicsgroup.,Non-OADS,/arxiv_data1/oa_pdf/3c/70/JFCM-23-179.PMC5009889.pdf
2016; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/db/48/ejifcc-27-186.PMC5009943.pdf
"Therefore, due to the high complexity of BNP- related peptides and the prevalence of proBNP  in the circulation, much of the BNP measured  by contemporary assays is either nonprocessed  proBNP or degradation products of BNP 1-32  rather than intact mature BNP 1-32.Figure 4 Antibodies and standard materials   used in commercial BNP immunoassays Adapted with modifications from:   http://www.ifcc.org/media/102208/NP%20Assay%20Table%20C%20SMCD%20vJuly_2011.pdf .",Non-OADS,/arxiv_data1/oa_pdf/fb/f8/ejifcc-27-189.PMC5009944.pdf
"The protein sST2 (also termed Interleukin-1  receptor-like 1, isoform B ) is 328 amino acids  in length, has a molecular weight of 36,993 Da  [http://www.uniprot.org/uniprot/Q01638 ; ac - cessed September 14, 2015], and is glycosylated  at several positions.",Non-OADS,/arxiv_data1/oa_pdf/ec/38/ejifcc-27-224.PMC5009947.pdf
"The protein galectin-3 (also  termed Mac-2 antigen or Carbohydrate-binding  protein 35) is 250 amino acids in length, has a  molecular weight of 26,152 Da [ http://www.un - iprot.org/uniprot/P17931 ; accessed September  14, 2015], and can form dimers and higher or - der oligomers.",Non-OADS,/arxiv_data1/oa_pdf/ec/38/ejifcc-27-224.PMC5009947.pdf
31. http://www.rndsystems.com/pdf/DGAL30.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/25/ejifcc-27-238.PMC5009948.pdf
Mobile general-pur - pose dual arm robots represent a new phase of  automation ( http://www.motoman.com ).,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
It is expected that  this type of testing may become more wide - spread and heavily utilized in the future for both  genomic ( https://www.genome.gov/10000533 )  and proteomic applications (4).,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"DNA Med Institute (DMI ), a  company that has developed a hand-held ana - lyzer for testing whole blood ( http://www.dna - medinstitute.com/ ), is among the finalists.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"It contains two tests strips: one detects  hCG and the other measures the level of hCG  to estimate time since ovulation (1-2 weeks, 2-3  weeks, 3+ weeks) ( http://www.clearblueeasy.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"An app on the smart phone provides test  instructions, indicates the time remaining to  the result (and provides distractions to reduce  stress while waiting for the test result), displays  the result of the test, and suggests next steps  (http://www.firstresponse.com/en/Products/ Pregnancy/Pregnancy-PRO ).",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"These  include Direct to Consumer Testing via the in - ternet, collection kits for drugs of abuse and in - fectious diseases (e.g., Home Access ® Express  HIV-1 Test System) ( http://www.homeaccess.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"Already, there are several cell-free DNA-based  methods for trisomy testing (12), and plans have  been announced for large scale tumor-free DNA  testing to enable the early detection of cancer in asymptomatic individuals ( http://www.grailbio.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
Big biology/data Large-scale mega-sequencing projects involving  thousands to millions of subjects are a recent  phenomenon ( http://blog.oup.com/2015/02/ millions-genomes-project/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"At the current  time, there are several studies (either in plan - ning stages or in progress) involving one mil - lion subjects, including studies organized by the  Beijing Genomics Institute (BGI) (14), National  Institutes of Health (NIH) ( https://www.nih.gov/ precision-medicine-initiative-cohort-program/ scale-scope ), Veterans Affairs (VA) ( http://www.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"research.va.gov/mvp/ ), and others planned  for 100,000 (UK, https://www.genomicseng - land.co.uk/the-100000-genomes-project ) and  200,000 subjects ( http://www.grailbio.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"In fact, the first patients  diagnosed through the UK 100,000 Genomes  Project were reported in 2015 ( http://www.ge - nomicsengland.co.uk/first-patients-diagnosed- through-the-100000-genomes-project/ ).",Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
Report - McKinsey  Global Institute  - May 2013. http://www.mckinsey.com/ business-functions/business-technology/our-insights/ disruptive-technologies .,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
Financial Times 2016:Feb - ruary 14. http://www.ft.com/cms/s/0/063c1176-d29a- 11e5-969e-9d801cf5e15b.html#axzz441y2CO1R .,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
2015. http://www.sen - simed.ch/images/pdf/PR_2016-03-15_sensimed_FDA_US_E.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
Harvard Health Lett  2016: January 15. http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
Pharmacogen Informat News 2015: No-vember 17. http://pharmacogeneticstesting.com/phar - macogenomic-companies/harmonyx-genetic-testing-kits-available-at-rite-aid-nationwide/.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
World China 2014:  October 9. http://www.theworldofchinese.com/article/ chinas-gene-dream/.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
2014:October 3.   http://www.fda.gov/downloads/medicaldevices/de - viceregulationandguidance/guidancedocuments/ucm416684.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"2015:November 16,  http://www.fda.gov/downloads/AboutFDA/ReportsMan - ualsForms/Reports/UCM472777.pdf .",OADS,/arxiv_data1/oa_pdf/fe/43/ejifcc-27-253.PMC5009949.pdf
"Bioinformatics To assess the conservation of phosphorylation sites among different species, we used the standalone versions of CPhos (Zhao et al, 2012) (http://helixweb.nih.gov/CPhos) to calculate a score for eachidentified phosphorylation site in our phosphoproteomics data.",OADS,/arxiv_data1/oa_pdf/de/c5/EMBJ-35-1810.PMC5010044.pdf
"Accessible surface area for each amino acid was calcu-lated from the crystal structure of PDB: 4WY4 (Diao et al, 2015) using STRIDE (http://webclu.bio.wzw.tum.de/stride) (Heinig &Frishman, 2004).",OADS,/arxiv_data1/oa_pdf/de/c5/EMBJ-35-1810.PMC5010044.pdf
"Modern technology, the Internet, and espe-cially GoogleScholar, allows access to all these articles, where the teach-ings of the essence and there, and even less originality, to get a simple search on the air, that is, to quote the fact that they are used to raise rat -EDITORIAL © 2016 Izet Masic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.168-171 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
We follow COPE Retraction Guidelines (http://publicationethics.org/fi  les/retrac- tion%20guidelines_0.pdf) and publish a separately citation for retracted article.,Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272501/The second case is:Latifi  -Popovci, H. Association Between Autoantibodies Against Thyroid Stimu- lating Hormone Receptor and Thyroid Diseases Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272499/The third case is:Sahin C, Aras HI.",Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
2015 Dec; 69(6): 393-395.  http://www.scopemed.org/?mno=223768,Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
Avail-able at: http://www.nature.com/news/the-scientists-who-get-credit-for-peer-review-1.16102 14.,Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
Available at: http://manu.edu.mk/prilozi/35_3/09-D_DONEV.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/82/58/MA-70-168.PMC5010053.pdf
ORCID ID: http://www.orcid.org/0000-0001-7685-8394.,OADS,/arxiv_data1/oa_pdf/1b/b5/MA-70-208.PMC5010054.pdf
"Recently, a cluster of  preventable and modifiable risk fac - tors such as tobacco use, heavy alco-hol consumption, physical inactivity ORIGINAL PAPER © 2016 Fatjona Kraja, Bledar Kraja, Iris  Mone, Ilda Harizi, Adriana Babameto, and Genc Burazeri This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.208-212 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/1b/b5/MA-70-208.PMC5010054.pdf
Detailed information about the research method and questionnaires used can be found at: http://microdata.worldbank.org/index.php/catalog/1970/get_microdata/.,Non-OADS,/arxiv_data1/oa_pdf/1b/b5/MA-70-208.PMC5010054.pdf
2013; 6: 20936. http://dx.doi.org/10.3402/gha.v6i0.20936.,OADS,/arxiv_data1/oa_pdf/1b/b5/MA-70-208.PMC5010054.pdf
(http://www.ishp.gov.al/wp-content/uploads/2015/01/Health-report-English-version.pdf).,Non-OADS,/arxiv_data1/oa_pdf/1b/b5/MA-70-208.PMC5010054.pdf
"Th  e most important surgical detail is the dissection plane at the level of deep dermis without a fat tissue and putting the graft on the way to keep in close touch the deep dermis of the temporal skin and deepithelialized PROFESSIONAL PAPER © 2016 Zlatko Vlajcic and Rado Zic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.217-218 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/9d/da/MA-70-217.PMC5010055.pdf
"However, the reasons for this rise do not seem linked to increased access to birth care, but rather related to an increase in elective and subjective use of CS, possibly reflecting patient and doctor preferences (5, 7, 8, 9).PROFESSIONAL PAPER © 2016 Jasenko Fatusic, Igor Hudic,  Zlatan Fatusic, Aida Zildzic-Moralic, and Milorad Zivkovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.213-216 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/be/aa/MA-70-213.PMC5010056.pdf
"2016 Jun; 70(3): 219-222 Received: JAN 25, 2016 | Accepted: APR 15, 2016 © 2016 Zahra Soltani and Fereydoun  Davatchi This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Published online: 31/05/2016 Published print: 06/2016",Non-OADS,/arxiv_data1/oa_pdf/bd/00/MA-70-219.PMC5010057.pdf
"The Albanian Urological Asso- ciation Guidelines Committee has reviewed the literature using a Med-line search of the English language.CASE REPORT © 2016 Nexhat Shabani, Halil Ajvazi,  Rezart Xhani, Albesa Shabani, and Mustafa Xhani This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.223-225 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/5a/15/MA-70-223.PMC5010058.pdf
"The patient was taken CASE REPORT © 2016 Nurullah Yilmaz, Ersin Koksal,  Gokce Ultan Ozgen, Ersan Ozen, Ahmet Dilek, Deniz Karakaya, and Fatma Ulger This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.226-228 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/62/f2/MA-70-226.PMC5010059.pdf
ORIC ID: http://orcid.org/0000-0002-0260-564X.,OADS,/arxiv_data1/oa_pdf/cc/e3/MA-70-229.PMC5010060.pdf
"Trans thoracic CASE REPORT © 2016 Alen Karic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.229-231 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/cc/e3/MA-70-229.PMC5010060.pdf
"Abdominal ultrasound showed en-larged hyperechogenic kidneys with CASE REPORT © 2016  Lidvana Spahiu, Besart Merovci,  Haki Jashari, Arbnore Batalli Këpuska, and Blerta Elezi Rugova This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.232-234 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/b1/59/MA-70-232.PMC5010061.pdf
"Multi-visceral resection of the stomach, pancreas and spleen was performed.CASE REPORT © 2016 Edvin Mulalic and Samir  Delibegovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.235-237 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/86/b6/MA-70-235.PMC5010062.pdf
"From the surgery point of view there is no importance in their dif -CASE REPORT © 2016 Mergime Prekazi Loxha, Sami  Salihu, Kaltrina Kryeziu, Sadushe Loxha, Zana Agani, Vjosa Hamiti, and Aida Rexhepi This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.238-240 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/ea/6a/MA-70-238.PMC5010063.pdf
2014 Jul; 7: zd31-zd32    available from  http://www.jcdr.net//back_issues.asp 5.,Non-OADS,/arxiv_data1/oa_pdf/ea/6a/MA-70-238.PMC5010063.pdf
"The product of COX-ORIGINAL PAPER © 2016 Lestari Dewi This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.172-17 6 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/a6/61/MA-70-172.PMC5010064.pdf
"Searching for Protein Sequences The component structure of aspirin (CID: 2244), al- ginate (CID: 91666324) and Fucoidan (CID: 10452) was obtained from PubChem Open Chemistry Database, whereas the protein sequence of COX-1 (GI: 3914292) and COX-2 (GI: 2970564) was obtained from sequence database of the National Center for Biotechnology In-formation (NCBI), the United States National Library of Medicine (NLM) and the National Institute of Health (NIH) (http://www.ncbi.nlm.nih.gov).2.2.",OADS,/arxiv_data1/oa_pdf/a6/61/MA-70-172.PMC5010064.pdf
"As usual in such sit - uations and in our age, we remem-ber good times – also often difficult REVIEW © 2016 Izet Masic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.241-242 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/de/46/MA-70-241.PMC5010065.pdf
"Since bronchopneumo-nia is an infectious disease, antimi-crobic agents must be used in the ORIGINAL PAPER © 2016 Svjetlana Loga Zec, Kenan  Selmanovic, Natasa Loga Andrijic, Azra Kadic, Lamija Zecevic, and Lejla Zunic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.177-181 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/cd/ff/MA-70-177.PMC5010066.pdf
"The inclusion criteria for the cohort were: Term neonates of <28 days age with manifested seizures and preterm babies with seizures prior to ORIGINAL PAPER © 2016 Suada Heljic, Sajra Uzicanin,  Feriha Catibusic, and Smail Zubcevic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.182-185 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/8d/7c/MA-70-182.PMC5010067.pdf
"The in-crease of intraabdominal pressure in visceral overweight rises diaphragm up which causes the compression of ORIGINAL PAPER © 2016 Amela Pasic, Fahrija Skokic, Fuad  Pasic, and Miroslav Ilic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.186-190 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/b0/1a/MA-70-186.PMC5010068.pdf
"1999).ORIGINAL PAPER © 2016 Senad Pesto, Mirsad Rahimic,  Muris Pecar, Sabina Prevljak, Edin Begic, and Izet Masic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.193-197 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/15/48/MA-70-193.PMC5010069.pdf
"Transforma-tion of Serrated polyps is achieved through methylation of CPG island whose pathway is different from transformation of Adenomatous to Adenocarcinoma.ORIGINAL PAPER © 2016 Ali Zare Mirzaie, Hakimeh  Khakpour, Masoud Mireskandari, Nasrin Shayanfar, and Ladan Fatahi This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.198-202 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/MA-70-198.PMC5010071.pdf
"In order to understand and assess the presence of glaucoma-ORIGINAL PAPER © 2016 Edita Dervisevic, Suzana  Pavljasevic, Almir Dervisevic, and Sanja Sefic Kasumovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.203-207 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/e1/1f/MA-70-203.PMC5010072.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2713–2722Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2713Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11285 2 clinical study in genital herpes: natural gene- eden-Vir/novirin versus acyclovir, valacyclovir,  and famciclovir hanan Polansky adrian Javaherian edan itzkovitz The center for the Biology of  chronic Disease ( cBcD), Valley  cottage, nY, UsaBackground:  This paper reports the results of a clinical study that tested the effect of suppres - sive treatment with the botanical product Gene-Eden-VIR/Novirin on the number of genital  herpes outbreaks.",Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
"Episodic therapy uses self-administration of the drug during  outbreaks, and the main objective is decreasing the duration of the outbreaks.6 Clinical  studies have shown that episodic treatment with these drugs shortens the time to lesion correspondence: hanan Polansky The center for the Biology of chronic  Disease (cBcD), 616 corporate  Way, suite 2-3665, Valley cottage,  nY 10989, Usa Tel +1 585 250 9999 email hpolansky@cbcd.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Polansky et al Running head recto: Natural formula for genital herpes: frequency results DOI: http://dx.doi.org/10.2147/DDDT.S112852 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
Or use: http://youtu.be/kJzAYDEEJt 0Video abstract,Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
Available from: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm073139.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/84/dddt-10-2713.PMC5010074.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/27/cia-11-1175.PMC5010075.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1175–1181Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1175OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10900 9 The predictive value of arterial stiffness on major  adverse cardiovascular events in individuals with  mildly impaired renal function Jie han* Xiaona Wang* Ping Ye ruihua Cao Xu Yang Wenkai Xiao Yun Zhang Y ongyi Bai hongmei Wu Department of geriatric Cardiology,   Chinese P lA general hospital,   Beijing, People’s republic of China *These authors contributed equally  to this workObjectives:  Despite growing evidence that arterial stiffness has important predictive value for  cardiovascular disease in patients with advanced stages of chronic kidney disease, the predictive  significance of arterial stiffness in individuals with mildly impaired renal function has not been  established.",Non-OADS,/arxiv_data1/oa_pdf/dc/27/cia-11-1175.PMC5010075.pdf
"Patients with CKD are more likely to die from  CVD than progress to end-stage renal disease (ESRD), let alone patients who have  already progressed to ESRD or dialysis.8 In addition to traditional CV risk factors,  including advanced age, diabetes, hypertension, dyslipidemia, and smoking, large- vessel arterial stiffness, which is a common issue in CKD, is considered another Correspondence: Ping Ye Department of geriatric Cardiology,  Chinese PlA general hospital,  28 Fuxing road, haidian, Beijing  100853, People’s republic of China Tel +86 10 6687 6369 Fax +86 10 6687 6349 email yeping301@sina.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Han et al Running head recto: Arterial stiffness and major adverse cardiovascular events DOI: http://dx.doi.org/10.2147/CIA.S109009",Non-OADS,/arxiv_data1/oa_pdf/dc/27/cia-11-1175.PMC5010075.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/dc/27/cia-11-1175.PMC5010075.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/cia-11-1175.PMC5010075.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/cia-11-1169.PMC5010076.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1169–1174Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1169OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10788 1 Comparative clinicopathological and outcome  analysis of differentiated thyroid cancer in saudi  patients aged below 60 years and above 60 years Khalid hussain Al-Qahtani1 Mutahir A T unio2 Mushabbab Al Asiri2 Yasser Bayoumi3 Ali Balbaid2 naji J Aljohani4 hanadi Fatani5 1Department of Otolaryngology-   head & neck surgery, College of  Medicine, King saud University,   riyadh, saudi Arabia; 2Department of  radiation Oncology, Comprehensive  Cancer Center, King Fahad  Medical City, riyadh, saudi Arabia;   3Department of radiation Oncology,   nCI, Cairo University, Cairo, egypt;   4Department of endocrinology and  Thyroid Oncology, 5histopathology,   Comprehensive Cancer Center, King  Fahad Medical City, riyadh, saudi  ArabiaIntroduction:  The aim of this study was to evaluate the treatment outcomes of differentiated  thyroid cancer in Saudi patients aged above 60 years.",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/cia-11-1169.PMC5010076.pdf
"Keywords:  differentiated thyroid cancers, patients aged above 45 years, aged above 60 years,  clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years,  comparative analysis Introduction The incidence of differentiated thyroid cancers (DTCs), including papillary thyroid  cancer (PTC) and follicular thyroid cancer variants, is rising significantly globally  over the past decades, with a wide geographic variation.1 In Saudi Arabia, DTC is the  second-most common malignancy, accounting for more than 10% of all cancers among  middle-aged women.2 Generally, age above 45 years is regarded as a poor prognostic  marker in DTC, using the American Joint Cancer Committee/Union Internationale  Contre le Cancer Tumor Nodes Metastasis staging system; the mortality rate climbs  gradually starting at age 45 years and above.3,4 DTC in older patients ( 60 years)  has some distinctive clinicopathological features: 1) large size of primary tumors at  the time of diagnosis; 2) high risk of distant metastases at the time of presentation;  3) more aggressive histopathological variants of DTC; and 4) higher recurrence rates.5,6 Correspondence: Mutahir A Tunio Department of radiation Oncology,  Comprehensive Cancer Center, King  Fahad Medical City, riyadh 11525,  saudi Arabia Tel +966 11 288 9999 Fax +966 11 288 9999 email drmutahirtonio@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: AL-Qahtani et al Running head recto: Differentiated thyroid cancer in elderly patients DOI: http://dx.doi.org/10.2147/CIA.S107881",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/cia-11-1169.PMC5010076.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/cia-11-1169.PMC5010076.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3c/b4/cia-11-1169.PMC5010076.pdf
"Available from http://www.cdsi.gov.s a. Accessed  May 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/cia-11-1169.PMC5010076.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 261–272Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 261 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S109599 Natural dipeptidyl peptidase-IV inhibitor  mangiferin mitigates diabetes- and metabolic  syndrome-induced changes in experimental rats Rajesh Kumar Suman1  Ipseeta Ray Mohanty1  Ujwala Maheshwari2  Manjusha K Borde1  YA Deshmukh1 1Department of Pharmacology,   2Department of Pathology, MGM  Medical College, Kamothe, Navi  Mumbai, IndiaBackground: Mangiferin (MNG) is known to possess antidiabetic and antioxidant activity.",Non-OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
"One of the recent additions to these antidiabetic drugs is the dipeptidyl peptidase-IV Correspondence: Rajesh Kumar Suman   Department of Pharmacology, MGM  Medical College, Sector 01, Kamothe, Navi Mumbai 410209, India   Mob +91 9699072649  Email rajesh_suman1986@hotmail.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Suman et alRunning head recto: Mangiferin mitigates experimental diabetes with metabolic syndromeDOI: http://dx.doi.org/10.2147/DMSO.S109599",Non-OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 272 Suman et al to provide additional informative parameters for the assess- ment of the chronicity and progress of the illness as well as of the response to therapy.,Non-OADS,/arxiv_data1/oa_pdf/82/1a/dmso-9-261.PMC5010077.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1159–1168Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1159OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10209 2 Chum salmon egg extracts induce upregulation  of collagen type I and exert antioxidative effects  on human dermal fibroblast cultures Atsushi Y oshino1 natalia Polouliakh1–3 Akira Meguro1 Masaki Takeuchi1,4 Tatsukata Kawagoe1 Nobuhisa Mizuki1 1Department of Ophthalmology  and Visual science, Y okohama City  University graduate school of  Medicine, Y okohama, Kanagawa, 2sony  Computer Science Laboratories Inc.,   Fundamental Research Laboratories,   3systems Biology Institute, T okyo,   Japan; 4Inflammatory Disease section,   national human genome research  Institute, national Institutes of health,   Bethesda, MD, UsAAbstract:  Components of fish roe possess antioxidant and antiaging activities, making them  potentially very beneficial natural resources.",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
"This in turn upregulates matrix  metalloproteinase expression, activating a positive-feedback loop that further acceler - ates collagen matrix degradation.8 Based on evidence that oxidative stress plays pivotal  roles in both intrinsic and extrinsic aging, it has been suggested that antioxidants may  be an efficient means of defense against aging processes.9–11 Numerous studies have examined compounds derived from marine and botani - cal organisms that show cosmetically useful antioxidant and antiaging activities.12,13 Correspondence: Nobuhisa Mizuki Department of Ophthalmology and Visual  science, Yokohama City University,  Fukuura 3-9, Kanazawa ward, Yokohama  City, Kanagawa Prefecture 236-0004,  Japan Fax +81 45 781 9755 email mizunobu@med.yokohama-cu.ac.j p Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y oshino et al Running head recto: Effects of CSE extracts on human dermal fibroblast cultures DOI: http://dx.doi.org/10.2147/CIA.S102092",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
"On the basis of these results, it is  reasonable that we infer that CSE supplementation improved  the overall antioxidant activity of the cells, with this effect  seeming to be dose dependent.Table 2  (Continued ) TF name PSSM Consensus MCS Positive Control Gene Location Motif PRDX3 [6–11] + TgTggT [1] (3) PRDX3 [6–11] − TgTggT [1] (3) GPX1 [692–697] TgTggT [1] (3) PRDX5 [153–158] TgTggT [1] (8) PRDX3 [43–48] TgTggT [1] (9) GCLC [281–286] TgTggT [1] (11) TXNRD1 [427–432] TgTggT [1] (18) PRDX1 [49–54] TgTggT [1] (19) GCLC [128–133] TgTggT [1] (20) GSTP1 [15–20] TgTggT [1] (23) PRDX3 [18–23] TgTggT [1] (24) GSTP1 [28–33] TgTggT [1] (25) Notes:  Columns are as follows: PSSM, matrix number in public Transfac database; consensus, motif consensus using International Union of Pure and Applied Chemistry (IUPAC) nucleotide ambiguity codes ( http://www.bioinformatics.org/ sms/iupac.htm l); positive, unique number of genes (out of the 33 induced genes) with the respective motif and the number of motif copies in brackets; control, unique number of genes (out of the 31 uninduced genes) with the respective  motif and the number of motif copies in brackets; gene, selected genes from the positive set; location, location in the promoter toward the transcriptional start site, with a +/− indication when the motif is on the reverse or complement  strand; motif, motif sequence identified, matching score to the consensus in square brackets, and the number of the Pareto front in parentheses.",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
"Due to its beneficial properties, astaxanthin is already included  in some cosmeceutical products, for example, Fujifilm Astalift  lineup ( http://www.astalift.com.s g).",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ca/d6/cia-11-1159.PMC5010078.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/4f/dddt-10-2723.PMC5010079.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2723–2728Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2723Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9969 6 Spotlight on tocilizumab and its potential in the  treatment of systemic sclerosis Lazaros i Sakkas Department of Rheumatology and  Clinical immunology, Medical School,   University of Thessaly, Larissa, GreeceAbstract:  Systemic sclerosis (SSc) is a multisystem disease characterized by extensive collagen  deposition in skin and internal organs, fibrointimal microvasculopathy, and activation of the  immune system.",Non-OADS,/arxiv_data1/oa_pdf/dc/4f/dddt-10-2723.PMC5010079.pdf
"TLRs recognize exogenous pathogen-associated molecular patterns Correspondence: Lazaros i Sakkas Department of Rheumatology and  Clinical immunology, Medical School,  University of Thessaly, Biopolis, Larissa  41110, Greece Tel +30 241 350 2813 Fax +30 241 350 1016 email lsakkas@med.uth.g r Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Sakkas Running head recto: Tocilizumab in systemic sclerosis DOI: http://dx.doi.org/10.2147/DDDT.S99696",Non-OADS,/arxiv_data1/oa_pdf/dc/4f/dddt-10-2723.PMC5010079.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dc/4f/dddt-10-2723.PMC5010079.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/4f/dddt-10-2723.PMC5010079.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/06/copd-11-2017.PMC5010080.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2017–2027International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2017OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11038 9 The efficacy and safety of combined tiotropium  and olodaterol via the respimat® inhaler in  patients with COPD: results from the Japanese  sub-population of the T onado® studies Masakazu Ichinose1 Hiroyuki Taniguchi2 Ayako Takizawa3 lars grönke4 lazaro loaiza4 Florian Voß4 Yihua Zhao5 Y oshinosuke Fukuchi6 1Department of Respiratory Medicine,   Tohoku University Graduate School of  Medicine, Sendai, Japan; 2Department  of Respiratory Medicine and Allergy,   T osei General Hospital, Aichi, Japan;   3Nippon Boehringer Ingelheim Co. Ltd,   T okyo, Japan; 4Boehringer Ingelheim  Pharma GmbH & Co. KG, Ingelheim,   Germany; 5Boehringer Ingelheim  Pharmaceuticals, Inc., Ridgefield,   Connecticut, USA; 6Juntendo  University School of Medicine,   T okyo, JapanBackground:  The efficacy and safety of once-daily tiotropium + olodaterol (T +O) maintenance  treatment was demonstrated in the large, multinational, replicate, randomized, Phase III,  Tonado® 1 (NCT01431274) and 2 (NCT01431287) studies in patients with moderate to very  severe COPD.",Non-OADS,/arxiv_data1/oa_pdf/a9/06/copd-11-2017.PMC5010080.pdf
"Keywords:  COPD, bronchodilators, maintenance treatment Introduction The incidence of COPD is predicted to increase in Japan and the People’s Republic  of China over the next 30 years due to factors such as greater tobacco use and an  ageing population.1,2 Furthermore, an epidemiology study of airflow limitation in  Japanese adults aged $40 years showed that COPD is under-recognized, with 10.9%  of those assessed having airflow limitation, yet only 9.4% had received a previous  diagnosis of COPD.2 In maintenance treatment of COPD, the combination of a Correspondence: Masakazu Ichinose Department of Respiratory Medicine,  Tohoku University Graduate School of  Medicine, 1-1 Seiryo-machi, Aoba-ku,  Sendai 980-8574, Japan Tel +81 22 717 8534 Fax +81 22 717 8549 email ichinose@rm.med.tohoku.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ichinose et al Running head recto: Effect of tiotropium and olodaterol in Japanese COPD patients DOI: http://dx.doi.org/10.2147/COPD.S110389",Non-OADS,/arxiv_data1/oa_pdf/a9/06/copd-11-2017.PMC5010080.pdf
Available from: http://goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/a9/06/copd-11-2017.PMC5010080.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a9/06/copd-11-2017.PMC5010080.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/06/copd-11-2017.PMC5010080.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2035–2040International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2035OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10872 3 Bronchodilator reversibility in patients with  COPD revisited: short-term reproducibility steven Pascoe1 Wei Wu2 Chang-Qing Zhu3 Dave singh4 1gsK, respiratory Medicines  Development Center, 2PareXel  International, research Triangle Park,   nC, Usa; 3gsK, Clinical statistics  (respiratory), Middlesex, UK;   4Medicines evaluation Unit, University  hospital of south Manchester nhs  Foundation Trust, University of  Manchester, Manchester, UKAbstract:  Categorization of patients with COPD as reversible or nonreversible to a  bronchodilator may change over time.",Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
"Keywords:  bronchodilator responsiveness, FEV1, correlation, short-acting bronchodilators,  spirometry Introduction COPD is characterized by persistent airflow limitation.1,2 Inhaled β2-agonists and anti - muscarinics have become central to the management of patients with COPD, as they  improve lung function.2 Improvements in exercise tolerance and quality of life, and  reductions in COPD symptoms including exacerbations have also been demonstrated  with these treatments.2 Long-acting bronchodilators are used as regular maintenance  therapies in patients with moderate-to-severe COPD, while short-acting bronchodila - tors are generally used as required to provide symptomatic relief.2 Despite little evidence to suggest a bimodal distribution of bronchodilator response  with two distinct groups of responders and nonresponders,3,4 the paradigm of the revers - ible and nonreversible COPD phenotype has been widely applied to classify patients in  clinical trials.5–8 However, bronchodilator responsiveness may be considered a continu - ous variable,9 with the effect of bronchodilators on lung function varying substantially  between patients.2,10 The 200 mL cut-off point used to establish reversibility6 is close to  the mean forced expiratory volume in 1 second (FEV1) response of patients with COPD  to albuterol (eg, Buhl et al reported mean FEV1 values of 164–177 mL in a population Correspondence: steven Pascoe gsK, respiratory Medicines  Development Center, 5 Moore Drive,  research Triangle Park, nC 27709-3398,  Usa Tel +1 919 491 8859 email steven.j.pascoe@gsk.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Pascoe et al Running head recto: Predictivity of bronchodilator response in COPD DOI: http://dx.doi.org/10.2147/COPD.S108723",Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
Available from: http://www.statsoft.com/textbook /.,Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/79/copd-11-2035.PMC5010081.pdf
"Pa-tients who are excluded from the study were as follows: patients in the terminal stage of chronic renal insufficiency (stage V), patients with kidney transplant, patients with un-stable renal function, patients with diagnosed diabetes, polycystic kid-ORIGINAL PAPER © 2016 Sandra Vegar Zubovic, Spomenka  Kristic, Sabina Prevljak and Irmina Sefic Pasic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.191-192 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/a1/6b/MA-70-191.PMC5010092.pdf
Supplementary material Supplementary material for this paper can be found at http://jcbfm.sagepub.com/content/by/supplemental-data.,Non-OADS,/arxiv_data1/oa_pdf/21/02/10.1177_0271678X15621500.PMC5010097.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/3a/56/10.1177_2325967116663706.PMC5010098.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/10.1177_2325967116662873.PMC5010099.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/a0/tcrm-12-1311.PMC5010151.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1311–1315Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1311ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11638 5 surgical versus conservative treatment following  acute rupture of the achilles tendon: is there a  pedobarographic difference?",Non-OADS,/arxiv_data1/oa_pdf/57/a0/tcrm-12-1311.PMC5010151.pdf
"Rehabilitation after rupture of the Achilles tendon is slow Correspondence: Fatih Karaaslan Department of Orthopedics and  Traumatology, Faculty of Medicine, Bozok  University, 18 Madrasa Adnan Menderes,  Boulevard, Yozgat 66200, Turkey Tel +90 354 212 7060 email fkaraaslan@gmail.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Karaaslan et al Running head recto: Surgical versus conservative treatment following acute rupture DOI: http://dx.doi.org/10.2147/TCRM.S116385",Non-OADS,/arxiv_data1/oa_pdf/57/a0/tcrm-12-1311.PMC5010151.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/57/a0/tcrm-12-1311.PMC5010151.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/a0/tcrm-12-1311.PMC5010151.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 267–271International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 267 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S110046Infectious crystalline keratopathy caused by  Cladosporium sp.",Non-OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
"2,3  This is the first description of a case of Cladosporium sp.-induced infectious crystal-line keratopathy, although other forms of keratitis caused by Cladosporium have been described.Correspondence: Rafael Allan Oechsler Rua Christina Blumenau, 204, Blumenau, Santa Catarina 89010-480, Brazil   Tel +55 47 9114 2875   Fax +55 47 3326 8597   Email rafallan@hotmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Stock et alRunning head recto: Infectious crystalline keratopathy caused by Cladosporium sp.DOI: http://dx.doi.org/10.2147/IMCRJ.S110046",Non-OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 271 Infectious crystalline keratopathy caused by Cladosporium sp.have greatly improved this patient’ s outcome.,Non-OADS,/arxiv_data1/oa_pdf/cd/a1/imcrj-9-267.PMC5010152.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1671–1678Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1671Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11170 8 Macular pigment optical density: repeatability,  intereye correlation, and effect of ocular  dominance Pinakin gunvant Davey silverio D alvarez Jessica Y lee College of Optometry, Western  University of health sciences,   Pomona, C a, UsaPurpose:  To evaluate short-term repeatability, intereye correlation, and effect of ocular  dominance on macular pigment optical density (MPOD) measurements obtained using the  QuantifEye Heterochromatic Flicker Photometer.",Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
"Keywords:  macular pigment optical density, heterochromatic flicker photometry, age-related  macular degeneration, ocular dominance, QuantifEye, repeatability, clinical protocol Introduction Age-related macular degeneration (AMD) is a leading cause of blindness in developed  countries worldwide.1–7 AMD is broadly classified into two categories, exudative  AMD and nonexudative AMD.8 Estimates indicate that in the US there were 2 million  patients with late AMD and 8 million patients with intermediate AMD in 2004, and  it is predicted that this number will double in the year 2024.9 There are numerous  breakthroughs in the understanding of pathogenesis of wet AMD, and treatments have  been developed in the form of antivascular endothelial growth factors.8 However, the Correspondence: Pinakin gunvant Davey College of Optometry, Western  University of health sciences, 309 e  second street, Pomona, Ca 91766, Usa Tel +1 909 469 8473 email contact@pinakin-gunvant.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Davey et al Running head recto: Factors influencing MPOD measurements DOI: http://dx.doi.org/10.2147/OPTH.S111708 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
Or use: http://youtu.be/PPdgyScfKB EVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
The poster’s abstract  was published in “Poster Abstracts” online program number  135209: http://www.aaopt.org/macular-pigment-optical- density-repeatability-inter-eye-correlation-and-effect-ocular- dominanc e. Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/28/opth-10-1671.PMC5010153.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/7d/ppa-10-1657.PMC5010154.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1657–1665Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1657Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11229 7 Limited evidence on persistence with  anticoagulants, and its effect on the risk of  recurrence of venous thromboembolism:  a systematic review of observational studies Pareen vora Montse Soriano-Gabarró Kiliana Suzart Gunnar Persson Brobert Department of epidemiology, Bayer  Pharma AG, Berlin, GermanyPurpose:  The risk of venous thromboembolism (VTE) recurrence is high following an initial  VTE event, and it persists over time.",Non-OADS,/arxiv_data1/oa_pdf/13/7d/ppa-10-1657.PMC5010154.pdf
"VTE associated with known acquired risk  factors is referred to as “provoked;” if there is no known clinical risk factor present, it  is referred to as “unprovoked”.1 It is estimated that there are 300,000–600,000 incident  VTE cases annually in the USA.2 Across six major European countries, the estimated  incidence per 100,000 person-years was 148 for DVT and 95 for PE.3 Subsequent VTE Correspondence: Pareen vora Department of epidemiology, Bayer  Pharma AG, Muellerstrasse 178,  13353 Berlin, Germany Tel +49 30 468 194 850 Fax +49 30 468 994 270 email pareen.vora@bayer.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Vora et al Running head recto: Persistence with anticoagulation treatment in VTE patients DOI: http://dx.doi.org/10.2147/PPA.S112297",Non-OADS,/arxiv_data1/oa_pdf/13/7d/ppa-10-1657.PMC5010154.pdf
2013; Available from: http://bmg.cochrane.org/sites/bmg.,Non-OADS,/arxiv_data1/oa_pdf/13/7d/ppa-10-1657.PMC5010154.pdf
Available from http://CRAN.R-project.org/package=meta.,Non-OADS,/arxiv_data1/oa_pdf/13/7d/ppa-10-1657.PMC5010154.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/13/7d/ppa-10-1657.PMC5010154.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/ott-9-5271.PMC5010155.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5271–5279OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5271Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10777 1 Expression and prognostic significance of unique  UlBPs in pancreatic cancer Jiong chen1,2,* Xing-Xing Zhu1,2,* hong Xu1,2 heng-Zhong Fang1,2 Jin-Qian Zhao1,2 1Department of General Surgery,   anhui Provincial hospital, anhui  Medical University, 2anhui  Provincial Key Laboratory of  hepatopancreatobiliary surgery,   Hefei, People’s Republic of China *These authors contributed equally  to this workBackground:  Pancreatic cancer is one of the most lethal cancers worldwide, due to the lack  of efficient therapy and difficulty in early diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/ott-9-5271.PMC5010155.pdf
"The NKG2D receptor and its ligands form an  important pathway of immunological defense.6 The NKG2D receptor is a C-type lectin- like transmembrane-activating receptor, which has been reported to be expressed on  many cytotoxic lymphocytes, including NK cells, NKT cells, CD8+ T cells, γδ T cells,  and certain subsets of human CD4+ T cells.7 Immunological surveillance was achieved  when NKG2D, present on the surface of immune cells, came into contact with ULBPs,  which were expressed in various malignancies and virus-infected tissues or when cells correspondence: Jiong chen Department of General Surgery, Anhui  Provincial hospital, anhui Medical  University, 17 Lujiang Road, Hefei, Anhui  230001, People’s Republic of China Tel +86 156 0567 0909 Fax +86 551 6228 3337 email chenjiong012@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: ULBP expression in pancreatic cancer DOI: http://dx.doi.org/10.2147/OTT.S107771",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/ott-9-5271.PMC5010155.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/ott-9-5271.PMC5010155.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/2a/ott-9-5271.PMC5010155.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/b2/ijn-11-4213.PMC5010156.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4213–4220International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4213OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11356 0 In situ precise electrospinning of medical glue  fibers as nonsuture dural repair with high sealing  capability and flexibility Fu-Yan lv1,* rui-hua Dong1,* Zhao-Jian Li2,* Chong-Chong Qin1 Xu Yan1,3 Xiao-Xiao he1 Yu Zhou4 Shi-Ying Yan1 Yun-Ze long1,3 1Collaborative Innovation Center  for Nanomaterials & Optoelectronic  Devices, College of Physics,   Qingdao University, 2Department  of Neurosurgery, Affiliated  Hospital of Qingdao University,   3Industrial Research Institute of  Nonwovens & T echnical T extiles,   College of T extiles & Clothing,   4Medical College, Qingdao University,   Qingdao, People’s Republic of China *These authors contributed equally  to this workPurpose:  In this work, we propose an in situ precise electrospinning of medical glue fibers  onto dural wound for improving sealing capability, avoiding tissue adhesion, and saving time  in dural repair.",Non-OADS,/arxiv_data1/oa_pdf/c1/b2/ijn-11-4213.PMC5010156.pdf
"N-octyl-2-cyanoacrylate (NOCA), an easily biocompatible  and bioresorbable polymer glue, provides an alternative to conventional rigid fixation  techniques.13 CA medical adhesives have been investigated for use as tissue adhesive correspondence: Yun-Ze long;   Shi-Ying Yan Collaborative Innovation Center for  Nanomaterials & Optoelectronic Devices,  College of Physics, Qingdao University,  No 308 Ningxia Road, Qingdao 266071,  People’s Republic of China Tel +86 139 5329 0681 Fax +86 532 8595 5977 email yunze.long@163.co m;  ysy5954418@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lv et al Running head recto: In situ electrospun medical glue fibers suture dura DOI: http://dx.doi.org/10.2147/IJN.S113560",Non-OADS,/arxiv_data1/oa_pdf/c1/b2/ijn-11-4213.PMC5010156.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c1/b2/ijn-11-4213.PMC5010156.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/b2/ijn-11-4213.PMC5010156.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/39/ott-9-5349.PMC5010157.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5349–5360OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5349Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10795 7 alDh1a1 induces resistance to chOP in diffuse  large B-cell lymphoma through activation of the  JaK2/sT aT3 pathway Jinqiong Jiang Yiping liu Y ouhong Tang li li ruolan Zeng shan Zeng Meizuo Zhong Department of Oncology, Xiangya  hospital, central south University,   changsha, hunan, People’s  republic of chinaAbstract:  Increasing evidence has shown that aldehyde dehydrogenase 1A1 (ALDH1A1),  a detoxifying enzyme, is responsible for chemoresistance in a variety of tumors.",Non-OADS,/arxiv_data1/oa_pdf/16/39/ott-9-5349.PMC5010157.pdf
"Although considerable efforts have been made to  understand the molecular basis for development of multidrug resistance in DLBCL,  current knowledge remains limited.4correspondence: Meizuo Zhong Department of Oncology, Xiangya  hospital, central south University,  87 Xiangya road, changsha 410008,  hunan, People’s republic of china Tel +86 139 7482 9582 Fax +86 731 8975 3734 email zhongmeizuo2015@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jiang et al Running head recto: ALDH1A1 induces resistance to CHOP in DLBCL DOI: http://dx.doi.org/10.2147/OTT.S107957",Non-OADS,/arxiv_data1/oa_pdf/16/39/ott-9-5349.PMC5010157.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/16/39/ott-9-5349.PMC5010157.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/39/ott-9-5349.PMC5010157.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/dd/ott-9-5371.PMC5010158.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5371–5381OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5371Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10997 9 Verteporfin, a suppressor of YAP–TEAD complex,  presents promising antitumor properties on  ovarian cancer Juntao Feng1 Jinhai gou1 Jia Jia1 Tao Yi2 Tao cui1 Zhengyu li1,2 1Department of Gynecology and  Obstetrics, 2sichuan Key laboratory  of Gynecologic Oncology, West China  Second University Hospital, Sichuan  University, Chengdu, People’s Republic  of ChinaAbstract:  Y es-associated protein (YAP) is a key transcriptional coactivator of Hippo pathway  and has been shown to be an oncoprotein in ovarian cancer (OC).",Non-OADS,/arxiv_data1/oa_pdf/a9/dd/ott-9-5371.PMC5010158.pdf
"These  observations indicate that YAP may be a novel potential target for antitumor drug.correspondence: Zhengyu li Department of Gynecology and  Obstetrics, West China Second Hospital  of Sichuan University, #20 Section 3,  Renmin South Road, Chengdu 610041,  People’s Republic of China Tel +86 28 189 8215 1025 Fax +86 28 8550 2391 email zhengyuli@scu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Feng et al Running head recto: Verteporfin presents promising antitumor properties on ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S109979",Non-OADS,/arxiv_data1/oa_pdf/a9/dd/ott-9-5371.PMC5010158.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a9/dd/ott-9-5371.PMC5010158.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/dd/ott-9-5371.PMC5010158.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/43/ndt-12-2237.PMC5010160.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2237–2243Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2237OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11322 0 Psychological distress and coping in military cadre  candidates can Nakkas1 hubert annen1 serge Brand2,3 1Department of Military Psychology  studies, Military academy at eTh  Zurich, Zurich, 2Psychiatric clinics of  the University of Basel, center for  affective, stress and sleep Disorders,   3Department of sport, exercise  and health, sport science section,   University of Basel, Basel, switzerlandBackground:  Soldiers must cope with stressors during both military operations and training  if they are to accomplish their missions successfully and stay mentally stable.",Non-OADS,/arxiv_data1/oa_pdf/8d/43/ndt-12-2237.PMC5010160.pdf
"Its goal is to enable service personnel to  perform under adverse conditions that offer little control, as a soldier’s performance  in military operations is mission-critical and allows for little leeway.3 It thus comes as no surprise that basic military training itself has also been shown to  be a biopsychosocial stressor, resulting in elevated cortisol levels4–7 and elevated self- reported psychological distress.8–10 Although most recruits adapt to basic training,9,11  the literature also includes reports of fluctuating levels of stress and negative mood  over time.8,9,12correspondence: can Nakkas ackersteinstrasse 130, Zurich  ch-8049, switzerland email c.nakkas@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Nakkas et al Running head recto: Psychological distress and coping in military cadre candidates DOI: http://dx.doi.org/10.2147/NDT.S113220",Non-OADS,/arxiv_data1/oa_pdf/8d/43/ndt-12-2237.PMC5010160.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8d/43/ndt-12-2237.PMC5010160.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/43/ndt-12-2237.PMC5010160.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cc/09/ijn-11-4141.PMC5010162.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4141–4155International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4141OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10949 4 Multicomponent, peptide-targeted glycol chitosan  nanoparticles containing ferrimagnetic iron oxide  nanocubes for bladder cancer multimodal imaging Jaehong Key1,2 Deepika Dhawan3 christy l cooper3,4 Deborah W Knapp3 Kwangmeyung Kim5 Ick chan Kwon5 Kuiwon choi5 Kinam Park1,6 Paolo Decuzzi7–9 James F leary1,3,4 1Weldon school of Biomedical  engineering, Purdue University, West  lafayette, IN, Usa; 2Department  of Biomedical engineering, Y onsei  University, Wonju, republic of Korea;   3school of Veterinary Medicine- Department of Basic Medical sciences,   Purdue University, West lafayette,   4Birck Nanotechnology center at  Discovery Park, Purdue University,   West lafayette, IN, Usa; 5Biomedical  research center, Korea Institute of  science and T echnology, sungbook-gu,   seoul, republic of Korea; 6Department  of Pharmaceutics, Purdue University,   West lafayette, IN, 7Department of  Translational Imaging, 8Department of  Nanomedicine, houston Methodist  research Institute, houston, TX  Usa; 9laboratory of Nanotechnology  for Precision Medicine, Fondazione  Istituto Italiano di T ecnologia (IIT),   genova, ItalyAbstract:  While current imaging modalities, such as magnetic resonance imaging (MRI),  computed tomography, and positron emission tomography, play an important role in detect - ing tumors in the body, no single-modality imaging possesses all the functions needed for a  complete diagnostic imaging, such as spatial resolution, signal sensitivity, and tissue penetra - tion depth.",Non-OADS,/arxiv_data1/oa_pdf/cc/09/ijn-11-4141.PMC5010162.pdf
"Nanoparticles ranging from tens to a  few hundred nanometers have improved the preferential delivery of imaging agents and  drugs to tumors by enhanced permeability and retention (EPR) effect.1,2 Moreover, spe - cific binding ligands on nanoparticles have a high affinity for tumor microenvironments  and vasculature.3–5 Several studies have shown that the physicochemical properties of  nanoparticles, including size, stiffness, and zeta-potential, can play an important role in  the efficacy of their cell binding and in vivo biodistribution.6–8 However, the following  limitations still restrict the clinical use of nanoparticles: 1) high toxicity, 2) limited  visualization effect, and 3) nonspecific accumulation to organs and tissues.correspondence: Jaehong Key Department of Biomedical engineering,  Yonsei University, 1 Yonseidae-gil,  Wonju, gangwon-do, 26493,   republic of Korea Tel +82 033 760 2857 email jkey@yonsei.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Key et al Running head recto: Glycol chitosan nanoparticles for bladder cancer multimodal imaging DOI: http://dx.doi.org/10.2147/IJN.S109494",Non-OADS,/arxiv_data1/oa_pdf/cc/09/ijn-11-4141.PMC5010162.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cc/09/ijn-11-4141.PMC5010162.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/09/ijn-11-4141.PMC5010162.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/01/e0/ndt-12-2225.PMC5010163.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2225–2232Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2225OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10941 4 association between sequence variations of   the Mediterranean fever gene and the risk of   migraine: a case–control study Salih Coşkun1 sefer Varol2 hasan h Özdemir2 sercan Bulut Çelik3 Metin Balduz4 Mehmet akif camkurt5 abdullah Çim1 Demet arslan2 Mehmet Ug ˘ur Çevik2 1Department of Medical genetics,   2Department of Neurology, Faculty of  Medicine, Dicle University, Diyarbakir,   3Family health center, Batman,   4Department of Neurology, Şanlıurfa  education and research hospital,   Şanlıurfa, 5Department of Psychiatry,   Afsin State Hospital, Kahramanmaraş,   T urkeyAbstract:  Migraine pathogenesis involves a complex interaction between hormones,  neurotransmitters, and inflammatory pathways, which also influence the migraine phenotype.",Non-OADS,/arxiv_data1/oa_pdf/01/e0/ndt-12-2225.PMC5010163.pdf
"The release of these neuropeptides leads to vasodilation,  plasma protein extravasation, and the release of proinflammatory mediators.3 These  molecules contribute to the sensitization of nociceptors and induce inflammation with Correspondence: Salih Coşkun Department of Medical genetics, Faculty  of Medicine, Dicle University, 21280  Sur, Diyarbakır, Turkey Tel +90 412 248 8001 Fax +90 412 248 8440 email scoskun9@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Co şkun et al Running head recto: Role of MEFV gene mutations in migraine susceptibility DOI: http://dx.doi.org/10.2147/NDT.S109414",Non-OADS,/arxiv_data1/oa_pdf/01/e0/ndt-12-2225.PMC5010163.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/01/e0/ndt-12-2225.PMC5010163.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/e0/ndt-12-2225.PMC5010163.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/8c/tcrm-12-1317.PMC5010164.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1317–1327Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1317Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S11431 6 Rituximab use in adult primary glomerulopathy:  where is the evidence?",Non-OADS,/arxiv_data1/oa_pdf/55/8c/tcrm-12-1317.PMC5010164.pdf
"We will emphasize on the pathophysiological  aspects and recent clinical trials supporting the use of rituximab in the management  of minimal change disease (MCD), idiopathic membranous nephropathy (IMN),  and primary focal and segmental glomerulosclerosis (FSGS), immunoglobulin A Correspondence: Bassem Y Tanios Department of internal Medicine,  American University of Beirut Medical  Center, PO Box 11-0236, Riad-el-Solh,  Beirut 1107 2020, Lebanon Tel +961 1 374 374 or +961 1 350 000  ext 5350/3 Fax +961 1 370 814 email bt08@aub.edu.l b Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Mallat et al Running head recto: Rituximab use in primary glomerulopathies DOI: http://dx.doi.org/10.2147/TCRM.S114316",Non-OADS,/arxiv_data1/oa_pdf/55/8c/tcrm-12-1317.PMC5010164.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/55/8c/tcrm-12-1317.PMC5010164.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/8c/tcrm-12-1317.PMC5010164.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 341–356Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress 341 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S81122Critical appraisal of paclitaxel balloon angioplasty  for femoral–popliteal arterial disease Monika Herten1  Giovanni B T orsello1,2  Eva Schönefeld3  Stefan Stahlhoff2 1Department of Vascular and  Endovascular Surgery, University  Hospital Münster, 2Department of  Vascular Surgery, St Franziskus Hospital, Münster,  3Institute for  Education and Student Affairs,  University Hospital Münster, Münster,  GermanyAbstract:  Peripheral arterial disease, particularly critical limb ischemia, is an area with urgent  need for optimized therapies because, to date, vascular interventions often have limited life  spans.",Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
"1,2 Correspondence: Monika Herten   Department of Vascular and Endovascular  Surgery, University Hospital Münster, Albert-Schweitzer-Campus 1, Building W30, 48149 Münster, Germany   Tel +49 251 835 1717   Fax +49 251 834 6502   Email Moherten@web.deJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2016V olume: 12Running head verso: Herten et alRunning head recto: Critical appraisal of paclitaxel balloon angioplastyDOI: http://dx.doi.org/10.2147/VHRM.S81122",Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: http://linc2015.cloudcontrolled.com/media/15t_1_1420_Gray.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: http://linc2015.cloudcon-trolled.com/media/15th_1_0830_Duda.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: http://linc2015.cloudcontrolled.com/media/15w_1_1454__S.%20Steiner.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: http://linc2015.cloudcon-trolled.com/media/15t_1_1620_Tepe.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: http://linc2015.cloudcon-trolled.com/media/15t_1_1410_Krankenberg.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: http://linc2015.cloudcontrolled.com/media/15t_1_1005_Tepe.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 356 Herten et al 59.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
Available from: https://linc2016.app.exo.io/media/1040_Christo-pher_Owens_26_01_2016_Room_1___Main_Arena_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/69/vhrm-12-341.PMC5010165.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/87/ott-9-5383.PMC5010166.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5383–5388OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5383Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10690 6 Pitavastatin suppressed liver cancer cells in vitro  and in vivo he-Yi Y ou Wei-Jian Zhang Xue-Meng Xie Zhi-hai Zheng heng-liang Zhu Fei-Zhao Jiang Department of T elescopic surgery, The  First affiliated hospital of Wenzhou  Medical University, Wenzhou, People’s  republic of chinaAbstract:  Pitavastatin classically functions as a blood cholesterol-lowering drug.",Non-OADS,/arxiv_data1/oa_pdf/f7/87/ott-9-5383.PMC5010166.pdf
"However, whether correspondence: Wei-Jian Zhang Department of Telescopic surgery,  The First Affiliated Hospital of Wenzhou  Medical University, nanbaixiang Town,  Wenzhou 325000, People’s republic  of china email 39209488@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ou et al Running head recto: Pitavastatin suppressed liver cancer DOI: http://dx.doi.org/10.2147/OTT.S106906",Non-OADS,/arxiv_data1/oa_pdf/f7/87/ott-9-5383.PMC5010166.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f7/87/ott-9-5383.PMC5010166.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/87/ott-9-5383.PMC5010166.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/21/ppa-10-1667.PMC5010167.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1667–1678Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1667OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11009 1 Factors influencing the perception of medical  staff and outpatients of dual practice in Shanghai,  People’s republic of china Haiping Chen Meina li* Zhixin Dai* Qiangyu Deng Lulu Zhang Department of Military Health  Management, College of Health  Service, Second Military Medical  University, Shanghai, People’s  republic of china *These authors contributed equally  to this workObjective:  Dual practice is defined as a physician’s performance of medical activities in  different health care institutions (two or more) simultaneously.",Non-OADS,/arxiv_data1/oa_pdf/55/21/ppa-10-1667.PMC5010167.pdf
"Keywords:  dual practice, perception of medical staff, outpatients’ perception, influential fac - tors, labor supply Introduction To reduce the shortage and unreasonable distribution of health resources and address  issues concerning insufficient outcome, low efficiency, and physicians’ lassitude in  public health institutions, health authorities in developed and developing countries have  begun to adopt dual practice policy to improve health efficiency and allow more patients  access to high-quality medical resources.1 Dual practice is defined as a physician’s  performance of medical activities in different health institutions (two  or more) Correspondence: Lulu Zhang Department of Military Health  Management, College of Health Service,  Second Military Medical University,  800 Xiangyin Road, Yangpu District,  Shanghai 200433, People’s  republic of china Tel +86 21 8187 1421 Fax +86 21 8187 1436 email zllrmit@aliyun.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chen et al Running head recto: Perception of medical staff and outpatients of dual practice in Shanghai DOI: http://dx.doi.org/10.2147/PPA.S110091",Non-OADS,/arxiv_data1/oa_pdf/55/21/ppa-10-1667.PMC5010167.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/55/21/ppa-10-1667.PMC5010167.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/09/ott-9-5195.PMC5010168.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5195–5202OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10839 5 Effect of DcR3-specific siRNA on cell growth  suppression and apoptosis induction in glioma  cells via affecting erK and aKT Yu Zhang1,* suning huang2,* Yuhua leng1 Xin chen1 Tiantian liu1 hanlin Wang1 Fanglin Wei1 Dianzhong luo1 gang chen1 Zhuxin Wei2 1Department of Pathology,   2Department of radiotherapy, First  affiliated hospital of guangxi  Medical University, nanning, guangxi  Zhuang autonomous region, People’s  republic of china *These authors contributed equally to  this workBackground:  Previously, we found that the expression of decoy receptor 3 (DcR3) in gliomas  was significantly upregulated compared to normal brain tissues.",Non-OADS,/arxiv_data1/oa_pdf/14/09/ott-9-5195.PMC5010168.pdf
"Keywords:  DcR3, glioma, siRNA, proliferation, viability, apoptosis Introduction Decoy receptor 3 (DcR3), also known as tumor necrosis factor receptor superfamily  member 6B (TNFRSF6B), is located on chromosome 20q13.3.1–4 Some studies  have published evidence on DcR3 overexpression in some malignant tumors such correspondence: Zhuxin Wei Department of radiotherapy, First  Affiliated Hospital of Guangxi Medical  University, 6 shuangyong road, nanning,  guangxi Zhuang autonomous region  530021, People’s republic of china Tel +86 0771 535 6509 Fax +86 0771 535 6509 email weizhuxin2015@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Effect of DcR3-specific siRNA on biological function of glioma cells DOI: http://dx.doi.org/10.2147/OTT.S108395",Non-OADS,/arxiv_data1/oa_pdf/14/09/ott-9-5195.PMC5010168.pdf
"The membrane was stained with DcR3 (ab11930; Abcam, Cambridge, UK), phospho-AKT (pS473; Invitro - gen Corp.), phospho-ERK1/2 (pTpY185/187; Invitrogen  Corp.), or β-actin (AC-15; Sigma-Aldrich) and subjected  to chemiluminescence detection assay (GE Healthcare  Bio-sciences/Amersham).14–18 Microarray datasets analysis Considering some microarray datasets could also help us  analyze the potential function of DcR3 in glioma, we then  collected the microarray datasets of DcR3 in glioma from  the European Bioinformatics Institute (EBI) Array Express  (http://www.ebi.ac.uk/arrayexpress /) database, National  Center of Biotechnology Information (NCBI), and the  Gene Expression Omnibus (GEO; http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/14/09/ott-9-5195.PMC5010168.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/14/09/ott-9-5195.PMC5010168.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/09/ott-9-5195.PMC5010168.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2233–2236Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2233ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11015 6 Investigation on Internet addiction disorder in  adolescents in Anhui, People’s Republic of China Yan Chen1 Yaowen Kang2 Weizhi Gong3 Lianping He1 Yuelong Jin1 Xiaoyue Zhu1 Yingshui Yao1 1School of Public Health, Wannan  Medical College, Wuhu, Anhui,   People’s Republic of China; 2Fushun  Administrative College, Fushun,   Liaoning, People’s Republic of China;   3Guangdong Polytechnic of Industry  and Commerce, Guangzhou, People’s  Republic of ChinaBackground and aim:  The purpose of this study was to describe the characteristics and  prevalence of Internet addiction (IA) in adolescents so as to provide a scientific basis for the  communities, schools, and families.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
"The American psychologists Beard and Wolf,4 also proposed that IAD refers  to the factor of this phenomenon is the network itself, such as network communication  and some low-quality content online.5 Some researchers found that IAD is associated with personality,6–8 self-esteem,9,10  social support,9 suicide ideation, disordered eating attitudes,11 defense styles,12   depressive symptoms,3 physiological.6 Although official diagnostic criteria do not  exist, IA can be defined as the excessive, obsessive–compulsive, uncontrollable, use Correspondence: Yingshui Yao School of Public Health, Wannan Medical  College, No 22 Road Wenchangxi,  Yijiang District, Wuhu, Anhui, 241002,  People’s Republic of China Tel +86 553 393 2651 Email yingshuiyao@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 12 Running head verso: Chen et al Running head recto: Internet addiction of adolescents DOI: http://dx.doi.org/10.2147/NDT.S110156",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
"Statistical analysis Epidata 3.0 software ( http://www.epidata.dk /) was used to  establish a database and entry data; SPSS 20.0 (IBM Cor - poration, Armonk, NY, USA) software was used for data  analysis; chi-square test was used to compare the detection  rate of IAD in adolescents for different variables.",OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
Available from: http://www.news.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/ndt-12-2233.PMC5010169.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 261–265International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 261 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S116771Retropupillary iris claw intraocular lens  implantation in aphakia for dislocated   intraocular lens Mun Yueh Faria1–3 Nuno Pinto Ferreira1–3 Joana Medeiros Pinto1–3 David Cordeiro Sousa1–3 Ines Leal1–3 Eliana Neto1–3 Carlos Marques-Neves1–3 1Centro de Estudos da Visão,   Universidade de Lisboa, 2Department  of Ophthalmology, Hospital de Santa  Maria, 3Faculty of Medicine, University  of Lisbon, Lisbon, PortugalBackground: Nowadays, dislocated intraocular lenses (IOLs) and inadequate capsular support  are becoming a challenge for every ophthalmic surgeon.",Non-OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
"Prof. Egas Moniz, 1649-035 Lisboa, PortugalTel +351 96 602 6791Email munfaria1@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE SERIESY ear: 2016V olume: 9Running head verso: Faria et alRunning head recto: Retropupillary iris claw intraocular lens for aphakiaDOI: http://dx.doi.org/10.2147/IMCRJ.S116771",Non-OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 265 Retropupillary iris claw intraocular lens for aphakia the minimum 6-month period.,Non-OADS,/arxiv_data1/oa_pdf/ab/d7/imcrj-9-261.PMC5010170.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 147–154Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 147 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S110873 Curcumin prevents muscle damage by regulating  NF-kB and Nrf2 pathways and improves  performance: an in vivo model Kazim Sahin1  Ragip Pala2  Mehmet T uzcu3  Oguzhan Ozdemir3  Cemal Orhan1  Nurhan Sahin1  Vijaya Juturu4 1Department of Animal Nutrition,   Faculty of Veterinary Medicine,   2Department of Movement and  Training Science, 3Department of  Biology, Firat University, Elazig, T urkey;   4OmniActive Health T echnologies Inc.,   Morristown, NJ, USAPurpose: Exercise (Ex) increases reactive oxygen species and impairs antioxidant defense  systems.",Non-OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
"Muscle mitochondrial biogenesis, fusion, and metabolism Correspondence: Vijaya Juturu   OmniActive Health Technologies Inc., 67  East Park Place, Morristown, NJ 07960, USA Email v.juturu@omniactives.comJournal name: Journal of Inflammation Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Sahin et alRunning head recto: Curcumin prevents muscle damage and improves performanceDOI: http://dx.doi.org/10.2147/JIR.S110873",Non-OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 154 Sahin et al  40.,Non-OADS,/arxiv_data1/oa_pdf/8e/f4/jir-9-147.PMC5010171.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/50/ndt-12-2213.PMC5010172.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2213–2223Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2213Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10777 7 Characteristics of binge eating disorder in relation  to diagnostic criteria Denise e wilfley1 Leslie Citrome2 Barry K Herman3 1Department of Psychiatry,   washington University School of  Medicine, St Louis, MO, 2Department  of Psychiatry & Behavioral Sciences,   New Y ork Medical College, valhalla,   NY, 3Global Medical Affairs, Shire,   Lexington, MA, USAAbstract:  The objective of this review was to examine the evidentiary basis for binge  eating disorder (BED) with reference to the Diagnostic and Statistical Manual of Mental  Disorders – Fifth Edition  (DSM-5 ) diagnostic criteria for BED.",Non-OADS,/arxiv_data1/oa_pdf/bb/50/ndt-12-2213.PMC5010172.pdf
"To be diagnosed with BED according to DSM-5  criteria, there must be recurrent  binge eating episodes (occurring on average at least once a week for 3 months)  characterized by the consumption of larger amounts of food in a discrete period than  is typical for most people under similar circumstances and a sense of loss of control  over eating during these episodes, and there must also be marked distress associated  with the binge eating behavior.1 Unlike bulimia nervosa (BN) and anorexia nervosa of  the binge eating/purging type (AN-BE/P), there are no recurrent inappropriate com - pensatory behaviors, such as excessive exercise or purging, with BED.1 The DSM-5   also delineates severity criteria for BED, with the minimum level of severity based on  the number of weekly binge eating episodes (mild, 1–3; moderate, 4–7; severe, 8–13; Correspondence: Denise E Wilfley Department of Psychiatry, washington  University School of Medicine, 660 South  euclid, Campus Box 8134, St Louis,  MO 63110, USA Tel +1 314 286 2079 Fax +1 314 286 2091 email wilfleyd@psychiatry.wustl.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Wilfley et al Running head recto: BED diagnostic criteria and characteristics DOI: http://dx.doi.org/10.2147/NDT.S107777",Non-OADS,/arxiv_data1/oa_pdf/bb/50/ndt-12-2213.PMC5010172.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bb/50/ndt-12-2213.PMC5010172.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/50/ndt-12-2213.PMC5010172.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/ea/opth-10-1679.PMC5010173.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1679–1684Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1679Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11078 9 Contralateral eye-to-eye comparison of  intravitreal ranibizumab and a sustained-release  dexamethasone intravitreal implant in recalcitrant  diabetic macular edema Benjamin J Thomas Y oshihiro Y onekawa Jeremy D Wolfe Tarek s hassan Department of Vitreoretinal surgery,   William Beaumont hospital, royal  Oak, M i, UsaObjective:  To compare the effects of intravitreal ranibizumab (RZB) or dexamethasone (DEX)  intravitreal implant in cases of recalcitrant diabetic macular edema (DME).",Non-OADS,/arxiv_data1/oa_pdf/5b/ea/opth-10-1679.PMC5010173.pdf
"Treatment of DME has shifted from the use of focal laser according to the Early  Treatment of Diabetic Retinopathy Study parameters to widespread use of intravitreal  pharmacologic agents.4 The most commonly used medications target elevated levels  of vascular endothelial growth factor (VEGF), including bevacizumab, ranibizumab  (RZB), and aflibercept, all of which have demonstrated efficacy in large studies.4 However, the pathologic microenvironment of DME contains elevated levels of  other biomarkers besides VEGF.5 Numerous cytokines, transcription factors, and inflam - matory stimulants are involved to varying degrees,5 and agents that target this broader  inflammatory process – namely corticosteroids formulated for intraocular use – have Correspondence: Tarek s hassan William Beaumont hospital, 3535  West Thirteen Mile road, suite 344,  royal Oak, Mi 48073, Usa Tel +1 248 288 2280 Fax +1 248 288 5644 email tsahassan@arcpc.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Thomas et al Running head recto: Contralateral comparison of ranibizumab and dexamethasone implant DOI: http://dx.doi.org/10.2147/OPTH.S110789",Non-OADS,/arxiv_data1/oa_pdf/5b/ea/opth-10-1679.PMC5010173.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5b/ea/opth-10-1679.PMC5010173.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/ea/opth-10-1679.PMC5010173.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/93/opth-10-1663.PMC5010175.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1663–1670Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1663Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10761 9 Prevalence and factors associated with trachoma  among children aged 1–9 years in Zala district,  gamo gofa Zone, southern ethiopia Kassahun Mengistu1 Mulugeta shegaze2 Kifle Woldemichael3 hailay gesesew3,4 Y ohannes Markos5 1Department of Zonal health  Office, gamo goffa Zone, arba  Minch, ethiopia; 2Department of  nursing, arba Minch University, arba  Minch, ethiopia; 3Department of  epidemiology, Jimma University, Jimma,   ethiopia; 4Discipline of Public health,   Flinders University, adelaide, australia;   5Department of Medical Physiology,   Jimma University, Jimma, ethiopiaBackground:  Trachoma is the leading cause of preventable blindness worldwide.",Non-OADS,/arxiv_data1/oa_pdf/39/93/opth-10-1663.PMC5010175.pdf
"In certain regions infectious diseases remains the most  important cause of ill health and have been responsible for 22% of all deaths and 27% of Correspondence: Yohannes Markos Department of Medical Physiology, Jimma  University, PO Box 378, Jimma, ethiopia Tel +251 941 189744 email yohannestry1@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mengistu et al Running head recto: Prevalence and factors associated with trachoma DOI: http://dx.doi.org/10.2147/OPTH.S107619",Non-OADS,/arxiv_data1/oa_pdf/39/93/opth-10-1663.PMC5010175.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/39/93/opth-10-1663.PMC5010175.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/93/opth-10-1663.PMC5010175.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/23/b5/10.1177_2325967116663921.PMC5010185.pdf
"Results from significance testing for fixed effects in all models are provided in Supplementary Data Tables S1 and S2 (see Tables, Supplemental Digital Content, http://links.lww.com/ASAIO/A104).",OADS,/arxiv_data1/oa_pdf/3e/5f/mat-62-613.PMC5010276.pdf
Available from: http://www.gambro.com/PageFiles/1729/ Revaclear%20sales%20sheet.pdf?epslanguage=en.,Non-OADS,/arxiv_data1/oa_pdf/3e/5f/mat-62-613.PMC5010276.pdf
Available  from: http://fmcna-dialyzers.com/dialyzers-site/pdf/Optiflux%20 Product%20Brochure%20Section/101046-01%20Optiflux%20High%20Flux.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3e/5f/mat-62-613.PMC5010276.pdf
"We applied principal component ana- lysis (Stacklies et al., 2007) to identify the correlation with possible covariates (see Supplementary digital content, Table 1S, Supplemental digital content 1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
"Anderson microarray power calcu- lator, URL 2: http://bioinformatics.mdanderson.org/Micro arraySampleSize/ ).",OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
http://links.lww.com/PG/A159 ).,Non-OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
"To determine significance thresh- olds, the matSPD spectral decomposition approach by Dale Nyholt was used (URL 3: http://neurogenetics.qimr berghofer.edu.au/matSpD/ ).",OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
"No modules were sig- nificantly associated with clozapine treatment, lithium, valproate or other antipsychotics (Supplementary digital content Tables 2S –5S, Supplemental digital content 3, http://links.lww.com/PG/A160 ; Supplemental digital con- tent 4, http://links.lww.com/PG/A161 ; Supplemental digital content 5, http://links.lww.com/PG/A162 ; Supplemental digital content 6, http://links.lww.com/PG/A163 , which pre- sent the statistics of each module association with drug treatment).",Non-OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
"Using KEGG (URL 4: http://www.genome.jp/kegg/ pathway.html ) pathway terms, this module is enriched for ECM receptor interaction ( P=0.0143).",OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
"We investigated the effect of bipolar diagnosis on the association of the moduleeigengenes to clozapine monotherapy treatment in alinear model (Supplementary digital content, Table 6S,Supplemental digital content 7, http://links.lww.com/PG/ A164 ).",Non-OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
This research was partly funded by the FP7 project CRESTAR ( http://www.cres tar-project.eu ) and was supported by capital equipment funding from the Maudsley Charity (grant ref 980) and the Guy ’s and St Thomas ’s Charity (grant ref STR130505).,Non-OADS,/arxiv_data1/oa_pdf/88/37/ypg-26-211.PMC5010277.pdf
Available at: http://www.who.int/media centre/factsheets/fs204/en/.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/meg-28-1172.PMC5010281.pdf
2008; 57:RR-8.Available at: http://www.cdc.gov/mmwr/pdf/rr/rr5708.pdf.,OADS,/arxiv_data1/oa_pdf/be/0a/meg-28-1172.PMC5010281.pdf
Available at: http://www.accessdata.fda.gov/d rugsatfda_docs/label/2012/103705s5367 s5388lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/meg-28-1172.PMC5010281.pdf
The early generations of most modern cultivars released by Japan’s public sector underwent such rapid generation advancement (http://ineweb.narcc.affrc.go.jp/).,Non-OADS,/arxiv_data1/oa_pdf/5a/aa/66_15038.PMC5010295.pdf
"‘Nipponbare’ is sensitive and ‘Yamadawara’ is insensitive to photoperiod, but they have almost equal heading periods under the general culti - vation conditions in western Japan (http://ineweb.narcc.affrc.go.jp/).",Non-OADS,/arxiv_data1/oa_pdf/5a/aa/66_15038.PMC5010295.pdf
"Discussion Evaluation of the factors that are important in the BBS and the sBBS In our evaluation of the effects of CO 2 application, tiller  removal, and root restriction, under a 10-h-day-length, the DTH of ‘Nipponbare’ under all treatment conditions was much smaller than that of ‘Yamadawara’ under the equiva-lent treatment conditions (Table 2), even though the culti - vars have almost equal heading times under the general field cultivation conditions in western Japan (http://ineweb.narcc.affrc.go.jp/).",Non-OADS,/arxiv_data1/oa_pdf/5a/aa/66_15038.PMC5010295.pdf
The linkage  mapping was performed with composite interval mapping (CIM) Model 6 using QTL Cartographer V 2.5_011 (http://statgen.ncsu.edu/qtlcart/).,OADS,/arxiv_data1/oa_pdf/ea/1d/66_15147.PMC5010299.pdf
"Based on the genetic map, the Williams 82 physical map  and the soybean whole-genome sequence in SoyBase (http://www.soybase.org), we compared the results for the three salt tolerance indices by QTL mapping with that by association mapping, and analyzed the results with previ-ously reported QTLs.",OADS,/arxiv_data1/oa_pdf/ea/1d/66_15147.PMC5010299.pdf
"For example, more than 68 Mt of  oranges and 131 Mt of other citrus fruits were produced  globally in 2012 (FAO Stats, http://faostat3.fao.org).",Non-OADS,/arxiv_data1/oa_pdf/d2/d4/66_15151.PMC5010300.pdf
The iCheck analytical kit developed by BioAnalyt Labo- ratory (http://www.bioanalyt.com) was used for measuring TCC (Ceballos and Parkes 2014).,OADS,/arxiv_data1/oa_pdf/10/9f/66_15159.PMC5010302.pdf
"http://data.fao.org/ref/262b79ca-279c-4517-93de- ee3b7c7cb553, 4th September 2015.",Non-OADS,/arxiv_data1/oa_pdf/10/9f/66_15159.PMC5010302.pdf
"Finally, PCR duplicates were removed by using Picard v1.61 MarkDuplicates (http://sourceforge.net/projects/picard/).",Non-OADS,/arxiv_data1/oa_pdf/a3/95/66_16018.PMC5010306.pdf
c Accessions in National Institute of Agrobiological Sciences Genebank (https://www.gene.affrc.go.jp/index_en.php).,OADS,/arxiv_data1/oa_pdf/a3/95/66_16018.PMC5010306.pdf
"FAOSTAT (Food and Agriculture Organization of the United Nations)  (2013) Production of apples in the world, http://faostat3.fao.org  (accessed on 2015/11/04).",Non-OADS,/arxiv_data1/oa_pdf/a3/95/66_16018.PMC5010306.pdf
Weather data were obtained from the Japan Meteorological Agency (http://www.data.jma.go.jp/obd/stats/etrn/select/prefecture00.php).,OADS,/arxiv_data1/oa_pdf/27/74/66_16026.PMC5010309.pdf
"The Japanese accessions are available via LegumeBase (https://www.legumebase.brc.miyazaki-u.ac.jp/), an integrated resource database of Lotus japonicus and Glycine max.",OADS,/arxiv_data1/oa_pdf/dd/2b/66_16028.PMC5010310.pdf
Raw sequences in FASTQ format obtained from the Illumina platform were analyzed using freely available tools (http://hannonlab.cshl.edu/fastx_toolkit/).,OADS,/arxiv_data1/oa_pdf/d7/c9/66_16037.PMC5010312.pdf
The re-sulting plasmid was sequenced and analyzed using BLAST (http://www.ncbi.nlm.nih.gov/BLAST/).,OADS,/arxiv_data1/oa_pdf/d7/c9/66_16037.PMC5010312.pdf
"About 40 genes conferring resistance against various races of Xoo have been identified in both cultivated rice and wild relatives of rice, and have been derived from artificial mutation induction (http://www.shigen.nig.ac.jp/rice/oryzabase/locale/change?lang=en).",Non-OADS,/arxiv_data1/oa_pdf/56/53/66_16062.PMC5010315.pdf
Oryza sativa (rice)  Nucleotide BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi?,Non-OADS,/arxiv_data1/oa_pdf/56/53/66_16062.PMC5010315.pdf
"2010,  http://www.shigen.nig.ac.jp/rice/oryzabaseV4/blast/search).",OADS,/arxiv_data1/oa_pdf/56/53/66_16062.PMC5010315.pdf
"Among the eight DNA markers on chromosome 3 used for developing IAS lines, DDBJ accession names of the partial sequence of the six markers, C515, C563, R3156, C1677, R19, and X249, were obtained from http://rgp.dna.affrc.go.jp/E/publicdata/geneticmap2000/chr03.html.",OADS,/arxiv_data1/oa_pdf/56/53/66_16062.PMC5010315.pdf
"Currently about 40 genes conferring host resistance to  Xoo have been identified and reported (http://www.shigen.nig.ac.jp/rice/oryzabase/locale/change?lang=en, Hutin et al.",OADS,/arxiv_data1/oa_pdf/56/53/66_16062.PMC5010315.pdf
"Using the  Rice Annotation Project Database (http://rapdb.dna.affrc.go.jp/, Kawahara et al.",OADS,/arxiv_data1/oa_pdf/56/53/66_16062.PMC5010315.pdf
2009. http://www.ispor.org/work- paper/FDA%20PRO%20Guidance.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ec/61/gox-4-0e826.PMC5010317.pdf
"Morley D, Jenkinson C, Fitzpatrick R. A structured review  of patient-reported outcome measures used in cosmetic  surgical procedures: report to Department of Health, 2013.  http://phi.uhce.ox.ac.uk/pdf/Cosmetic%20Surgery%20 PROMs%20Review2013.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ec/61/gox-4-0e826.PMC5010317.pdf
Available  at: http://www.suicidology.org/Portals/14/docs/Resources/ FactSheets/2013datapgsv2alt.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/e6/gox-4-0e828.PMC5010319.pdf
Available at: http://www.suicidology.org/resources/ warning-signs.,Non-OADS,/arxiv_data1/oa_pdf/97/e6/gox-4-0e828.PMC5010319.pdf
"All the board mem- bers are happy to learn that ISPRES now has more than  1,100 members registered through its website (http://www.ispres.org).",Non-OADS,/arxiv_data1/oa_pdf/87/2b/gox-4-0e830.PMC5010321.pdf
"(See figure, Supplemental Digital Content 1,  which depicts schematically the standardized surgical pro-cedure used in the study, http://links.lww.com/PRSGO/ A238.)",Non-OADS,/arxiv_data1/oa_pdf/8e/1f/gox-4-0e832.PMC5010323.pdf
"(See survey,  Supplement Digital Content 2, which depicts the satisfac- tion questionnaire, http://links.lww.com/PRSGO/A238.)",Non-OADS,/arxiv_data1/oa_pdf/8e/1f/gox-4-0e832.PMC5010323.pdf
This video is available in the “re- lated videos” section of the full-text article on PRSGlo- balOpen.com or available at http://links.lww.com/PRSGO/ A245.),Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
This video is available  in the “related videos” section of the full-text article on  PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A246.),Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
com or available at http://links.lww.com/PRSGO/A248.).,Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
This video is available in the “re - lated videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A245.,Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
This video is available in the “re - lated videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A246.,Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
This video is available in the “related videos” section of the full-text article on PRS - GlobalOpen.com or available at http://links.lww.com/PRSGO/A247.,Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
This video is available in the “related videos” section of the full-text article on PRS - GlobalOpen.com or available at http://links.lww.com/PRSGO/A248.,Non-OADS,/arxiv_data1/oa_pdf/5b/2b/gox-4-0e834.PMC5010325.pdf
Available at:   http://www.allergan.com/assets/pdf/botox_pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/b1/gox-4-0e837.PMC5010328.pdf
Available at: http://www.allergan.com/assets/pdf/botox_cosmetic_ pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/b1/gox-4-0e837.PMC5010328.pdf
"The transfection efficiency (approximately 20%) was  evaluated by observing the GFP expression that was tagged  on C-terminal of the BMP2 gene (Supplemental	 Digital	 Content	1, http://links.lww.com/PRSGO/A231).",Non-OADS,/arxiv_data1/oa_pdf/2e/0f/gox-4-0e838.PMC5010329.pdf
"The bone defect space was filled  with or without PEG-PLLA scaffolds (Supplemental	 Digi- tal	Content	 2, http://links.lww.com/PRSGO/A232).",Non-OADS,/arxiv_data1/oa_pdf/2e/0f/gox-4-0e838.PMC5010329.pdf
Available at:  https://www.cdc.gov/oralhealth/infectioncontrol/faq/allografts.,Non-OADS,/arxiv_data1/oa_pdf/2e/0f/gox-4-0e838.PMC5010329.pdf
This video is available in the “Related Videos” section of PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A243.),Non-OADS,/arxiv_data1/oa_pdf/a7/b0/gox-4-0e841.PMC5010332.pdf
this video is available in  the “Related videos” section of PRsGlobalopen.com or available at  http://links.lww.com/PRSGO/A243.,Non-OADS,/arxiv_data1/oa_pdf/a7/b0/gox-4-0e841.PMC5010332.pdf
"(See	 Video	 1,	Supplemental	 Digital	 Content	 1, which displays full mobility of the shoulder,  elbow, forearm, wrist, and fingers 10 years after surgery,  http://links.lww.com/PRSGO/A233.)",Non-OADS,/arxiv_data1/oa_pdf/a0/d6/gox-4-0e844.PMC5010335.pdf
"(See	 Video	 1,	 Supplemental	 Digital	 Content	 1, which displays full mobility  of the shoulder, elbow, forearm, wrist, and fingers 10 years  after surgery, http://links.lww.com/PRSGO/A233.)",Non-OADS,/arxiv_data1/oa_pdf/a0/d6/gox-4-0e844.PMC5010335.pdf
This video is available in the “related videos”  section of the full-text article on PRSGlobalOpen.com or  available at http://links.lww.com/PRSGO/A241.),Non-OADS,/arxiv_data1/oa_pdf/ba/18/gox-4-0e847.PMC5010338.pdf
this video is available in the “related videos” section of the full-text  article on PRsGlobalopen.com or available at http://links.lww.com/PRSGO/A241.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/gox-4-0e847.PMC5010338.pdf
Available at: http://www.plasticsurgery.org/news/plastic- surgery-statistics/2015-plastic-surgery-statistics.html.,Non-OADS,/arxiv_data1/oa_pdf/de/ee/gox-4-0e849.PMC5010340.pdf
Available at: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/ md-im/sbd_smd_2012_ natrelleround_61865_60524-eng.php.,OADS,/arxiv_data1/oa_pdf/de/ee/gox-4-0e849.PMC5010340.pdf
Available at: http://hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/md-im /sbd_smd_2011_mentorround-69312-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/de/ee/gox-4-0e849.PMC5010340.pdf
Available at http://www.surgery.org.,Non-OADS,/arxiv_data1/oa_pdf/8b/c4/gox-4-0e851.PMC5010342.pdf
"(See  Supplemental	 Digital	 Content	 1, which shows an example  of a patient satisfaction form provided for each patient  at 1-year follow-up, http://links.lww.com/PRSGO/A240.)",Non-OADS,/arxiv_data1/oa_pdf/71/83/gox-4-0e854.PMC5010345.pdf
This  video is available in the “Related Videos” section of the Full-Text article on PRSGlobalOpen.com or available at  http://links.lww.com/PRSGO/A242).,Non-OADS,/arxiv_data1/oa_pdf/a7/4a/gox-4-e1005.PMC5010350.pdf
This video is available in the “Re-lated Videos” section of the Full-Text article on PRSGlo- balOpen.com or available at http://links.lww.com/PRSGO/ A249).,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/gox-4-e1019.PMC5010356.pdf
This video is available in the “Re-lated Videos” section of the Full-Text article on PRSGlo-balOpen.com or available at http://links.lww.com/PRSGO/ A250).,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/gox-4-e1019.PMC5010356.pdf
this video is available  in the “Related Videos’ section of the Full- text article on PRSglobalO - pen.com or available at http://links.lww.com/PRSGO/A250.Video Graphic 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/gox-4-e1019.PMC5010356.pdf
this video is available  in the “Related Videos’ section of the Full- text article on PRSglobalO - pen.com or available at http://links.lww.com/PRSGO/A249.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/gox-4-e1019.PMC5010356.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1601318/DC1Supplementary Methodstable S1.,Non-OADS,/arxiv_data1/oa_pdf/2c/0e/1601318.PMC5010368.pdf
Western blots wereperformed using the antibodies described above.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1601167/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/b6/d2/1601167.PMC5010369.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1601114/DC1 Kinetics of the BZ reaction in a polymer gel.Osmotic pressure of the polymer in a gel.Properties of a bending PZ bimorph plate.Procedure used to map phase dynamics to 0 ≤φ≤0.5.,OADS,/arxiv_data1/oa_pdf/d4/cd/1601114.PMC5010370.pdf
"We downloaded the microarray (U133 Plus 2.0 Affymetrix) gene expression data sets GSE9195, GSE10780,GSE10810, GSE12276, GSE19615, GSE20711, and GSE21653 from GEO (http://ncbi.nlm.nih.gov/geo/).",OADS,/arxiv_data1/oa_pdf/97/8e/1600220.PMC5010371.pdf
Staining of F-actin was performed following themanufacturer ’s protocol (http://cytoskeleton.com).,Non-OADS,/arxiv_data1/oa_pdf/97/8e/1600220.PMC5010371.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1600220/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/1600220.PMC5010371.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1601240/DC1Supplementary Text fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/83/1601240.PMC5010372.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/3f/main.PMC5010635.pdf
"She  had  an  uncomplicated postoperative  course,  and  was  performing  normal  daily  activities http://dx.doi.org/10.1016/j.ijscr.2016.07.020 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3d/3f/main.PMC5010635.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/ff/main.PMC5010636.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.019 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/ff/main.PMC5010636.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/f3/main.PMC5010637.pdf
"In  order  to  correct  this,  orthodontic  treatment was  proposed  to  align  the  teeth,  with  subsequent  orthognathic http://dx.doi.org/10.1016/j.ijscr.2016.07.023 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/71/f3/main.PMC5010637.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5010638.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.010 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5010638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 61 e64,Non-OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5010638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/be/main.PMC5010639.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.009 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/be/main.PMC5010639.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 65 e67,Non-OADS,/arxiv_data1/oa_pdf/1b/be/main.PMC5010639.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/c8/main.PMC5010640.pdf
"Most  of  the  tumours  arise in  women  aged  between  35  and  55  years,  approximately  20  years http://dx.doi.org/10.1016/j.ijscr.2016.07.022 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f7/c8/main.PMC5010640.pdf
"2 (2) (2011)  141–144,  http://dx.doi.org/ 10.1007/s13193-011-0077-3  (April–June).",Non-OADS,/arxiv_data1/oa_pdf/f7/c8/main.PMC5010640.pdf
"Methylation specific polymerase chain reaction   According to previous studies (1 1-13), Meth - Primer program (http://www.urogene.org/ -meth - primer/) was applied to design the primers for CpG  islands in the upstream 2000 bp from transcription  initiation site of target genes.",Non-OADS,/arxiv_data1/oa_pdf/c3/1d/IJBMS-19-755.PMC5010848.pdf
The uniqueness of  primers was confirmed in NCBI primer blast  (http://www.ncbi.nlm.nih.gov/tools/primer -bl ast/).,OADS,/arxiv_data1/oa_pdf/c3/1d/IJBMS-19-755.PMC5010848.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/84/ircmj-18-06-37331.PMC5010857.pdf
Based on using gene sets with annotations by Figure 4 Screenshot of SPHINX website (http://emergesphinx.org).ARTICLES CLINICAL PHARMACOLOGY & THERAPEUTICS | VOLUME 100 NUMBER 2 | AUGUST 2016 165,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
"To encour- age the similar use of eMERGE-PGx data in the broader pharma- cogenomics community, variant-level data are viewable onSPHINX with each data release through the online SPHINX portal (http://www.emergesphinx.org).",OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
Residual Variation Intolerance Scores (RVISs) for captured genes relative to the ExAC release 0.3 wereaccessed online (http://chgv.org/GenicIntolerance/).,OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
CPIC Level A indicates that “Genetic information should be used to change prescribing of affected drug” 8and can be found at https://www.pharmgkb.org/page/cpic.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
WEB RESOURCES SPHINX: http://www.emergesphinx.org; SNPeff: http://snpeff.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
sourceforge.net/download.html#databases; ExAC: ftp://ftp.broad- institute.org/pub/ExAC_release/release0.3/; PharmGKB: https:// www.pharmgkb.org/page/cpicStatusLegend; ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/VCF/; ftp://ftp-trace.ncbi.nih.gov/ 1000genomes/ftp/release/20130502/.,OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
The two sources of top prescribed drugs are available here: http://www.medscape.com/ viewarticle/825053#vp_2; http://www.imshealth.com/en/thought- leadership/ims-institute/reports/use-of-medicines-in-the-us-2013.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/CPT-100-160.PMC5010878.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/f5/ircmj-18-06-35387.PMC5010879.pdf
"Allelic, geno- typic, and haplotype analyses were performed with SHEsis software (http://analysis.bio-x.cn; Bio-X institutes of Shang- hai Jiao Tong University; China).",OADS,/arxiv_data1/oa_pdf/9a/f5/ircmj-18-06-35387.PMC5010879.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/53/ircmj-18-06-38903.PMC5010880.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/50/hepatmon-16-06-37011.PMC5010881.pdf
A partition-ligation- combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio- x.cn).,OADS,/arxiv_data1/oa_pdf/ac/50/hepatmon-16-06-37011.PMC5010881.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/df/hepatmon-16-06-35824.PMC5010882.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/b9/hepatmon-16-06-34432.PMC5010883.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/f4/hepatmon-16-06-35566.PMC5010884.pdf
Available from: http://www.health.gov.au/internet/main/ publishing.nsf/Content/ohp-bbvs-hbv-testing-policy .,Non-OADS,/arxiv_data1/oa_pdf/f3/f4/hepatmon-16-06-35566.PMC5010884.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/7c/hepatmon-16-06-35736.PMC5010885.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/3b/hepatmon-16-06-35256.PMC5010886.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/7d/hepatmon-16-06-37927.PMC5010887.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/80/evw138.PMC5010888.pdf
Supplementary Material Supplementary ﬁgures S1–S2 andtables S1–S9 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/9c/80/evw138.PMC5010888.pdf
Part of the computations was performed at theVital-IT ( http://www.vital-it.ch ) Center for high-performance computing of the SIB Swiss In stitute of Bioinformatics.,OADS,/arxiv_data1/oa_pdf/9c/80/evw138.PMC5010888.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/cb/evw149.PMC5010889.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/3c/evw153.PMC5010891.pdf
"Assembled transcriptomes, candidate toxin gene BLAST search results, candidate toxin genes sequence alignments, GO outputs, and differential gene expression tables are deposited online at (https://bitbucket.org/JasonMacrander/anemone_tissue/ ).",OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
"Candidate Toxin Gene Identification Using toxin genes from sea anemones and other venomouslineages in the ToxProt data set ( http://www.uniprot.org/pro- gram/Toxins , last accessed 15 June 2015) as query sequences, we conducted a tBLASTn search ( E-value<10.0 and match- ing length >60%) in order to identify toxin gene candidates from the combined transcriptomes for each focal taxa.",OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
Using a custom Python script all of the sea anemone toxin-candidate transcripts were trimmedto include only the open-reading frame (ORF) identiﬁed by Transdecoder ( http://transdecoder.github.io ).,OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
"As an alternative GO analysis, we used the Trinotate pipeline ( http://trinotate.github.io/ , last accessed May 12, 2015) in combination with custom Python scripts to accountfor different GO levels and an overabundance of GO group-ings based on information within the UniProtKB BLAST results.Using the same BLASTX parameters ( E-value 0.0001) against the UniProt database, we queried each tissue-speciﬁc tran-scriptome.",OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
Reasons for the difﬁculty of assembling the H. crispa column tissue-speciﬁc transcriptome remain unclear: Closer inspection of the Trimmomatic-cleaneddata revealed no outliers or errors when compared with anyother tissue in the FastQC analysis ( http://www.bioinformatics.,Non-OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
"For a full list of candidate toxins, visit the associated bitbucket site ( https://bitbucket.org/JasonMacrander/anemone_tissue/ ).",Non-OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
"For a full list of candidate toxins, visit the associated bitbucket site ( https://bitbucket.org/ JasonMacrander/anemone_tissue/ ).Tissue-Speciﬁc Venom Composition in Sea Anemones GBE Genome Biol.",OADS,/arxiv_data1/oa_pdf/4f/cd/evw155.PMC5010892.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/87/evw156.PMC5010893.pdf
"Materials and Methods Identification of Human-Spec ific Retrocopies Harboring 50 CGI The list of human CGI sequences was downloaded from the table browser of the UCSC Genome Bioinformatics Site (http://genome.ucsc.edu/cgi-bin/hgTables , last accessed July 11, 2016) setting assembly to GRCh37/hg19 and track to CpG Islands.",OADS,/arxiv_data1/oa_pdf/40/87/evw156.PMC5010893.pdf
"Each human CGI sequence as is in the list was used for query and the entire sequence of the speciﬁc orthologous chromosome of nonhuman primate spe- cies downloaded from Ensembl ( http://www.ensembl.org ,l a s t accessed July 11, 2016) was used for database.",OADS,/arxiv_data1/oa_pdf/40/87/evw156.PMC5010893.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/evw157.PMC5010894.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"2009 ), 2) Picard-Tools (v1.106) (http://broadinstitute.github.io/picard/ , last accessed July 20, 2016), and 3) GATK (v2.8-1) ( McKenna et al.",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"2011 ) and TransDecoder (http://transdecoder.github.io/ , last accessed July 20, 2016) were used to generate the transcriptome assembly and infer the likely coding sequences (CDSs).",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"ﬂor- idaecomparison were deposited at GitHub ( https://github.com/ yjx1217/SupplementaryData_for_Asymmetron_CNE_paper_ 2016.git , last accessed July 20, 2016).",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"The genome assembly and gene annotation information of B. belcheri used for this analysis were retrieved from http://mosas.sysu.edu.cn/ genome/download_data.php , last accessed July 20, 2016 (v18h27.r3) ( Huang et al.",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"belcheri comparison were also deposited at GitHub ( https://github.com/yjx1217/ SupplementaryData_for_Asymmetron_CNE_paper_2016.git , last accessed July 20, 2016).",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
The protein domain co mposition of our annotated genes was further veriﬁed by Pfam v27.0 ( http://pfam.xfam.,OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
The genome assemblies (rep eat soft-masked version) and gene annotations (in the gene transfer format [GTF]) of elephantshark were downloaded from http://esharkgenome.imcb.a-star.,OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"The genome assembly for B. belcheri was ob- tained from http://mosas.sysu.edu.cn/genome/download_ data.php (last accessed July 20, 2016).",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"We examined these eight CNEs using Ensembl (http://www.ensembl.org/ , last accessed July 20, 2016) and the UCSC genome browser ( http://genome.ucsc.edu/index.",OADS,/arxiv_data1/oa_pdf/3b/d4/evw158.PMC5010895.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/evw159.PMC5010896.pdf
Supplementary Material Supplementary tables S1–S3 and ﬁgures S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/ae/bd/evw159.PMC5010896.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/evw160.PMC5010897.pdf
"Single-Sensillum Recordings We conducted all experiments on wild strains of D. melano- gaster and D. suzukii collected in Trento Province (Italy), and reared on a semi-artiﬁcial diet ( https://stockcenter.ucsd.edu/ info/food_cornmeal.php , last accessed July 15, 2016) at 23- 25/C14C, 65 ± 5% relative humidity (R.H.), and 16L:8D photope- riod.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/evw160.PMC5010897.pdf
"This work was partly funded by Project LExEM (Laboratory of excellence for epidemiology and modeling, http://www.lexem.eu).Literature Cited Abascal F, Zardoya R, Telford MJ.",OADS,/arxiv_data1/oa_pdf/07/d1/evw160.PMC5010897.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/15/evw163.PMC5010898.pdf
[cited 2016 Jul 14] Available from: http://www.bioinfor- matics.babraham.ac.uk/projects/fastqc/ .,Non-OADS,/arxiv_data1/oa_pdf/d6/15/evw163.PMC5010898.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/51/evw165.PMC5010899.pdf
received a doctoral scholarship from Ecole Normale Suprieure de Lyon (http://www.ens-lyon.eu/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/51/evw165.PMC5010899.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/20/evw167.PMC5010901.pdf
Supplementary Material Supplementary tables S1 and S2 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/20/evw167.PMC5010901.pdf
Acknowledgments We thank Paul Wolf for maintaining an online list of available fern plastomes ( http://www.paulwolﬂab.com/data-protocols/ fern_plastome_list ) that helped to propel this study.,Non-OADS,/arxiv_data1/oa_pdf/46/20/evw167.PMC5010901.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/e6/evw168.PMC5010902.pdf
"GO terms were summarized and visualized in semantic space by REVIGO ( http://revigo.irb.hr/ , last accessed on July 15) ( Supek et al.",OADS,/arxiv_data1/oa_pdf/02/e6/evw168.PMC5010902.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Quality assessment for the resulting data was done using FastQC ( Andrews 2015 ;http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
"Additionally, a genome guided assembly of transcriptome was made with Trinity ( http://trinityrnaseq.github.io/ #genome_guided ), using draft genome consisting of 6,599 scaffolds with N50 of 345 kb and half of the genome assem- bled in 174 largest scaffolds (Konczal et al.",OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
A minimum expression ﬁlter of 5 transcripts per kilobase million (TPM) in at least one sample was used to remove lowly expressed genes from further analysis ( https://github.com/trinityrnaseq/ trinityrnaseq/wiki/Trinity-Transcript-Quantiﬁcation#counting- numbers-of-expressed-transcripts-or-genes ).,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
2009 ) was performed for the gene model reference transcriptome using the Swissprot data- base on NCBI FTP site ( ftp://ftp.ncbi.nlm.nih.gov/blast/db/ )( v e r - sion 21-03-2016) and the results were imported intoBlast2GO (Version 3.0) ( Conesa et al.,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
"2008), and GOstatsPlus (https://github.com/davfre/GOstatsPlus/ blob/master/vignettes/GOstatsPl us.Rmd#use-gostats-to-test-for- over-represented-go-terms ).",Non-OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
2015) and the GO categories for these domains were identiﬁed with EMBL-EBI InterPro ( http://www.ebi.ac.uk/interpro/ ;Mitchell et al.,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: http://pasapipeline.github.io/#A_ComprehensiveTranscriptome .,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: ftp://ftp.ncbi.,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: https://github.com/ davfre/GOstatsPlus/blob/master /vignettes/GOstatsPlus.Rmd#use- gostats-to-test-for-over-represented-go-terms .,Non-OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Counting numbers of expressed transcripts or genes [cited 2016 March 3] Available from: https://github.com/trinityrnaseq/trinityrna- seq/wiki/Trinity-Transcript-Quantiﬁcation#counting-numbers-of- expressed-transcripts-or-genes .,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: http://bioconductor.org/packages/release/bioc/html/GSEABase.html .,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi .,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
Available from: http://trinityrnaseq.github.io/#genome_guided .,OADS,/arxiv_data1/oa_pdf/6a/df/evw169.PMC5010903.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/2c/evw170.PMC5010904.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org (2008).",Non-OADS,/arxiv_data1/oa_pdf/09/2c/evw170.PMC5010904.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/b5/evw172.PMC5010906.pdf
"Implementation and Availability The SEX-DETector code was written in perl and a Galaxy work- ﬂow was also developed (see user guide and source codes at http://lbbe.univ-lyon1.fr/-SEX-DETector-.html , last accessed 30 July 2016).",OADS,/arxiv_data1/oa_pdf/43/b5/evw172.PMC5010906.pdf
Supplementary Material Supplementary tables S1–S6 and ﬁgures S1–S2 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/43/b5/evw172.PMC5010906.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/af/evw173.PMC5010907.pdf
"Adiantum raddianum and Pteris biaurita were obtained from a commercial source (Exotic Plants, Mannheim: http://www.exotic-plants.de ).",Non-OADS,/arxiv_data1/oa_pdf/0e/af/evw173.PMC5010907.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/ac/evw175.PMC5010908.pdf
"doi: http://dx.doi.org/10.1016/ j.biochi.2015.10.023 Legendre M, et al.",OADS,/arxiv_data1/oa_pdf/72/ac/evw175.PMC5010908.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/13/evw178.PMC5010909.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtable S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/a2/13/evw178.PMC5010909.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/55/evw179.PMC5010910.pdf
"sapiens gene (identiﬁed by RepeatMasker [http://www.repeatmasker.org/ ; last accessed on March 21, 2016]) (continued)Identifying Factors That Inﬂuence Phylogenetic Inference GBE Genome Biol.",OADS,/arxiv_data1/oa_pdf/ba/55/evw179.PMC5010910.pdf
"The eMRC phylogeny was summarized from individual estimated ML gene trees using the CONSENSE program in PHYLIP package ( http://evolution.genetics.washington.edu/ phylip.html ; last accessed on March 21, 2016).",OADS,/arxiv_data1/oa_pdf/ba/55/evw179.PMC5010910.pdf
Supplementary Material Supplementary tables S1–S11 and ﬁgures S1–S2 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/ba/55/evw179.PMC5010910.pdf
"Available from: http://codonw.sourceforge.net/ , last accessed on February 17, 2015.",OADS,/arxiv_data1/oa_pdf/ba/55/evw179.PMC5010910.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/d8/evw180.PMC5010911.pdf
Supplementary Material Supplementary ﬁgures S1–S7 and tables S1–S8 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/9d/d8/evw180.PMC5010911.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/f3/evw181.PMC5010912.pdf
We ob- tained the genomic sequences from the Drosophila GenomeNexus [ http://www.johnpool.net/genomes.html ;(Lack et al.,OADS,/arxiv_data1/oa_pdf/82/f3/evw181.PMC5010912.pdf
2009 );http://www.cs.waikato.ac.nz/ml/weka/ ].,Non-OADS,/arxiv_data1/oa_pdf/82/f3/evw181.PMC5010912.pdf
2009 ) using the software suite Salford Predictive Modeler (v.7) from Salford Systems ( http://www.salford-systems.,Non-OADS,/arxiv_data1/oa_pdf/82/f3/evw181.PMC5010912.pdf
Supplementary Material Supplementary tables S1–S4 andﬁgures S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/82/f3/evw181.PMC5010912.pdf
"Pigs are one of the most important livestock animals in the world, accounting for up to 36% of global meat consumption (FAO, http://www.fao.org/ag/againfo/themes/en/meat/back gr_sources.html , Sources of Meat, last updated 2014).",Non-OADS,/arxiv_data1/oa_pdf/04/1c/evw182.PMC5010913.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/1c/evw182.PMC5010913.pdf
Supplementary Material Supplementary table S1 and ﬁgures S1 and S2 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/04/1c/evw182.PMC5010913.pdf
Available from: http://www.fao.org/ag/ againfo/themes/en/meat/backgr_sources.html .,Non-OADS,/arxiv_data1/oa_pdf/04/1c/evw182.PMC5010913.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/25/evw187.PMC5010914.pdf
This tool was called masking_package and is available with a brief tutorial from the GitHub repository https://github.com/ mozoo/masking_package.git .,OADS,/arxiv_data1/oa_pdf/a1/25/evw187.PMC5010914.pdf
"The best-known likelihood tree computed by RAxML was used to obtain a time-scaled chronogram using r8s 1.70 (Sanderson 2003 ) and the r8s bootstrap kit by Torsten Eriksson (downloaded from https://github.com/ TorstenEriksson/r8s-bootstrap in February, 2015).",OADS,/arxiv_data1/oa_pdf/a1/25/evw187.PMC5010914.pdf
"First appear- ance data for six calibration point were downloaded from thePaleobiology Database ( http://fossilworks.org ) in February, 2015: the root of all bivalves, Mytilidae, Ostreidae, Pectinidae, Unionidae, and Veneridae ( M’Coy 1847 ;Tillyard and Dunstan 1916 ;Cromptok and Parrington 1955 ;Drysdall and Kitching 1963 ;Nakazawa and Newell 1968 ;Brasier and Hewitt 1978 ;Baird and Brett 1983 ;Grasso 1986 ;B r e t te ta l .",OADS,/arxiv_data1/oa_pdf/a1/25/evw187.PMC5010914.pdf
"A Python script was written to compute the HERMES scores of a given assemblage of species, providing the GenBank an-notation, gene alignments and a phylogenetic tree; this soft-ware can be downloaded from the GitHub repository at theURL https://github.com/mozoo/HERMES.git , along with sample data and a tutorial.",OADS,/arxiv_data1/oa_pdf/a1/25/evw187.PMC5010914.pdf
http://dx.doi.org/10.1016/j.palaeo.2015.12.,OADS,/arxiv_data1/oa_pdf/a1/25/evw187.PMC5010914.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/a9/evw191.PMC5010915.pdf
Supplementary Material Supplementary tables S1–S5 and ﬁgures S1–S5 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/82/a9/evw191.PMC5010915.pdf
Available from: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/82/a9/evw191.PMC5010915.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
Material and Methods Phylogenetic Ages We downloaded completely sequenced eukaryotic genomes from Ensembl Genomes ( http://www.ensembl.org/ ;V 3 1 )a n d bacterial/archaeal genomes from RefSeq ( http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
"CEL and PPI Data We extracted the integrated CEL and PPI data from theSTRING database ( http://string-db.org/ ), which quantitatively integrates protein interaction data for a large number of or- ganisms and includes data from other well-known interaction databases.",OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
"Expression Levels E. coli RNA-seq data (of SRR794833, SRR794834, SRR794835, SRR794836, SRR794837 and SRR794838) were extractedfrom the Sequence Read Archive database ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
cerevisiae from the Integrated Fitness Information for Microbial Genes (IFIM;http://cefg.uestc.edu.cn/iﬁm ) database ( Wei and Ye et al.,OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
Mutation Data There are 33 sequenced MA datasets in the current version (v1.7) of the SMAL ( http://cefg.uestc.edu.cn/smal ) database (Wei and Ning et al.,OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
Supplementary Material Supplementary tables S1 and S2 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour- nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/54/evw198.PMC5010916.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   479Asthma is one of the most common chronic respiratory dis - eases worldwide.",Non-OADS,/arxiv_data1/oa_pdf/4c/34/aair-8-479.PMC5011046.pdf
"ORCID Hae-Sim Park http://orcid.org/0000-0003-2614-0303Factors Predicting Recovery From Asthma Exacerbations Chang Gyu Jung, Hae-Sim Park* Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/34/aair-8-479.PMC5011046.pdf
2016 November;8(6):479-480. http://dx.doi.org/10.4168/aair.2016.8.6.479 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/4c/34/aair-8-479.PMC5011046.pdf
"2016 November;8(6):479-480. http://dx.doi.org/10.4168/aair.2016.8.6.479Volume 8, Number 6, November 2016 480  http://e-aair.orgREFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/4c/34/aair-8-479.PMC5011046.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   481INTRODUCTION Lipid mediators participate in intercellular interactions as a  paracrine signaling system which has evolved over a period of  600 million years in primitive metazoans: sponges and corals.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"Marek Sanak* Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481Volume 8, Number 6, November 2016 482  http://e-aair.orgeicosanoids.",OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481AAIR http://e-aair.org   48315, or 12-lipoxygenases are activated, and some studies have  associated their genetic variants with particular phenotypes of  inflammation.2 Another site-specific oxidation, at terminal  ω-carbon number 20 is catalyzed by monooxygenases belong - ing to the cytochrome P450 family (CYP4A11, CYP4A22, CY - P4F2, and CYP4F3) and contributes to the metabolic degrada - tion pathway of eicosanoids.3 This takes place in the microsom - al fraction of the liver or in the kidney and is accompanied by  β-oxidation, shortening the carbon backbone of oxylipins.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481Volume 8, Number 6, November 2016 484  http://e-aair.orgBIOLOGICAL ACTIVITY OF EICOSANOIDS The biological activity of eicosanoids requires expression of  their specific receptors.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481AAIR http://e-aair.org   485the patient, but is well tolerated.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481Volume 8, Number 6, November 2016 486  http://e-aair.orgflammation in the airways.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481AAIR http://e-aair.org   487sal mucosa from AERD patients demonstrated another intrigu - ing feature of the disease.,Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481Volume 8, Number 6, November 2016 488  http://e-aair.orgoccurs during induction of COX-2 enzyme, probably because  the intracellular supply of arachidonic acid exceeds catalytic  activity of cyclooxygenases.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481AAIR http://e-aair.org   489sanoid mediators in EBC or IS will enable screening of asthmat - ics to better characterize their inflammatory phenotypes or  even to monitor the course of the disease.25,48 A recent meta- analysis on a diagnostic value of volatile organic compounds in  the exhaled breath showed some encouraging results, although  methods for eicosanoid detection and quantification in the ex - haled breath still require collection of EBC, IS, or urine and la - borious measurement techniques.49 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"2016 November;8(6):481-490. http://dx.doi.org/10.4168/aair.2016.8.6.481Volume 8, Number 6, November 2016 490  http://e-aair.orgCa2+ wave propagation involving positive feedback between  CRAC channels and cysteinyl leukotrienes.",OADS,/arxiv_data1/oa_pdf/90/ed/aair-8-481.PMC5011047.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   491INTRODUCTION Periostin is an extracellular matrix (ECM) protein belonging  to the fasciclin family, based on its homology to fasciclin 1  (FAS1).1-3 Periostin also acts as a matricellular protein that func - tions in cell activation by binding to its receptors, several integ - rins— αVβ1, αVβ3, αVβ5, α6β4, and αMβ2—on the cell surface.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"As it turns out,  IL-13 plays a central role; it was shown that IL-13 alone was suf - ficient to cause asthma-like phenotypes in mice, whereas the  blockage of IL-13 signals alone was sufficient to inhibit asthma- like phenotypes in ovalbumin-induced asthma model mice.7,8  Particularly in the pathogenesis of asthma, actions of IL-13 on  airway epithelial cells have been shown to be important for in - ducing goblet cells and for enhancing airway hyper-responsive - ness.9,10Using Periostin as a Biomarker in the Treatment of Asthma Kenji Izuhara,1* Shoichiro Ohta,1 Junya Ono1,2  1Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan 2Shino-test Co. Ltd., Sagamihara, Japan This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 Volume 8, Number 6, November 2016 492  http://e-aair.orgTo elucidate the effects of IL-13 on human airway epithelial  cells, we comprehensively identified IL-13-inducible genes us - ing the DNA microarray method.11 Consequently, we found  that periostin is one of the highly expressed genes.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 AAIR http://e-aair.org   493expect that type 2 antagonists would show efficacy.,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 Volume 8, Number 6, November 2016 494  http://e-aair.orgare effective for most patients, 5%-10% are resistant or hypore - sponsive to them.35,36 Measurement of serum periostin is rec - ommended for these patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 AAIR http://e-aair.org   495tory dysfunction, and allergic rhinitis, are common comorbidi - ties of asthma.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 Volume 8, Number 6, November 2016 496  http://e-aair.org serum periostin levels between patients with childhood asth - ma and control subjects.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 AAIR http://e-aair.org   497nick DM, et al.",OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"2016 November;8(6):491-498. http://dx.doi.org/10.4168/aair.2016.8.6.491 Volume 8, Number 6, November 2016 498  http://e-aair.orget al.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/aair-8-491.PMC5011048.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   499INTRODUCTION Asthma is characterized by episodic bronchial obstruction  that is typically reversible.1 Some patients experience severe  asthma exacerbations during their clinical course, which is a  significant burden.1-4 A variety of factors, such as viral upper re - spiratory infection, pollens, air pollution, and poor adherence  to medication, can induce asthma exacerbations.1,2,5,6 The intro - duction of safe and effective inhaled corticosteroids (ICSs) has  enabled marked improvement in the control of asthma for  most patients.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
"Some of the studies demonstrated significant variability in pa - tient response to ICS; 25%-35% of patients with asthma showed Factors Affecting Recovery Time of Pulmonary Function in  Hospitalized Patients With Acute Asthma Exacerbations Hyo-Jung Kim, Jaemoon Lee, Jung-Hyun Kim, So-Young Park, Hyouk-Soo Kwon, Tae-Bum Kim, Hee-Bom Moon,   You Sook Cho* Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
2016 November;8(6):499-504. http://dx.doi.org/10.4168/aair.2016.8.6.499 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
"2016 November;8(6):499-504. http://dx.doi.org/10.4168/aair.2016.8.6.499 Volume 8, Number 6, November 2016 500  http://e-aair.orglittle improvement in FEV1% and/or bronchial hyper-respon - siveness (BHR).11,12 Others have investigated factors associated  with prolonged recovery time after an asthma exacerbation and  reported that allergic rhinitis, older patient age, and poor asth - ma control status significantly affected the recovery time of pul - monary function.13,14 Nevertheless, further studies are needed  to clarify precise causes linked to delayed recovery from an ex - acerbation because differences in ethnic background or socio- environmental factors may have an impact on exacerbation  outcome.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
2016 November;8(6):499-504. http://dx.doi.org/10.4168/aair.2016.8.6.499 AAIR http://e-aair.org   501er sociodemographic and baseline clinical characteristics are  presented in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
"2016 November;8(6):499-504. http://dx.doi.org/10.4168/aair.2016.8.6.499 Volume 8, Number 6, November 2016 502  http://e-aair.orgpneumonia, lower O 2 saturation, lower systolic and diastolic BP  at admission, and lower FEV1% predicted at discharge.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
"2016 November;8(6):499-504. http://dx.doi.org/10.4168/aair.2016.8.6.499 AAIR http://e-aair.org   503exacerbations and their potential relationship with lung func - tion,8,15 factors critically linked to poor recovery from asthma  have not been clearly defined.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
"2016 November;8(6):499-504. http://dx.doi.org/10.4168/aair.2016.8.6.499 Volume 8, Number 6, November 2016 504  http://e-aair.orglar ICS use probably due to corticosteroid resistance in sub - types of asthma.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
Avail - able from: http://www.ginasthma.org/.,Non-OADS,/arxiv_data1/oa_pdf/5f/ee/aair-8-499.PMC5011049.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   505INTRODUCTION Peanut allergy patients have diverse clinical manifestations,  depending on age, ethnicity, and sensitization profiles.",Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
"The Ara h 2 com - ponent allergen is a storage protein in peanuts and well known  to be suitable for diagnosing PA.9 However, OAS patients can Clinical Significance of Component Allergens in Fagales Pollen- Sensitized Peanut Allergy in Korea Kyung Hee Park,1,2 Young Woong Son,1 Sang Chul Lee,1 Kyunguk Jeong,3 Da Woon Sim,1,2 Hye Jung Park,1,2 Sooyoung Lee,3   Jae-Hyun Lee,1,2 Jung-Won Park1,2* 1Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea 2Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea 3Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
"2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 Volume 8, Number 6, November 2016 506  http://e-aair.orgexperience oral symptoms after peanut consumption; these  cases are usually associated with Ara h 8, which belongs to the  pathogenesis-related protein (PR)-10 family.",Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 AAIR http://e-aair.org   507speculated that group 4 patients were not sensitized to birch.,Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
"2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 Volume 8, Number 6, November 2016 508  http://e-aair.orggens (Ara h 1, Ara h 2, or Ara h 3) was 100% in group 4.",Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 AAIR http://e-aair.org   509calized symptom group and 0.21 kU/L in the PA group.,OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
"2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 Volume 8, Number 6, November 2016 510  http://e-aair.orgSensitization profiles of peanut component allergens can be  used for precise risk assessments and prediction of symptom  severity.",Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
2016 November;8(6):505-511. http://dx.doi.org/10.4168/aair.2016.8.6.505 AAIR http://e-aair.org   511it compare?,Non-OADS,/arxiv_data1/oa_pdf/6a/99/aair-8-505.PMC5011050.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 512  http://e-aair.orgINTRODUCTION There are strong seasonal trends in asthma-related hospital  admissions and cold dry air can trigger asthma symptoms.1-3  Weather conditions also influence the levels of air pollutants,  some of which have been suggested as asthma triggers.4-6 How - ever, studies exploring relationships among weather condi - tions, air pollution, and asthma have reported inconclusive and  inconsistent results.5,7 This might suggest that the effects of the  outdoor environment on asthma are complex and not depen - dent simply on the amount of exposure but related to complex  interactions among environmental factors and personal com - ponents.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"The population of  Bermuda considered a north wind to be bad for asthma, from Emergency Department Visits for Asthma Exacerbation due to  Weather Conditions and Air Pollution in Chuncheon, Korea: A  Case-Crossover Analysis Jae-Woo Kwon,1,2 Young-Ji Han,3 Moo Kyung Oh,4 Chang Youl Lee,5 Ja Yeun Kim,6 E Jin Kim,6 Ho Kim,6 Woo Jin Kim2* 1Department of Allergy and Clinical Immunology, Kangwon National University School of Medicine, Chuncheon, Korea 2Department of Internal Medicine and Environmental Health Center, Kangwon National University Hospital, Chuncheon, Korea 3Department of Environmental Science, Kangwon National University, Chuncheon, Korea 4Department of Preventive Medicine, Kangwon National University Hospital, Chuncheon, Korea 5Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea 6Department of Biostatistics, Graduate School of Public Health, Seoul National University, Seoul, Korea  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512AAIR http://e-aair.org   513experience.,OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512Volume 8, Number 6, November 2016 514  http://e-aair.orgfoggy days over a 6-year period.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512AAIR http://e-aair.org   515 Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512Volume 8, Number 6, November 2016 516  http://e-aair.orgafter adjusting for the lowest temperature (risk increase: -29.2%  (95% CI =-46.2% to -6.9%), P=0.014).",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512AAIR http://e-aair.org   517Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512Volume 8, Number 6, November 2016 518  http://e-aair.orgTable 4.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512AAIR http://e-aair.org   519acute asthma exacerbations with 1- or 2-day lag times.,Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512Volume 8, Number 6, November 2016 520  http://e-aair.orgthe different effects of wind speed and fog on the 2 populations  is not clear.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"2016 November;8(6):512-521. http://dx.doi.org/10.4168/aair.2016.8.6.512AAIR http://e-aair.org   521asthma ED visits, and that fog was associated with a decreased  risk of asthma ED visits.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/aair-8-512.PMC5011051.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 522  http://e-aair.orgINTRODUCTION Chronic urticaria (CU) is defined as the persistence of an urti - carial episode for at least 6 weeks.1 The prevalence of CU in  children is one-tenth of that in adults (0.1% vs 1%).2,3 Autoim - mune disorders, physical stimuli, infections, vasculitis, and al - lergies are the primary causes of CU.",Non-OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
"This  study aims to clarify this topic.Plasma Levels of Matrix Metalloproteinase-9 in Children With  Chronic Spontaneous Urticaria  Fatih Dilek,1* Deniz Ozceker,2 Emin Ozkaya,1 Zeynep Tamay,2 Mebrure Yazici,1 Siddika Kesgin,3 Abdurrahim Kocyigit,3   Nermin Guler4 1Department of Pediatric Allergy and Immunology, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey  2Department of Pediatric Allergy, Istanbul University Istanbul Medical  Faculty, Istanbul, Turkey 3Department of Clinical Biochemistry, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey 4Department of Pediatrics, Istanbul Bilim University, Istanbul, Turkey This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
2016 November;8(6):522-526. http://dx.doi.org/10.4168/aair.2016.8.6.522 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
2016 November;8(6):522-526. http://dx.doi.org/10.4168/aair.2016.8.6.522AAIR http://e-aair.org   523MATERIALS AND METHODS  Study population Seventy-two consecutive patients who were referred between  January and June of 2015 to the pediatric allergy outpatient  clinics of 2 university hospitals (Istanbul University/Istanbul  Medical Faculty and Bezmialem Vakif University) with the di - agnosis of CSU were assessed for study eligibility.,Non-OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
"2016 November;8(6):522-526. http://dx.doi.org/10.4168/aair.2016.8.6.522Volume 8, Number 6, November 2016 524  http://e-aair.orgmean±standard deviation (SD), and non-parametric data are  expressed as the median, interquartile range (IQR).",OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
"2016 November;8(6):522-526. http://dx.doi.org/10.4168/aair.2016.8.6.522AAIR http://e-aair.org   525adults.17 Even comprehensive guidelines written on this topic  include little information about children.1,6,15 Undoubtedly, it is  not the proper approach to interpret children as “small adults.",Non-OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
"2016 November;8(6):522-526. http://dx.doi.org/10.4168/aair.2016.8.6.522Volume 8, Number 6, November 2016 526  http://e-aair.org2014;306:H1398-407.",Non-OADS,/arxiv_data1/oa_pdf/f5/db/aair-8-522.PMC5011052.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   527INTRODUCTION Chronic respiratory disease accounts for 4 million deaths an - nually, 4% of the global burden of disease, and 8.3% of chronic  disease burden.1 Chronic obstructive pulmonary disorder  (COPD) is one of the main causes of mortality in Korea.2 The Burden of Respiratory Disease in Korea: An Observational Study  on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis Kwang-Ha Yoo,1 Hae-Ryun Ahn,2 Jae-Kyoung Park,3 Jong-Woong Kim,4 Gui-Hyun Nam,5 Soon-Kwan Hong,6 Mee-Ja Kim,7  Aloke Gopal Ghoshal,8 Abdul Razak Bin Abdul Muttalif,9 Horng-Chyuan Lin,10 Sanguansak Thanaviratananich,11   Shalini Bagga,12 Rab Faruqi,13 Shiva Sajjan,13 Santwona Baidya,14 De Yun Wang,15 Sang-Heon Cho16* 1Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea  2Dami IM Clinic, Seoul, Korea 3Seoulbom IM Clinic, Seoul, Korea 4Jong-Woong Kim IM Clinic, Seoul, Korea 5Hamchun Medical Clinic, Incheon, Korea 6Coco ENT Clinic, Seoul, Korea 7Myung ENT Clinic, Seoul, Korea 8National Allergy Asthma Bronchitis Institute, Kolkata, India 9Institute of Respiratory Medicine, Kuala Lumpur, Malaysia 10Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan 11Department of Otorhinolaryngology, Khon Kaen University, Khon Kaen, Thailand 12Merck & Co., Inc., Kenilworth, NJ, USA 13Merck & Co., Inc. (retired), Kenilworth, NJ, USA 14Optum, Sydney, Australia 15Department of Otolaryngology, National University of Singapore, Singapore, Singapore 16Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
"2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527Volume 8, Number 6, November 2016 528  http://e-aair.orgprevalence of asthma, allergic rhinitis (AR), and rhinosinusitis is  also increasing and has become the major health priority in Ko - rea.3-6 These preventable chronic respiratory diseases have a  major adverse impact on quality of life, disability, and produc - tivity, resulting in an increased socioeconomic burden.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527AAIR http://e-aair.org   529Costs A broad societal perspective was adopted for cost analysis.,Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
"2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527Volume 8, Number 6, November 2016 530  http://e-aair.org Fig.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527AAIR http://e-aair.org   531Fig.,Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
"2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527Volume 8, Number 6, November 2016 532  http://e-aair.orgFig.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527AAIR http://e-aair.org   533quently diagnosed combinations.,Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
"2016 November;8(6):527-534. http://dx.doi.org/10.4168/aair.2016.8.6.527Volume 8, Number 6, November 2016 534  http://e-aair.orgwith review of this manuscript while Jiyun Lee provided project  management services during the study duration.",Non-OADS,/arxiv_data1/oa_pdf/6a/28/aair-8-527.PMC5011053.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   535INTRODUCTION Anaphylaxis is a severe, systemic allergic reaction typically  caused by food, drugs, or insect venom.",Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"The lifetime prevalence A Multicenter Retrospective Case Study of Anaphylaxis Triggers  by Age in Korean Children So-Yeon Lee,1 Kangmo Ahn,2 Jihyun Kim,2 Gwang Cheon Jang,3 Taek Ki Min,4 Hyeon-Jong Yang,4 Bok Yang Pyun,4   Ji-Won Kwon,5 Myung Hyun Sohn,6 Kyung Won Kim,6 Kyu-Earn Kim,6 Jinho Yu,7 Soo-Jong Hong,7 Jung Hyun Kwon,8  Sung-Won Kim,9 Tae Won Song,10 Woo Kyung Kim,10 Hyung Young Kim,11 You Hoon Jeon,1 Yong Ju Lee,1 Hae Ran Lee,1  Hye-Young Kim,11 Youngmin Ahn,12 Hye Yung Yum,13 Dong In Suh,5 Hyun Hee Kim,14 Jin-Tack Kim,14 Jeong Hee Kim,15  Yong Mean Park,16 Sooyoung Lee17 on behalf of the Korean Academy of Pediatric Allergy and Respiratory Diseases Food  Allergy and Atopic Dermatitis Study Group 1Department of Pediatrics, Hallym University College of Medicine, Seoul, Korea 2Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 3Department of Pediatrics, National Health Insurance Corporation Ilsan Hospital, Seoul, Korea 4Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea 5Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea 6Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea 7Department of Pediatrics, University of Ulsan College of Medicine, Seoul, Korea 8Department of Pediatrics, Korea University, College of Medicine, Seoul, Korea 9Department of Pediatrics, Pusan Saint Maria Hospital, Busan, Korea 10Department of Pediatrics, Inje University College of Medicine, Seoul, Korea 11Department of Pediatrics, Pusan National University School of Medicine, Yangsan, Korea 12Department of Pediatrics, Eulji University School of Medicine, Seoul, Korea 13Department of Pediatrics, Seoul Medical Center, Seoul, Korea 14Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, Korea 15Department of Pediatrics, Inha University College of Medicine, Incheon, Korea 16Department of Pediatrics, Konkuk University School of Medicine, Seoul, Korea 17Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
2016 November;8(6):535-540. http://dx.doi.org/10.4168/aair.2016.8.6.535 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"2016 November;8(6):535-540. http://dx.doi.org/10.4168/aair.2016.8.6.535Volume 8, Number 6, November 2016 536  http://e-aair.orgof anaphylaxis from all triggers is estimated to be 0.05%-2%.1 Al- though anaphylaxis is predominately a childhood condition,  most studies reporting on the clinical features and causes have  focused on adult or combined adult and pediatric popula - tions.2-4 Therefore, the prevalence and triggers of anaphylaxis in  childhood cannot be assessed accurately because there are  minimal pediatric data.",Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"2016 November;8(6):535-540. http://dx.doi.org/10.4168/aair.2016.8.6.535AAIR http://e-aair.org   537preschoolers, 191 (19.3%) were school age, and 167 (16.9%)  were adolescents.",OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"2016 November;8(6):535-540. http://dx.doi.org/10.4168/aair.2016.8.6.535Volume 8, Number 6, November 2016 538  http://e-aair.orgtoes), and others (perilla, sesame, pumpkins, cacao, red gin - seng, garlic, and goat milk).",Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"2016 November;8(6):535-540. http://dx.doi.org/10.4168/aair.2016.8.6.535AAIR http://e-aair.org   539duced anaphylaxis, respectively.",Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"2016 November;8(6):535-540. http://dx.doi.org/10.4168/aair.2016.8.6.535Volume 8, Number 6, November 2016 540  http://e-aair.orgNSAIDs, vaccines and drugs, and RCM.",Non-OADS,/arxiv_data1/oa_pdf/01/23/aair-8-535.PMC5011054.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org   541INTRODUCTION  Anaphylaxis is a severe and life-threatening hypersensitivity  reaction, and its occurrence rate appears to be increasing.1,2 An- tibiotics, especially β-lactams, nonsteroidal anti-inflammatory  drugs (NSAIDs), and chemotherapeutic agents are often impli - cated in drug reactions;2,3 however, any medication or biologi - cal agent can potentially trigger anaphylaxis.",Non-OADS,/arxiv_data1/oa_pdf/ee/93/aair-8-541.PMC5011055.pdf
"In this study, anaphylaxis was defined The Basophil Activation Test Is Safe and Useful for Confirming  Drug-Induced Anaphylaxis Suk Yeon Kim,1 Joo-Hee Kim,1* Young-Sook Jang,1 Jeong-Hee Choi,2 Sunghoon Park,1 Yong Il Hwang,1 Seung Hun Jang,1  Ki-Suck Jung1 1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of  Medicine, Anyang, Korea 2 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University  College of Medicine, Hwaseong, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/93/aair-8-541.PMC5011055.pdf
2016 November;8(6):541-544. http://dx.doi.org/10.4168/aair.2016.8.6.541 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/ee/93/aair-8-541.PMC5011055.pdf
"2016 November;8(6):541-544. http://dx.doi.org/10.4168/aair.2016.8.6.541Volume 8, Number 6, November 2016 542  http://e-aair.orgbased on the criteria proposed at the second anaphylaxis sym - posium.1,7 SPTs and IDTs were performed using a culprit drug  in all patients, and all procedures followed the criteria of the Eu - ropean Network for Drug Allergy.8 In certain cases, oral chal - lenge tests were performed with associated drugs, but not with  the suspected drug to ensure that they were tolerated, thus re - stricting causality to the suspected drug.",Non-OADS,/arxiv_data1/oa_pdf/ee/93/aair-8-541.PMC5011055.pdf
2016 November;8(6):541-544. http://dx.doi.org/10.4168/aair.2016.8.6.541AAIR http://e-aair.org   543Comparison of skin tests and BATs The results of BATs and skin tests were not correlated in this  study ( P=0.530).,OADS,/arxiv_data1/oa_pdf/ee/93/aair-8-541.PMC5011055.pdf
"2016 November;8(6):541-544. http://dx.doi.org/10.4168/aair.2016.8.6.541Volume 8, Number 6, November 2016 544  http://e-aair.orgmay have been involved.",Non-OADS,/arxiv_data1/oa_pdf/ee/93/aair-8-541.PMC5011055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/34/main.PMC5011080.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.017 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/fc/34/main.PMC5011080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/86/main.PMC5011087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/86/main.PMC5011087.pdf
http://dx.doi.org/10.1016/j.shaw.2016.01.006Safety and Health at Work 7 (2016) 208 e212,Non-OADS,/arxiv_data1/oa_pdf/9e/86/main.PMC5011087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
http://dx.doi.org/10.1016/j.shaw.2016.01.004Safety and Health at Work 7 (2016) 231 e236,Non-OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
Available from: http://www.bls.gov/news.release/ archives/osh_10252012.pdf .,OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
Available from: http://scholarcommons.usf.,Non-OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
HSE; 2013 [cited 2016 Jan 14].Available from: http://www.hse.gov.uk/risk/casestudies/pdf/mvr.pdf .,OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
Available from: http://www.aulbremen.de/triatria/en/en_modules/en_m06/en_module_06- 00.pdf .,OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
Available from: http://www.anfac.es/estadisticas.,Non-OADS,/arxiv_data1/oa_pdf/df/d0/main.PMC5011088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/f1/main.PMC5011090.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.001,OADS,/arxiv_data1/oa_pdf/af/f1/main.PMC5011090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/54/main.PMC5011091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/54/main.PMC5011091.pdf
http://dx.doi.org/10.1016/j.shaw.2016.02.003Safety and Health at Work 7 (2016) 175 e184,Non-OADS,/arxiv_data1/oa_pdf/d7/54/main.PMC5011091.pdf
"There are numerous tools that allow convenient, ef ﬁcient cal- culations, including Hugin ( http://www.hugin.com ), Genie ( http:// genie.sis.pitt.edu/ ), Netica ( http://www.norsys.com ), and Matlab.",OADS,/arxiv_data1/oa_pdf/d7/54/main.PMC5011091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
http://dx.doi.org/10.1016/j.shaw.2016.01.003Safety and Health at Work 7 (2016) 244 e250,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
Available from: https://www.dss.gov.au/sites/default/ ﬁles/documents/05_ 2012/vawc_economic_report.pdf .J.C.D.,OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
Available from: http://www.ncdsv.org/images/Corporate% 20Leaders%20and%20America%27s%20Workforce%20on%20DV%20Summary_ 9-25-07.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
Available from: http://learningtoendabuse.ca/makeitourbusiness/ makeitourbusiness/sites/learningtoendabuse.ca.makeitourbusiness/ ﬁles/ MIOB_Warning_Signs_for_Workplace.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
Available from: http://www2.gov.bc.ca/assets/gov/law- crime-and-justice/criminal-justice/bc-criminal-justice-system/if-victim/ publications/help-hope-healing-someone-being-abused.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
Available from: http://www.iapa.ca/main/documents/ 2010_april_violence_toolkit.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC5011092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
http://dx.doi.org/10.1016/j.shaw.2016.01.002Safety and Health at Work 7 (2016) 225 e230,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
Available from: http://www.ilo.org/safework/ areasofwork/hazardous-work/WCMS_124598/lang –en/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
Available from: http://www.ghanachamberofmines.org .,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
Available from: http://www.ilo.org/wcmsp5/groups/public/ —ed_protect/ —protrav/ — safework/documents/publication/wcms_301214.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
Available from: http://www.bAsafe.net/articles/bsms1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
Available from: http://ibacnet.org/bai2007/proceedings/Papers/2007bai7280.doc .,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
Available from: http://www.nsc.org/osha .,Non-OADS,/arxiv_data1/oa_pdf/7b/e1/main.PMC5011093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/84/main.PMC5011095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/84/main.PMC5011095.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.006Safety and Health at Work 7 (2016) 251 e255,Non-OADS,/arxiv_data1/oa_pdf/49/84/main.PMC5011095.pdf
Available from: https://www.osha.gov/pls/oshaweb/owadisp.show_ document?p_table=FEDERAL_REGISTER&p_id=17847 .,OADS,/arxiv_data1/oa_pdf/49/84/main.PMC5011095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/66/main.PMC5011096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/66/main.PMC5011096.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.005Safety and Health at Work 7 (2016) 194 e200,Non-OADS,/arxiv_data1/oa_pdf/d5/66/main.PMC5011096.pdf
Avail- able from: http://www.previnfo.net/sections.php?op ¼viewarticle&artid ¼19.,Non-OADS,/arxiv_data1/oa_pdf/d5/66/main.PMC5011096.pdf
Available from: http://michel.jean.free.fr/publi/JM298.html .,Non-OADS,/arxiv_data1/oa_pdf/d5/66/main.PMC5011096.pdf
Available from: http://www.icsi-eu.org/francais/dev_cs/cahiers/ .,Non-OADS,/arxiv_data1/oa_pdf/d5/66/main.PMC5011096.pdf
DOI of original article: http://dx.doi.org/10.1016/j.shaw.2016.02.005 .,OADS,/arxiv_data1/oa_pdf/30/56/main.PMC5011097.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/56/main.PMC5011097.pdf
http://dx.doi.org/10.1016/j.shaw.2016.06.004Safety and Health at Work 7 (2016) 257,Non-OADS,/arxiv_data1/oa_pdf/30/56/main.PMC5011097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/ae/main.PMC5011098.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/ae/main.PMC5011098.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.007Safety and Health at Work 7 (2016) 213 e217,Non-OADS,/arxiv_data1/oa_pdf/e0/ae/main.PMC5011098.pdf
Available from: http://www.kosha.or.kr/www/boardView.do?,Non-OADS,/arxiv_data1/oa_pdf/e0/ae/main.PMC5011098.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
http://dx.doi.org/10.1016/j.shaw.2016.04.003Safety and Health at Work 7 (2016) 201 e207,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
The website address of the tailored analysis system that we developed is as follows: http://www.kosha.or.kr/jsp/kwcs/index.,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
Available from: http://kosis.kr/ statisticsList/statisticsList_01List.jsp?vwcd ¼MT_OTITLE&parmTabId ¼M_01_02 .,OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
Available from: http://en.wikipedia.org/wiki/Duplex_(telecommuni cations) .,OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
Available from: http://en.wikipedia.org/wiki/Two-way_communication .,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
Available from: http://www.kosha.or.kr/ .,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
Available from: http://en.wikipedia.org/wiki/Social_learning_theory .,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
Available from: http://www.eurofound.europa.eu/ewco/surveys/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/46/1d/main.PMC5011101.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.505 www.annlabmed.org  505Ann Lab Med 2016;36:505-512 http://dx.doi.org/10.3343/alm.2016.36.6.505Review Article Diagnostic Hematology Current Pathological and Laboratory Considerations in  the Diagnosis of Disseminated Intravascular  Coagulation  Cheng-Hock Toh, M.D.1,2, Yasir Alhamdi, Ph.D.1, and Simon T. Abrams, Ph.D.1 Institute of Infection and Global Health1, University of Liverpool, Liverpool; Roald Dahl Haemostasis & Thrombosis Centre2, Royal Liverpool University  Hospital, Liverpool, United Kingdom Systemically sustained thrombin generation in vivo  is the hallmark of disseminated intra - vascular coagulation (DIC).",Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
Diagnosis of DIC 506  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.505DIC as “an acquired syndrome characterized by intravascular  activation of coagulation with loss of localization arising from dif - ferent causes.,Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
Diagnosis of DIC http://dx.doi.org/10.3343/alm.2016.36.6.505 www.annlabmed.org  5071.,Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
Diagnosis of DIC 508  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.505multiple sites.,OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
"Diagnosis of DIC http://dx.doi.org/10.3343/alm.2016.36.6.505 www.annlabmed.org  509oratories where PT in seconds is not reported, the international  normalized ratio (INR) could provide reliable information [45].",Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
Diagnosis of DIC 510  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.505and D-dimer provide sufficient robustness without needing PC or  AT levels [39].,Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
Diagnosis of DIC http://dx.doi.org/10.3343/alm.2016.36.6.505 www.annlabmed.org  51113.,Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
Diagnosis of DIC 512  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.50575-9.,Non-OADS,/arxiv_data1/oa_pdf/a1/91/alm-36-505.PMC5011102.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.513 www.annlabmed.org  513Ann Lab Med 2016;36:513-520 http://dx.doi.org/10.3343/alm.2016.36.6.513Review Article Diagnostic Genetics Development and Characterization of Reference  Materials for Genetic Testing: Focus on Public  Partnerships Lisa V. Kalman, Ph.D.1, Vivekananda Datta, M.D.2, Mickey Williams, Ph.D.2, Justin M. Zook, Ph.D.3, Marc L. Salit, Ph.D.3,   and Jin-Yeong Han, M.D.4 Centers for Disease Control and Prevention1, Atlanta, GA, USA; Frederick National Laboratory for Cancer Research2, National Cancer Institute, Gaithersburg,  MD, USA; National Institute of Standards and Technology3, Gaithersburg, MD, USA; Department of Laboratory Medicine4, Dong-A University College of  Medicine, Busan, Korea Characterized reference materials (RMs) are needed for clinical laboratory test develop - ment and validation, quality control procedures, and proficiency testing to assure their  quality.",Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
Reference materials for genetic testing 514  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.513gene.,OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
Reference materials for genetic testing http://dx.doi.org/10.3343/alm.2016.36.6.513 www.annlabmed.org  5153.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
"Reference materials for genetic testing 516  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.513on the AJ Panel [29] (Bloom syndrome, Canavan disease, Fan - coni anemia, familial dysautonomia, Gaucher disease, mucolipi - dosis IV, Niemann Pick disease and Tay Sachs disease), cystic  fibrosis [26], Huntington disease [27], methylenetetrahydrofo - late reductase ( MTHFR )-related homocysteinemia, α1-antitrypsin  deficiency, multiple endocrine neoplasia, BRCA1 - and 2-related  cancers [28], Duchenne muscular dystrophy [30], myotonic  dystrophy [31], Rett syndrome [32], and two large-scale DNA  studies from 244 cell lines for a number of polymorphisms in  28 pharmacogenetic loci [33, 34].",Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
"Reference materials for genetic testing http://dx.doi.org/10.3343/alm.2016.36.6.513 www.annlabmed.org  517differences in SNP, indels, or copy number variants were de - tected among DNA samples sequenced.",OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
Reference materials for genetic testing 518  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.513regions included in assays to allow for the calculation of false  positive and negative rates.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
"Reference materials for genetic testing http://dx.doi.org/10.3343/alm.2016.36.6.513 www.annlabmed.org  519quencing chemistries, platforms, and bioinformatics pipelines  [42].",OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
"National Institutes of Standards and Technology (NIST), RM 8398.  https://www-s.nist.gov/srmors/view_detail.cfm?srm=8398 (Updated in  2015).",OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
https://www.iso.org/ obp/ui/#iso:std:iso:guide:30:ed-3:v1:en.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://www.nist.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://www.erm-crm.org/ (Updated on Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://wwwn.cdc.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
Reference materials for genetic testing 520  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.513gov/clia/Resources/GetRM/pdf/HigherOrderGeneticRMsTableWebsite.,OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://www.cap.org/apps/cap.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://www.ncbi.nlm.nih.gov/gtr/ 23.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://wwwn.cdc.gov/clia/ Resources/GetRM/ (Updated on Mar 2015).,OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
https://catalog.coriell.org/ 25.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
Personal Genome Project: Harvard- http://www.personalgenomes.org/ 36.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://www.ncbi.nlm.nih.gov/variation/tools/get- rm.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
http://cancer.sanger.ac.uk/cosmic.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/alm-36-513.PMC5011103.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.521 www.annlabmed.org  521Ann Lab Med 2016;36:521-528 http://dx.doi.org/10.3343/alm.2016.36.6.521Original Article Clinical Chemistry Comparing Results of Five Glomerular Filtration Rate- Estimating Equations in the Korean General  Population: MDRD Study, Revised Lund-Malm ӧ, and  Three CKD-EPI Equations Misuk Ji, M.D.1,*, Yoon-Hee Lee, M.T.2,*, Mina Hur, M.D.3, Hyesun Kim, M.T.2, Han-Ik Cho, M.D.2, Hyun Suk Yang, M.D.4,  Silvia Navarin, M.D.5, and Salvatore Di Somma, M.D.5; on Behalf of GREAT Network Department of Laboratory Medicine1, Veterans Health Service Medical Center, Seoul; Korea Association of Health Promotion2, Seoul; Departments of  Laboratory Medicine3 and Cardiovascular Medicine4, Konkuk University School of Medicine, Seoul, Korea; Department of Medical Sciences and Translational  Medicine5, University of Rome Sapienza, Sant’Andrea Hospital, Rome, Italy Background:  Estimated glomerular filtration rate (eGFR) is a widely used index of kidney  function.",OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
"Comparison of five eGFRs 522  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.521tion was derived from subjects with CKD, and had the limitation  of systematically underestimating GFR in healthy individuals  with GFR ≥60 mL/min/1.73 m2 [8, 9].",Non-OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
Comparison of five eGFRs http://dx.doi.org/10.3343/alm.2016.36.6.521 www.annlabmed.org  523structions and standard laboratory procedures.,OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
Comparison of five eGFRs 524  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.521Table 2.,OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
Comparison of five eGFRs http://dx.doi.org/10.3343/alm.2016.36.6.521 www.annlabmed.org  525age groups.,OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
Comparison of five eGFRs 526  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.521pared with the MDRD Study equation; these two equations  showed a very high correlation and a similar prevalence of re - duced GFR.,OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
"Comparison of five eGFRs http://dx.doi.org/10.3343/alm.2016.36.6.521 www.annlabmed.org  527Cr-CysC (5%) and eGFR CKD-EPI CysC  (4.7%) in 4,189 Belgian patients  over 50 yr old.",OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
Comparison of five eGFRs 528  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.521Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
http://www.kdigo.org/clinical_practice_guidelines/pdf/ CKD/KDIGO_2012_CKD_GL.pdf (Updated on Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
http://www.cap.,Non-OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
Kidney Inter (Suppl) 2012;2:1-138. http://www.kdigo.org/clinical_ practice_guidelines/pdf/KDIGO%20AKI%20Guideline.pdf (Updated on  Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/48/4a/alm-36-521.PMC5011104.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.529 www.annlabmed.org  529Ann Lab Med 2016;36:529-535 http://dx.doi.org/10.3343/alm.2016.36.6.529Original Article Clinical Microbiology Prevalence and Molecular Characteristics of  Carbapenemase-Producing Enterobacteriaceae  From  Five Hospitals in Korea Seok Hoon Jeong, M.D.1, Han-Sung Kim, M.D.2, Jae-Seok Kim, M.D.2, Dong Hoon Shin, M.D.2, Hyun Soo Kim, M.D.2,   Min-Jeong Park, M.D.2, Saeam Shin, M.D.2, Jun Sung Hong, B.S.3, Seung Soon Lee, M.D.4, and Wonkeun Song, M.D.2 Department of Laboratory Medicine and Research Institute for Antimicrobial Resistance1, Yonsei University College of Medicine, Seoul; Departments of  Laboratory Medicine2 and Internal Medicine4, Hallym University College of Medicine, Chuncheon; Brain Korea 21 PLUS Project for Medical Science3, Yonsei  University College of Medicine, Seoul, Korea Background:  The emergence of carbapenemase-producing Enterobacteriaceae  (CPE)  represents a major clinical problem because these bacteria are resistant to most antibiot - ics.",Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
"Carbapenemase-producing Enterobacteriaceae  in Korea 530  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.529lactamases (New Delhi metallo- β-lactamase [NDM], imipene - mase [IMP], and Verona integron-encoded metallo- β-lactamase  [VIM]), and class D β-lactamases (oxacillinase [OXA]-48).",Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
"For tigecycline  and colistin, the European Committee for Antimicrobial Suscep - tibility Testing (EUCAST) criteria (http://www.eucast.org/clinical_ breakpoints, January 2014) were used.",Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
"Statistical analysis All calculations were performed using R software, version 3.2.4  (R Development Core Team 2016; http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
Carbapenemase-producing Enterobacteriaceae  in Korea http://dx.doi.org/10.3343/alm.2016.36.6.529 www.annlabmed.org  531RESULTS 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
"Carbapenemase-producing Enterobacteriaceae  in Korea 532  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.529of them were resistant to all cephalosporins, aztreonam, ertape - nem, meropenem, and ciprofloxacin, but the imipenem resis - tance rate was 69% (Table 4).",OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
Carbapenemase-producing Enterobacteriaceae  in Korea http://dx.doi.org/10.3343/alm.2016.36.6.529 www.annlabmed.org  533Table 4.,Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
Carbapenemase-producing Enterobacteriaceae  in Korea 534  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.5291.4% to 4.2% [12].,Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
Carbapenemase-producing Enterobacteriaceae  in Korea http://dx.doi.org/10.3343/alm.2016.36.6.529 www.annlabmed.org  535losporins and can be susceptible or resistant to carbapenems  [6].,Non-OADS,/arxiv_data1/oa_pdf/ef/8d/alm-36-529.PMC5011105.pdf
"ISSN 2234-3806 • eISSN 2234-3814  536  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.536Ann Lab Med 2016;36:536-541 http://dx.doi.org/10.3343/alm.2016.36.6.536Original Article Clinical Microbiology Prevalence of Major Methicillin-Resistant  Staphylococcus aureus  Clones in Korea Between 2001  and 2008 Gi Su Kang, M.S., Yung Hee Jung, Ph.D., Hwa Su Kim, Ph.D., Yeong Seon Lee, Ph.D., Chan Park, Ph.D.,   Kwang Jun Lee, Ph.D., and Jeong Ok Cha, Ph.D. Division of Antimicrobial Resistance, Center for Infectious Disease, National Research Institute of Health, Centers for Disease Control and Prevention (KCDC),  Cheongju, Korea  Background:  Methicillin-resistant Staphylococcus aureus  (MRSA) are important patho - gens causing nosocomial infections in Korean hospitals.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
Prevalence of epidemic MRSA in Korea http://dx.doi.org/10.3343/alm.2016.36.6.536 www.annlabmed.org  537vided a basis for the identification of toxic genes in these clones.,Non-OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
"Prevalence of epidemic MRSA in Korea 538  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.536guishable, similar, or different according to bands interpreted  using the DL analysis guide (software version 3.4).",OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
Prevalence of epidemic MRSA in Korea http://dx.doi.org/10.3343/alm.2016.36.6.536 www.annlabmed.org  539as KMRSA-8.,Non-OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
"Prevalence of epidemic MRSA in Korea 540  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.536throughout most of the country, including Seoul and Gyeonggi- do Province.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
"Prevalence of epidemic MRSA in Korea http://dx.doi.org/10.3343/alm.2016.36.6.536 www.annlabmed.org  541tics of an HA-MRSA of SCC mec III type with the staphylococcal  enterotoxin genes sea and seb, and the other showed molecular  characteristics of a CA-MRSA of SCC mec IV type with the  staphylococcal enterotoxin genes seg and sei.",OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
"Antibiotic resistance  threats in the United States, 2013. http://www.cdc.gov/drugresistance/ threat-report-2013/ (Updated on Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/alm-36-536.PMC5011106.pdf
